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ABSTRACT
The reciprocally connected GABAergic external globus pallidus (GPe) and glutamatergic 
subthalamic nucleus (STN) occupy pivotal positions in cortico-basal ganglia-thalamo-
cortical networks essential for normal voluntary movement. In both idiopathic and 
experimental PD characterized by degeneration of midbrain dopamine neurons, the 
GPe and STN exhibit hypo- and hyper-activity, respectively, and hypersynchronous 
rhythmic burst firing (<30 Hz). Deep brain stimulation (DBS) of STN (>60 Hz) 
suppresses the pathological oscillations and improves motor impairments, although the 
therapeutic mechanisms are unclear. Given the GPe potently patterns STN activity, the 
decorrelated nature of GPe–STN network is intriguing. Therefore, the main objective 
of this thesis is to study the regulation of GPe–STN input in health, PD and DBS, 
using complementary anatomical, molecular, electrophysiological and computational 
modelling approaches.
 Studies comparing GPe–STN transmission in control and 6-OHDA-lesioned 
rodents revealed that following chronic dopamine depletion the GPe–STN projections 
strengthened remarkably through proliferation in the number of functional synaptic 
connections. The enhanced GPe–STN transmission is predicted to increase the 
capability of the GPe to generate synchronous rhythmic burst firing in the parkinsonian 
STN.
 Recent optogenetic studies showed that high-frequency driving of afferents 
expressing channelrhodopsin-2 (ChR2) in the STN of Thy1-ChR2 transgenic mice 
rescued parkinsonian symptoms. Characterization of the mouse line revealed ChR2 
expression in not only glutamatergic but GABAergic afferents in the STN, implying DBS 
may exert its therapeutic effects through manipulation of GPe–STN transmission.
 The work from this thesis also demonstrates that GABAergic inhibition in STN 
neurons activates HCN channel currents that limit synaptic hyperpolarisation and 
deinactivation of low-voltage-activated Ca2+ channels, hence reducing the propensity 
of rebound burst firing. Uniform HCN channel distribution across the somatodendritic 
axis most effectively counteracts the GABAergic inhibition. These results suggest that 
HCN channels in STN neurons may partly underlie the decorrelated nature of GPe–
STN activity and prevent excessive burst firing observed in PD.
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1CHAPTER 1
GENERAL INTRODUCTION
21.1. Introduction to the basal ganglia
The basal ganglia are a group of interconnected subcortical nuclei crucial for the 
fundamental processes of action selection and reinforcement. Basal ganglia nuclei in 
primates include the striatum, external segment of the globus pallidus (GPe, homologous 
to globus pallidus or GP in rodents), internal segment of the globus pallidus (GPi, 
homologous to entopeduncular nucleus or EP in rodents), the subthalamic nucleus 
(STN) and the substantia nigra, consisting of the pars compacta (SNc) and the pars 
reticulata (SNr).
 The basal ganglia receive external inputs primarily via the striatum (and 
to a lesser extent the STN and SNc). The striatum receives direct excitatory inputs 
from the cerebral cortex, limbic structures, and indirect inputs from the brainstem 
structures through the thalamus. It then relays signals, via direct and indirect routes, 
to the principal output nuclei, GPi and SNr. The output nuclei project directly to the 
thalamus, midbrain and brainstem structures, and indirectly, through the thalamus, to 
cortical and limbic regions from which the basal ganglia inputs originated (Redgrave et 
al., 1992; Smith et al., 2004; Takakusaki et al., 2004).
 The arrangement of these connections can be viewed as a series of parallel 
projecting re-entrant circuits that are partially segregated (Redgrave et al., 2011). The 
spatial segregation between the loops is determined by the functional status of inputs: 
the ventral territories receive information from brain areas primarily involved in limbic 
functions, the dorsomedial territories from structures concerned with associative 
functions, and dorsolateral territories from brain regions involved in sensorimotor 
control of behaviour (Alexander et al., 1986). This unique architecture is maintained 
throughout the basal ganglia nuclei in a topographic manner. Although the internal 
microcircuits of the basal ganglia nuclei are of certain quantitative differences, each of 
the structure is qualitatively similar across the different functional zones. It is therefore 
proposed that similar input-output computations are applied to the vastly different 
functional signals (Redgrave et al., 1999; Redgrave et al., 2011).
 Motor and non-motor regions of the basal ganglia differ mainly by their 
external connections, whereas the intrinsic connections within the basal ganglia are 
3the same for these circuits. In a simplistic view of the motor circuit, the basal ganglia 
receive information from the cerebral cortex and provide feedback input back to the 
cortex through the thalamus, forming a closed loop. The information flow through the 
basal ganglia is modulated by dopamine released from dopaminergic neurons in the 
SNc. Historically, the sensorimotor aspect of the basal ganglia has been receiving the 
most attention because its loss of function leads to debilitating movement disorders, 
including Parkinson’s disease (PD), Huntington’s disease (HD), hemiballismus and 
dystonia (Delong, 1990; Albin et al., 1995).
 Because the architecture of the basal ganglia and their connections with the 
external structures have largely been conserved almost throughout the evolution of 
vertebrates (Stephenson-Jones et al., 2011; Stephenson-Jones et al., 2012), studies 
on rodent and primate models have provided important insights on the function and 
dysfunction of the basal ganglia in humans. To simplify the terminology used in this 
thesis, the term “GPe” will not only refer to that structure in primates but also include its 
homologous equivalent, GP in rodents. Likewise the term “GPi” will include reference 
to its rodent equivalent, EP.
1.2. Disease of the basal ganglia
Many movement disorders have origins in basal ganglia dysfunction. Three broad 
categories of these disorders are hyperkinetic (eg. HD), hypokinetic (eg. PD), and 
dystonia. The focus in this thesis is the pathophysiology of PD, which hence will be 
further described in this section.
1.2.1. Parkinson’s disease
PD is the most common type of basal ganglia disorder, affecting 1-2% percent of people 
older than 65 years old. On a worldwide basis, approximately 10 million people are 
affected by PD. Because of the aging population, it is predicted that by the year 2020 
over 40 million people in the world will have this debilitating neurodegenerative 
4condition (Morris, 2000). It is clinically characterised by motor disabilities including 
muscle stiffness (rigidity), poverty of movement (akinesia), slowness of movement 
(bradykinesia), tremor at rest, postural instability and gait disturbance (Samii et al., 
2004). These symptoms manifest when more than 60% of dopaminergic neurons in 
the SNc degenerate (Dauer and Przedborski, 2003). The mechanisms of dopamine 
cell death are not exactly clear, but the main contributing molecular factors might be 
aberrant proteostasis (aggregation of α-synuclein), impaired mitochondrial function, 
oxidative stress, and/or perturbed Ca2+ homeostasis (Dawson and Dawson, 2003; 
Mattson, 2007; Henchcliffe and Beal, 2008; Surmeier et al., 2011).
 Because of  the  obscurity  of  molecular  events  leading  to neurodegeneration, 
a gold standard for treating PD patients has been dopamine replacement therapy using 
the prodrug levodopa. However, long-term drug use leads to the development of motor 
complications in up to 80% of patients (Thanvi and Lo, 2004). For patients who no 
longer respond to levodopa treatment, there have been efforts focused on fetal nerve 
cell transplantation into the SNc to replace the lost dopamine cells. Unfortunately the 
relief of motor symptoms often last only several years due to the spread of PD pathology 
to the grafted cells (Mendez et al., 2008; Kordower et al. 2008; Li et al., 2008).
 For the last two decades, deep brain stimulation has emerged as an effective 
treatment for advanced PD patients. It is a technique used in functional neurosurgery, 
which involves delivery of high-frequency electrical stimulation through implanted 
electrodes into the STN (and less commonly the GPi). Acute and chronic DBS results 
in a dramatic and stable improvement of motor symptoms (Benabid, 2003). However, 
the therapeutic mechanisms of DBS are still not clearly defined. The understanding 
of basal ganglia functions in health and PD is therefore important to improve current 
treatment efficacy and/or to devise new mechanism-based functional therapies.
 The progress in this field of research was hastened by the development of 
animal models carrying disease conditions. In particular, the use of dopamine-depleted 
models, including 6-hydroxydopamine (6-OHDA)-treated rodents, and the 1-methyl-4-
phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated primates has remarkably improved 
our understanding of the underlying aberrations leading to motor symptoms of PD.
51.3.	Information	flow	through	the	basal	ganglia
The striatum is the main structure that receives glutamatergic cortical input in the basal 
ganglia. In the nucleus, this information is processed by a striatal network consisting 
of 90% gamma-aminobutyric acid-(GABA)ergic medium spiny neurons (MSNs) and 
10% interneurons (Kreitzer, 2009). The output nuclei of the basal ganglia are the GPi 
and SNr, both of which express mainly GABAergic neurons and are often considered 
as one functional unit due to their anatomical and physiological similarities (Deniau 
et al., 2007; Nambu, 2007). Based on findings from post mortem human anatomical 
and neurochemical studies and experimental models of basal ganglia disease, a model 
of information flow through the basal ganglia that accounts for normal and abnormal 
motor function has been constructed (Albin et al., 1989; Delong, 1990).
1.3.1. Classical model of direct and indirect pathways
According to the direct/indirect model of the basal ganglia motor circuit, the intrinsic 
basal ganglia connections are divided into two pathways based on projections of the 
MSNs consisting of 2 subpopulations of similar size: neurons that express D1 dopamine 
receptors (D1-MSNs) and those that express D2 dopamine receptors (D2-MSNs). D1-
MSNs that predominantly project to the GABAergic GPi/SNr neurons, which tonically 
inhibit the thalamus, constitute the direct pathway; D2-MSNs that preferentially project 
to the GABAergic GPe neurons, which innervate the glutamatergic STN neurons that 
project to the GPi/SNr, constitute the indirect pathway (Albin et al., 1989; Fig. 1). The 
striatum is heavily innervated by dopaminergic projections from the SNc. Dopamine 
release exerts an excitatory effect on the D1-MSNs through activation of D1 receptors, 
and an inhibitory effect on the D2-MSNs due to activation of D2 receptors. When D2-
MSNs are activated, GPe neurons are inhibited, thereby disinhibiting the STN that 
excites the GPi/SNr. As a result motor signals are inhibited in the thalamus.  When D1-
MSNs are activated, GPi/SNr neurons are inhibited, hence disinhibiting thalamus that 
feeds back the motor signals to the cortex. Therefore, activation of the direct pathway 
6Figure 1. Schematic diagram of the direct/indirect pathway model of the cortico-basal ganglia thalamo-cortical motor circuitry and additional connections not considered by the model. Excitatory glutamatergic projections are shown as red arrows, while inhibitory GABAergic projections are indicated by blue arrows.A. According to the direct/indirect pathway model, cortical signals sent to the striatum during movement is relayed to the basal ganglia output nuclei GPi and SNr via two pathways: direct and indirect. Striatal projection neurons that express D1 dopamine receptors (D1-MSNs) predominantly project to the GPi, which tonically inhibits the thalamus, constituting the direct pathway; MSNs that express D2 dopamine receptors (D2-MSNs) preferentially project to the GPe, which innervates the STN that projects to the GPi, constituting the indirect pathway. The dopamine projections (yellow arrows) from the substantia nigra pars compacta (SNc) regulate the corticostriatal information through dopamine opposing actions on D1- and D2-MSNs: dopamine activation of D1 receptors excites D1-MSNs, whereas D2 receptor activation inhibits D2-MSNs. When D1-MSNs are excited, GPi neurons are inhibited, hence disinhibiting thalamus that feeds back the motor signals to the cortex. When D2-MSNs are inhibited by dopamine, GPe neurons are disinhibited, thereby inhibiting STN that excites the GPi. As a result motor signals are also disinhibited in the thalamus. Therefore, dopamine signals promote movement by both upregulating and suppressing the direct and indirect pathway activities, respectively.B. In Parkinson’s disease, loss of dopaminergic neurons in the SNc causes imbalance of the direct and indirect pathway activities favouring the latter. Hence, the excitatory direct pathway becomes hypoactive, whereas the inhibitory indirect pathway is hyperactive, leading to the lack of motor movement generation. The relative increase and decreases in activity are represented by thickening or thinning of arrows, respectively, in comparison to A. Imbalanced direct/indirect pathways overall lead to the hyperactivity of GPi/SNr, which therefore excessively inhibits activity of thalamus. Excessive thalamic inhibition in turn suppresses the motor system in cortex, leading to motor impairment including akinesia and bradykinesia. Excessive inhibition of midbrain and/or brainstem locomotor regions by GPi/SNr may give rise to gait and posture abnormalities.
C. Recent studies have emphasised on the functional significance of several additional 
connections that challenge the role of direct/indirect pathway model in information flow through the cortico-basal ganglia thalamo-cortical network. Notably, direct projection from the cortex to the STN contradicts with the direct/indirect pathway model that is centered by striatal activity, hence acquired the term “hyperdirect” pathway. Additionally, the STN innervated by inhibitory GPe projects feedforward excitation back to the GPe, hence forming reciprocal connections between the nuclei. The existence of STN–GPe network contradicts the notion that STN is simply a relay station in the feedforward scheme of information 
flow explained by the classical model. STN, along with the GPe, also receives substantial dopaminergic innervations by SNc neurons, supporting the growing evidence that dopamine 
neuromodulation in the basal ganglia is far more complex than net activity influence on D1- 
and D2-MSNs. Note that this diagram is still a simplification as a number of other connections 
identified are not shown, some of which have also been implicated in PD pathophysiology. 
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8stimulates movement, whereas activation of the indirect pathway inhibits movement. 
SNc, another major input nucleus in the basal ganglia, integrates inputs from a 
diverse collection of areas including sensorimotor cortices and brainstem structures 
and conveys motivational signals through phasic dopaminergic neurotransmission 
(Matsumoto and Hikosaka, 2009; Watabe-Uchida et al., 2012). The general impact of 
dopamine action within the striatum might be to modulate cortical signals to balance 
the activity of the direct and indirect pathways for appropriate voluntary movement.
1.3.2. Dysfunction of direct/indirect pathways in PD
The excitatory balance between the two pathways in response to direct cortical 
inputs is modulated by dopamine, such that dopamine released from SNc afferents 
acting on D1- and D2-MSNs activates and inhibits the direct and indirect pathways 
respectively. According to this model, the loss of dopamine results in the imbalance 
of direct and indirect pathway favouring the latter (Fig. 1). Thus, the excitatory direct 
pathway becomes hypoactive, whereas the inhibitory indirect pathway is hyperactive, 
leading to the lack of motor movement. Imbalanced direct/indirect pathways lead 
to hyperactivity of GABAergic GPi/SNr neurons, which therefore excessively inhibit 
activity in the thalamus. Excessive thalamic inhibition in turn suppresses the motor 
system in the cortex, presumably leading to motor impairments including akinesia and 
bradykinesia (Drouot et al., 2004). On the other hand, excessive inhibition of midbrain 
and/or brainstem locomotor regions by GPi/SNr may instead give rise to gait and 
posture abnormalities (Takakusaki et al., 2008).
 A considerable body of studies has shown that changes in the mean firing 
rates in GPe, STN, GPi and SNr in PD and PD models (predominantly MPTP-treated 
primates) are consistent with those predicted by the direct/indirect pathways (Filion 
and Tremblay, 1991; Boraud et al., 1998; Drouot et al., 2004). Thus, GPe activity may 
be reduced by 30% while STN and GPi activity may be increased by 40% and 25%, 
respectively (Galvan and Wichmann, 2008). D1 and D2 receptor antagonisms induce 
an imbalance of direct/indirect circuits in favour of the indirect pathway (Degos et al., 
2005). An increase in neuronal firing rate in STN was reported to correlate with PD 
progression, implying its role in the manifestation of symptoms (Remple et al., 2011). 
The overactivation of the indirect pathway in PD is also consistent with improvement 
9of motor symptoms after lesioning of the STN or GPi, and exacerbation of symptoms 
after lesioning of GPe (Aziz et al., 1991; Baron et al., 1996; Patel et al., 2003; Zhang 
et al., 2006). Recent optogenetic studies in mice further demonstrated that specific 
photostimulation of the direct-pathway MSNs increased locomotion, whereas activation 
of the indirect-pathway MSNs suppressed movements (Kravitz et al., 2010). 
 These above-mentioned results, nonetheless, do not establish a causative 
relationship between aberrant firing rates in basal ganglia nuclei and motor 
impairments. Additionally, there have been other reports demonstrating a lack of firing 
rate changes after MPTP administration in primates (Bergman et al., 1994; Raz et al., 
2000; Wichmann et al., 1999). The direct/indirect pathway model is inconsistent with 
the therapeutic effects of stimulating STN and GPi at high frequency. It is, likewise, 
paradoxical that GPi activity in PD and HD patients was found to be similar (Tang et 
al., 2005).
 Therefore, changes in the mean firing rates in the direct and indirect pathways 
might not be necessary for parkinsonism, although they should not be overlooked as an 
important component of PD pathophysiology. The classical model has had substantial 
impact on our understanding of the way basal ganglia organise motor behaviour and 
provided a basic framework for our investigations into the basal ganglia dysfunctions 
in movement disorders.
 However, the model is oversimplistic considering the intricacy of intrinsic basal 
ganglia connections. Many additional connections have not been considered by the 
model. First and foremost, dopaminergic modulation of the striatum is far more complex 
than postsynaptic influence on D1- and D2-MSNs. Striatal circuitry, a network of not 
just MSNs but various classes of interneurons, is dynamically regulated by dopamine 
via other types of dopamine receptors besides D1 and D2 expressed in MSNs, the 
expression of pre and postsynaptic dopamine receptors in striatal interneurons, and 
D2-class autoreceptors on dopamine terminals (Surmeier et al., 2011). Furthermore, 
dopamine modulation does not occur only at the level of striatum, but is found in the 
GPe (Fallon and Moore, 1978; Lindvall and Björklund 1979; Cossette et al., 1999) and 
STN (François et al., 2000; Cragg et al., 2004).
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 Notably, a second port of external input entry to the basal ganglia is overlooked: 
the direct projection from the cortex to the STN (Monakow et al., 1978; Kitai and 
Deniau, 1981; Bevan et al., 1995). Direct cortical-STN connection has been termed the 
“hyperdirect” pathway, reflecting its contradiction with the direct/indirect pathway 
model that is centered by striatal activity. Many of the STN neurons that receive GPe 
innervations also project back to the GPe, forming a unique reciprocal GPe–STN 
circuitry (Moriizumi et al., 1987; Groenewegen and Berendse et, 1990; Shink et al., 
1996). The existence of STN–GPe network contradicts the notion that STN is simply a 
relay station in the feedforward scheme of information flow explained by the classical 
model.
 Indeed, the activity of the cortico-basal ganglia thalamo-cortical network is 
more complicated than bidirectional changes in firing rates. A great amount of work 
has demonstrated that a range of oscillatory phenomena also exists in the network. 
Although the frequency of activity is likely crucial for basal ganglia function, activity 
pattern and synchronisation of neuronal discharge may be at least equally significant. 
The often dramatic effectiveness of DBS and the availability of data from PD patients 
during electrode implantation have turned our attention focus on the pathological role 
of oscillatory activity in the basal ganglia.
1.4. Oscillatory activity in the basal ganglia
The term “oscillation”, in this thesis, refers to rhythmically recurring neuronal activities 
within and/or between neuronal structures, or rhythmic fluctuations of membrane 
potential recorded from single neurons. Various oscillatory phenomena occur in the 
basal ganglia and in related regions of the thalamus and cortex. Autonomous activity 
of GPe and STN neurons may also represent important sources of oscillatory activity in 
the cortico-basal ganglia-thalamocortical networks. The ionic mechanisms of intrinsic 
pacemaking in STN neurons, the main sources of oscillatory activity (except potential 
contributions from thalamic input which has not been explored in detail) in the basal 
ganglia and the role of abnormal oscillatory activity in PD pathophysiology will be 
discussed in this section.
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1.4.1. Intrinsic pacemaking mechanisms of STN neurons
In slice recordings, most STN neurons tonically discharge at 5–15 Hz. AP initiation is 
driven autonomously by persistent and resurgent Nav channels at the soma and axon 
initial segment (Atherton et al., 2008).The spontaneous firing is highly regular, due to 
the presence of small-conductance apamine-sensitive Ca2+-dependent K (SK) channels 
that underlie the medium duration component of AP afterhyperpolarisation. SK 
current is activated by Ca2+ influx through Cav2.2 channels during depolarisation phase 
of action potential (AP) (Ramanathan et al., 2008). Besides Cav2.2 channels, Cav1.2–1.3 
and Cav3 channels are also present in almost all STN neurons, but remain inactivated 
during autonomous firing (Bevan and Wilson, 1999; Song et al., 2000; Hallworth et al., 
2003). Prolonged hyperpolarisation to – 80 mV leads to their deinactivation, leading 
to a rebound burst firing upon repolarization. During sustained hyperpolarisation, an 
inward, non-inactivating, non-selective cation current (Ih) mediated by HCN channels 
is activated (Bevan and Wilson, 1999; Beurrier et al., 2000), although they participate 
minimally in autonomous firing of STN neurons.
1.4.2. Oscillations in the GPe–STN network
Because of its reciprocal connectivity, the GPe–STN network has received a lot of 
attention as a potential pacemaker in the basal ganglia. The strongest supporting 
evidence comes from Plenz and Kitai (1999) who demonstrated that coculture of 
GPe and STN neurons in vitro spontaneously produces slow, synchronised bursting 
activity (<5 Hz). The generation of synchrony in the GPe–STN circuitry depends 
largely on the ability of STN neurons to generate rebound burst firing in response to 
strong hyperpolarised GABAergic input from the GPe neurons (Bevan et al., 2006). 
The rebound burst amplifies the feedback glutamatergic STN–GPe input and hence 
subsequent pallidal activity, thus generating and sustaining a sequence of inhibitory 
postsynaptic potential (IPSP) and rebound burst events in the STN. Similar IPSP-
rebound sequence of feed-forward/feed-back interactions between the STN and GPe 
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have been observed in absence epileptic seizures (7–10 Hz). However, there is no 
evidence thus far of such oscillatory interactions in vivo or in native preparations with 
preserved GPe–STN connectivity under normal conditions. 
1.4.3. Oscillatory interaction between cortex and STN
As the only extrastriatal basal ganglia structure receiving direct cortical input, STN in 
rodents and primates has been shown to be coherent with cortical activity (EcoG) under 
various brain states. This is true both when cortical synchronisation is widespread (eg. 
under slow-wave sleep and anaesthetised conditions), or reduced in awake state due 
to increased somatotopic activity within/between the structures and broader spectral 
power of activity (Magill et al., 2000; Urbain et al., 2000; Wichmann et al., 2002; 
Magill et al., 2004; Magill et al., 2005; Sharott et al., 2005a; Gatev et al., 2006). In 
urethane-anaesthetised rats exhibiting cortical SWA, simultaneous EcoG and STN 
single-unit or LFP recordings showed that coherence between the cortex and the STN 
is restricted to slow (~ 1 Hz) and spindle (7–12 Hz) frequency oscillations (Magill et 
al., 2005). The rhythm entirely relies on cortical input, because cortical ablation or 
depression leads to single spike firing in the STN and GPe (Magill et al., 2000), which 
is similar to that observed in slice preparations where cortical innervations of the STN 
are mostly severed. 
1.4.4. Oscillatory interaction between cortex and striatum
The significant reentrant connectivity between the cortex and the basal ganglia has been 
shown to be a major contributor to the oscillatory activity observed in the basal ganglia. 
As mentioned previously, the striatum receives massive direct inputs from the cortex. 
Simultaneous electrocorticogram (ECoG) and in vivo intracellular, single unit or local 
field potential (LFP) recordings in the striatum demonstrated that striatal activity can 
be heavily influenced by cortical oscillatory inputs (Tseng et al., 2001a; Courtemanche 
et al., 2003; Berke et al., 2004). D1- and D2-MSN subtypes, which display nearly 
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identical intrinsic physiological properties, both exhibit “up” and “down” states. Up 
states are caused by synchronous upward membrane fluctuations of corticostriatal 
neurons. The depolarised membrane potential is important for AP discharge in the 
MSNs. Taking advantage of the cortical slow wave activity (SWA, similar to natural 
sleep waves) of urethane-anaesthetised rats, the up and down states of MSNs were 
shown to correlate tightly with the cortical oscillations (Tseng et al., 2001a). However, 
these neurons often do not fire APs even during up states owing to strong GABAergic 
inhibition from MSN collaterals and fast-spiking interneurons.
1.5. Excessive synchrony in PD
An increased tendency of basal ganglia neurons at multiple levels to fire in a 
synchronised oscillatory manner at low frequencies has been well documented in both 
PD patients and models. Currently, a leading view on the development of this disorder 
is that pathological oscillatory activity in the cortico-basal ganglia-thalamocortical 
networks interferes with the normal information coding in the basal ganglia, leading 
to the manifestation of motor symptoms in parkinsonism.
1.5.1. Observations in idiopathic and experimental PD
The excessive synchrony is largely observed in the extrastriatal basal ganglia 
structures. Under resting condition, STN, GPe, and GPi neurons fire at high frequency 
in distinct patterns, with minimal rhythm or correlations within or between the nuclei. 
During movement, the structures display complex somatotopically organised activity 
pattern with higher degree of synchronisation in functionally related territories. In 
PD, activity within and across the nuclei becomes correlated and rhythmic, with the 
loss of spatiotemporal patterns of somatotopical activity and increased bursting. LFP 
recordings from implanted DBS electrodes in STN or GPi of PD patients reveal coherent 
activity in the 8–12 Hz (delta), 13–30 Hz (beta) and 4–7 Hz (tremor) bands (Brown 
et al., 2007). These activity patterns are associated with different symptoms and may 
arise from distinct processes. While delta and beta band activity are highly correlated 
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with akinesia, bradykinesia and rigidity (Kühn et al., 2009), tremor band activity is 
associated with resting tremor. Additionally, tremor is not tightly correlated with the 
degree of dopamine loss like the other symptoms and is not developed in some PD 
patients (Hammond et al., 2007; Zaidel et al., 2009; Helmich et al., 2011). 
 Excessive widespread synchronisation is also observed in primates where 
parkinsonism is induced by neurotoxin MPTP treatment, although occurring at lower 
frequencies than in human patients. Coherent bursting of single cells in GPe, STN and 
GPi is typically around 3–8 Hz band and 8–15 Hz band (Gatev et al., 2006; Hammond 
et al., 2007). The lower frequencies could be attributed to more severe parkinsonian 
syndrome associated with MPTP treatment in primate models. However, in rodent 
PD models generated by unilateral midbrain lesioning with 6-OHDA, the enhanced 
oscillatory activity seen in the extrastriatal basal ganglia LFPs occurs at frequencies 
similar to those observed in PD patients (Sharott et al., 2005b; Mallet et al., 2008a).
1.5.2. Correlation with motor impairments
A substantial body of evidence indicates that the excessive beta band synchrony is 
particularly anti-kinetic. First, dopamine replacement therapy or high-frequency 
STN stimulation (>60 Hz in DBS) leads to the suppression of synchronised beta band 
activity, which correlates with the degree of motor symptom improvements (Benabid, 
2003; Kühn et al., 2006; Kühn et al., 2008). Likewise, lesioning of the STN, a common 
PD treatment before being replaced by high-frequency stimulation (HFS), is shown 
to reduce synchronised burst firing (Ryan and Sanders, 1993; Burbaud et al., 1995; 
Ni et al. 2000; Tseng et al., 2001b). Moreover, the distribution of beta band activity 
in the STN is concentrated in the motor territories (Weinberger et al., 2006). The fact 
that low-frequency (<30 Hz) stimulation (LFS) of the STN in PD patients worsens 
the symptoms strongly suggests that the hypersynchronous activity is mechanistically 
crucial for causing motor impairments (Chen et al., 2007; Eusebio et al., 2008; Chen 
et al., 2011). The manifestation of parkinsonian symptoms due to excessive beta band 
activity is also consistent with its functional role in motor control. Under normal 
condition, beta band rhythm is particularly pronounced during steady contractions, 
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movement prevention in Go, NoGO tasks, and holding periods following movements, 
but is attenuated by movement preparation and execution (Engel and Fries, 2010). 
Therefore it has been suggested that the exaggerated beta-band synchronized bursting 
in PD restricts the ability of neurons to code information spatially and temporally, 
since both adjacent and spatially distributed neurons are preferentially locked to the 
same rhythm (Brown, 2007; Hammond et al., 2007).
1.5.3. Possible underlying pathophysiological mechanisms
How loss of dopamine in PD leads to excessive synchronised bursting in the STN and 
associated nuclei, and the anatomical origin(s) of its occurrence, is still unclear. The 
generation of pathological synchrony may have an intrinsic origin within the basal 
ganglia, and/or requires externally driven forces through the input nuclei.
 Being potential pacemaker in the basal ganglia, the pathological rhythms could 
arise from the STN–GPe network under dopamine-depleted condition. As discussed 
previously, cocultured STN and GPe neurons in dopamine-free medium exhibit 
low-frequency (~ 1 Hz) rhythmic bursting activity (Plenz and Kitai, 1999). A critical 
component driving the rhythm is rebound burst firing in the STN neurons due to strong 
hyperpolarising input from GPe neurons. However, similar experimental observation 
of such oscillatory interaction in native preparations is lacking. Extracellular recordings 
of STN slices showed that the nucleus fails to exhibit synchrony even when the neurons 
are in burst firing mode (Wilson et al., 2004), or after chronic dopamine depletion with 
preserved GPe–STN connectivity (Wilson et al., 2006). Synchronised firing between 
neurons in the GPe and STN are also not observed either in resting state or when burst 
spiking in the STN and GPe is induced (Loucif et al., 2005).
 These results suggest that external sources of input are required to entrain 
oscillatory activity in the STN–GPe network. This leads to another hypothesis, 
proposing that abnormal hypersensitivity of STN to idling cortical rhythms is required 
for pathological synchrony in STN–GPe–GPi network. In PD, low-frequency (<30 Hz) 
synchronisations within and across STN, GPe, and GPi are coherent with the cortical 
activity (Hutchison et al., 2004; Hammond et al., 2007; Dejean et al., 2008; Litvak 
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et al., 2011). PD patients and parkinsonian animals also exhibit cortical synchronized 
oscillations with overall phase that precedes those in the STN (Williams et al., 2002a; 
Magill et al., 2006), suggesting that cortical input is driving the widespread synchrony. 
In anaesthetised rats lesioned by 6-OHDA, coherence of oscillatory spiking activity in 
STN and GPe with the cortex is dependent on the cortical SWA (Magill et al., 2001). 
According to this hypothesis, STN relays the directly received cortical rhythmic activity 
to the GPe and GPi through feedforward excitation. Feedback inhibition from GPe may 
further enhance the coupling of excitatory input to intrinsic firing (Baufreton et al., 
2005). In genetic absence epilepsy rats, cortical input is capable of driving ~ 7–10 
Hz rhythmic activity within STN and GPe during cortical seizures, sustained through 
rebound burst excitation in the STN by feedback inhibition from GPe (Paz et al., 
2005).
 Another hypothesis puts forward striatum as the source of beta band frequency 
rhythms in PD. Acute dopamine depletion in dopamine transporter knockout mice is 
associated with a relative increase in beta (and delta) frequency band activities in the 
striatum (Costa et al., 2006). Enhanced levels of cholinergic drive, a condition found 
in 6-OHDA-lesioned rats (Ikarashi et al., 1997), lead to increased beta oscillations in 
the striatum of normal rats (McCarthy et al., 2011). Activity at beta band frequency 
can be readily detected in LFP recordings from distributed striatal regions of normal 
monkeys (Courtemanche et al., 2003). In 6-OHDA-lesioned rats, MSNs exhibit higher 
firing probability during the up states driven by cortical input (Tseng et al., 2001a). 
Although it has been proposed that the synchronised pauses and bursts in GPe neurons 
originate from the striatal–GPe input, there is little evidence from PD and classical 
PD models that beta band synchronisation is exacerbated in the MSNs. Instead, 
in vivo electrophysiological studies suggest that increased effective connectivity 
from the striatum to GPe in parkinsonism may profoundly contribute to beta band 
synchronisation in the extrastriatal basal ganglia (Cruz et al., 2011; Moran et al., 2011). 
Hyperactivity of the striatal–GPe input might alter the interaction mode between STN 
and GPe, thus contributing to the genesis of pathological activity pattern (Terman et 
al., 2002). Therefore, activity changes in the striatum are presumably more important 
for promoting the emergence of pathological synchronisations in the extrastriatal basal 
ganglia through altered connectivity in the indirect pathway.
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1.6. Cellular principles underlying the regulation of GPe-STN 
inhibition 
Growing evidence indicates strong correlation of activity patterns in STN with the 
symptoms of PD and has highlighted pivotal roles of GABAergic GPe–STN input in the 
emergence of synchronised, burst firing activity in the extrastriatal basal ganglia (as 
discussed in Section 1.5.3). Whether cortical–STN pathway, indirect pathway, and/or 
STN–GPe network itself are the primary generators of pathological activity patterns in 
PD, GABAergic transmission in the STN is likely to be crucial for their manifestation. 
The purpose of this section is to explore the cellular principles underlying the patterning 
of STN activity by GABAergic inhibition arising from the GPe in PD, the possible effect 
of DBS on GPe-STN  transmission, and why GPe-STN activity is largely uncorrelated 
under normal conditions.
1.6.1. GABAergic inhibition in the STN
GABAergic input to the STN predominantly arises from the GPe. The GPe innervates 
widely distributed regions of STN through ipsilateral and topographically-organised 
projections (Smith et al., 1990; Shink et al., 1996; Bevan et al., 1997), and are largely 
reciprocated by an excitatory projection from the STN (Shink et al., 1996). The GPe–
STN input is mainly mediated by phasic transmission at synaptic GABAA receptors 
(Hallworth et al., 2005), which are fast-acting, ligand-gated Cl- channels (Goetz et 
al., 2007). Brief single electrical stimulation of GPe axons evokes a rapidly decaying 
inhibitory postsynaptic potential or current (IPSP or IPSC) that reverses at –83 mV 
and is blocked by GABAA receptors antagonists (Bevan et al., 2002, Hallworth et al., 
2005, Loucif et al., 2005). Although perisynaptic GABAB receptors are also expressed 
on postsynaptic STN neurons, they are only activated by multiple synchronous GPe-
STN inputs (Baufreton et al., 2005). Presynaptic GABAB receptors are only involved 
in tonic inhibition of synaptic inputs to the STN (Shen and Johnson, 2001; Chen and 
Yung, 2005). Therefore, GABAergic inhibition in the STN is predominantly defined by 
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GPe-STN input that is mediated through synaptic GABAA receptors.
1.6.2. The impact of GPe-STN inhibition on STN activity rate in PD
The loss of dopamine neuromodulation in PD lead to changes in the firing rate of 
elements within the indirect pathway of basal ganglia. Dopamine actions at the 
striatum are particularly crucial for the regulation of striatal–GPe transmission and 
thus the impact of GPe on STN activity. Specifically, dopamine acting at postsynaptic 
D2 receptors reduces the excitability of striatal–GPe neurons by reducing voltage-
dependent Ca2+ (Cav) class 1.3 current (Hernandez-Lopez et al., 2000). Hypoactivation 
of postsynaptic D2 receptors due to dopamine depletion enhances Cav1.3 current (Day 
et al., 2006), thus increasing the firing activity of striatal–GPe projection neurons. 
This consequently leads to the enhancement of striatal–GPe transmission (Ingham et 
al., 1997).
 SNc dopaminergic neurons also innervate the GPe (Rommelfanger and 
Wichmann, 2010). At striatal–GPe synapses, dopamine acting on presynaptic D2 
receptors reduces release probability of GABA (Cooper and Stanford, 2001; Watanabe 
et al., 2009). Postsynaptic D4 receptors in GPe also mediate reduction of GABAA 
IPSCs (Shin et al., 2003). Intrapallidal injection of 6-OHDA caused moderate motor 
impairment, accompanied by reduction in spontaneous firing rate of GPe neurons 
(Bouali-Benazzouz et al., 2009), suggesting that local dopaminergic modulation overall 
exerts an excitatory effect on GPe neurons. Therefore, dopamine loss at both striatal 
and GPe level enhances the activity of indirect pathway, consistent with the prediction 
by classical Albin-Delong model (Albin et al.,1989; Delong, 1990).
 The enhanced striatal–GPe pathway could be observed in vivo through 
the response of STN to cortical activation following loss of dopamine modulation. 
In response to a brief excitation of the cortex, STN exhibits a triphasic sequence of 
activity. First response is excitatory, mediated by cortical–STN pathway, followed by 
a brief period of strong feedback inhibition from the GPe. This is, in turn, followed 
by a second phase of excitation because of GPe inhibition by the striatal input, hence 
relieving inhibition on the STN. Application of dopamine receptor antagonists enhanced 
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the second phase of excitation, which could be explained by enhanced striatal–GPe 
transmission in the indirect pathway (Degos et al., 2005). Likewise, cortical activation 
in dopamine-depleted animals powerfully inhibits GPe neurons and disinhibits STN 
neurons (Magill et al., 2001).
 Increased activity of the indirect pathway in PD following dopamine depletion 
leads to hyperactivity of the STN, which more powerfully excites the inhibitory basal 
ganglia output nuclei, GPi and SNr.  Indeed, inactivation of the STN, either through 
chemical injections (lidocaine or GABA agonist muscimol) or ablative lesioning 
alleviates parkinsonian motor symptoms in MPTP-treated primates and humans with 
PD (Wichman et al., 1994; Levy et al., 2001; Patel et al., 2003). However, PD-related 
changes in activity rate are often accompanied by changes in abnormal pattern. The 
relationship between the two phenomena has yet to be defined due to the difficulty 
in studying these variables separately. Thus, besides reduced and increased GPe and 
STN mean firing rate respectively in experimental PD, firing activities of GPe and 
STN neurons are in synchronised bursting mode and more rhythmically entrained 
by the cortex (Mallet et al., 2008a,b). In vivo electrophysiological and computational 
modelling studies also suggested that increased activity of the striatal–GPe pathway in 
the dopamine-depleted and PD brain might promote rhythmic oscillatory activity in 
the STN–GPe network (Terman et al., 2002; Moran et al., 2011). Taken together, these 
results imply that the loss of dopamine actions alters firing rate and pattern of STN, 
both of which may be important for PD pathophysiology.
1.6.3. The impact of GPe-STN inhibition on STN activity pattern in PD
Synchronised, rhythmic low-frequency burst firing in the STN of idiopathic and 
experimental PD individuals is well documented, and is highly correlated to motor 
impairments, as described in previous section. Data from in vivo electrophysiological 
studies suggests that GPe–STN input plays a critical role in the manifestation of the 
abnormal activity pattern within the STN. Thus, GPe-STN neurons fire in antiphase 
synchrony with the STN neurons in experimental PD (Mallet et al., 2012). Inactivation 
of GPe with muscimol abolishes the synchronised burst firing in the STN and rescues 
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parkinsonian motor symptoms (Tachibana et al., 2011). Ex vivo studies, on the 
other hand, have provided us important observations for understanding the cellular 
mechanisms underlying the pathophysiological role of GPe–STN input in STN firing 
pattern.
 Consistent with the anatomical studies, electrophysiological recordings from 
rodent brain slices found that STN neurons receive multiple synaptic connections from 
single GPe neurons because the unitary GABAA receptor-mediated conductance is 
about 10 times larger than the mean the miniature (univesicular) synaptic conductance 
(0.7 nS; Baufreton et al., 2009). Each STN neuron is estimated to receive ~ 880 GPe–
STN synaptic inputs and each input contributes a conductance of ~ 0.7 nS. Therefore, 
the total conductance arising from GPe–STN transmission is potentially very potent 
(~ 600 nS). Although smaller single IPSPs tend to disrupt firing of STN in a more 
variable and partial fashion, large IPSPs, which may be provided by synchronous GPe 
input in vivo, reset the phase of oscillatory activity by complete deactivation of the 
voltage-dependent Na+ (Nav) channels that underlie autonomous activity (Bevan et al., 
2002; Baufreton et al., 2005). Indeed, dynamic clamp approach (i.e. injecting various 
synthetic GPe–STN synaptic conductances into the STN neurons) suggests that only 4% 
synchronised GPe–STN inputs are sufficient to inhibit and synchronise autonomous 
firing of STN neurons (Baufreton et al., 2009).
 Apart from direct patterning of GPe–STN input on STN firing activity, the 
GABAergic inhibition also plays a critical role in the synaptic integration of glutamatergic 
input. STN receives glutamatergic inputs mainly from the cortex and intralaminar 
thalamus (Bevan et al., 1995). Glutamatergic excitation of the STN neurons is 
mediated by rapidly deactivating, highly Ca2+-permeable amino-3-hydroxy-5-methyl-
4-isoxazoleproprionic acid (AMPA) receptors and slowly deactivating, relatively 
weakly voltage-dependent N-methyl-D-aspartate (NMDA) receptors (Gotz et al., 1997; 
Otsuka et al., 2001). Even though EPSPs alone are sufficient to advance spiking onset 
in STN neurons, EPSPs preceded by GABAA receptor-mediated IPSPs are coupled to 
the next APs more efficiently, i.e. increased rapidity and precision (Baufreton et al., 
2005; Farries et al., 2010). This is because about 40% Nav channels are in inactivated 
states during autonomous firing, but are deinactivated by IPSPs and hence become 
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available for depolarisation during the following AP (Do and Bean, 2003). Therefore, 
threshold of AP generation is lower after an IPSP-EPSP event.
 The more effective EPSP-AP coupling in the presence of IPSPs may contribute 
to enhanced sensitivity of STN to cortical idling rhythms in PD. The rhythmic cortical 
input could more effectively entrain phase-locked firing in the STN neurons in the 
presence of feedback and feedforward inhibition from the reciprocally connected GPe. 
Therefore, synchronised GABAergic inhibition from the GPe might lead to excessive 
pathological synchrony with cortical beta band oscillations in the STN and subsequently 
in associated basal ganglia nuclei. Besides, enhanced excitation of GPe neurons due 
to feedforward hyperactive STN–GPe input in PD may be functionally important 
for sustaining recurrent inhibition and excitation of the STN–GPe network through 
stronger feedback GPe-STN inhibition. In addition, synchronised bursts of GPe–STN 
transmission can generate strong hyperpolarization required for rebound burst firing, 
mediated by the deinactivation of Ca2+ (Cav1 and Cav3) channels in STN neurons (Bevan 
et al., 2002; Hallworth and Bevan, 2005). Although inhibition through GABAA receptor 
alone is sufficient to hyperpolarize and generate rebound burst firing, synchronous 
phasic GPe–STN transmission leads to coincident recruitment of perisynaptic GABAB 
receptors that produces even longer and higher-frequency form of rebound activity 
(Hallworth and Bevan, 2005).
 Indeed, in vivo electrophysiological studies and computational modelling 
suggest that enhanced functional connectivity between GPe and STN in PD will augment 
the capability of GPe input to synchronise STN neurons and generate rhythmic burst 
firing (Cruz et al., 2011; Moran et al., 2011). The strengthening of GPe–STN connectivity 
could be induced by long-term loss of dopamine neuromodulation in the basal ganglia. 
In experimental PD, GABAA receptor agonists generate larger whole cell currents in 
the postsynaptic STN neurons (Shen and Johnson, 2005). Autoradiography of GABAA 
receptor binding also revealed upregulation of its gene expression after chronic 
dopamine deletion (Yu et al., 2001). However, it is still not clear whether the receptor 
upregulation is due to changes in the receptor number at synaptic/extrasynaptic sites, 
receptor subunit composition, and/or the number of functional synapses.
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1.6.4. DBS and its possible effects on GPe-STN input
The suppression of synchronised rhythmic bursting in the STN by local DBS is highly 
effective in improving motor symptoms in PD (Benabid, 2003). It is still not clear how 
DBS exerts its therapeutic effects, although several mechanisms have been proposed. 
One possibility is that HFS leads to inactivation of STN neurons (Beurrier et al., 2001; 
Deniau et al., 2010). Many STN neurons indeed display somatic inhibition during the 
stimulation (Beurrier et al., 2001; Deniau et al., 2010). However, their axons could be 
directly stimulated to transmit APs (Nowak and Bullier, 1998; Maurice et al., 2003; 
Miocinovic et al., 2006) and others may still be able to generate somatically-generated 
firing faithful to the stimulation frequencies (Garcia et al., 2003, 2005). In addition, 
afferent axons could be antidromically stimulated and therefore alter the firing activity 
of neurons projecting to the STN (Li et al., 2007; Santaniello et al., 2012; Walker et al., 
2012). Through axon collaterals, antidromic activation of axon terminals can further 
lead to widespread activation or inhibition of targets remote from site of stimulation 
(Grill et al., 2008). Fibers of passage within the region of stimulation may also be 
activated (Miocinovic et al., 2006; Johnson and McIntyre, 2008). Therefore, the 
impact of DBS on the basal ganglia output nuclei is likely to be very complex.
 Another theory proposes that DBS regularizes the firing of basal ganglia output 
nuclei neurons at high-frequency, increasing synchrony but abolishing pathological 
low-frequency oscillations (Rubin and Terman, 2004; Guo et al., 2008; Dorval et al., 
2010). This is thought to regularize pallidothalamic inhibition and allow the passage of 
signals through the thalamus to the motor cortex. Contradictory to the belief that DBS 
entrains STN firing, optogenetic excitatory driving of the neurons at high frequency 
(and thus replaced the pathological low-frequency burst activity) did not improve 
motor symptoms in experimental PD (Gradinaru et al., 2009).
 A relatively less emphasised feature of STN DBS is that it causes a diversification 
of basal ganglia output. The cellular and network effects of DBS are very heterogeneous 
depending on multiple factors, including the intensity and frequency of stimulation, the 
intrinsic neuronal excitability, the distance of neuronal structures from the stimulation 
electrodes, and the properties of synaptic transmission on target neurons (Deniau et 
al., 2010). STN DBS in PD patients and parkinsonian animals (rats and primates) 
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consistently lead a mixture of increased and decreased firing rates in the basal ganglia 
output nuclei, along with the suppression of synchronised burst firing (Hashimoto et 
al., 2003; Degos et al., 2005; Shi et al., 2006; Maltête et al., 2007; Dorval et al., 2008 
Reese et al., 2011). Therefore, desynchronisation of firing in the STN (and hence the 
downstream output nuclei) by DBS could be a key therapeutic effect of the stimulation 
(Meissner et al., 2005; Wilson et al., 2011; Humphries and Gurney, 2012). The relief 
from widely synchronised activity may partially allow the coding and transmission of 
useful motor signals within the cortico-basal ganglia thalamo-cortical networks. 
 The mechanisms underlying the desynchronisation of neuronal activity in the 
STN remain unclear. Besides direct heterogenous effects of HFS on STN neuronal 
somata and their axonal processes, its synaptic effects on STN afferents may also 
critically underlie the desynchronising effect. Considering that GPe–STN synaptic 
transmission is heavily depressed even upon short bouts of stimulation (Baufreton et 
al., 2009), HFS of the afferents in DBS could effectively abolish GPe input to the STN, 
hence preventing the genesis and/or exacerbation of pathological oscillatory activity 
in STN. Indeed, optogenetic HFS driving of afferents within the STN of parkinsonian 
rodents rescued motor impairments (Gradinaru et al., 2009).
1.6.5. The decorrelated nature of GPe-STN network
Although unitary multisynaptic GPe–STN inputs powerfully pattern STN activity, 
correlated GPe–STN activity is rarely observed ex vivo or in vivo under normal 
conditions (Wichmann et al. 1994; Raz et al. 2000; Urbain et al. 2000; Hallworth and 
Bevan, 2005; Loucif et al., 2005; Mallet et al. 2008b). In slices where connections 
between the GPe and STN are retained, STN neurons fire less frequently and more 
irregularly compared to the absence of synaptic inputs due to the disruption by tonic 
but asynchronous autonomous firing of GPe neurons (Hallworth and Bevan, 2005). 
Given the potency of GPe input to pattern STN activity and high frequency tonic firing 
of GPe neurons in vivo (eg. ~ 33 Hz in rat; Urbain et al., 2000), it is surprising that 
the GPe–STN activity is uncorrelated in nature and that STN neurons are capable 
of maintaining their tonic discharge. The underlying cellular mechanisms could be 
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functionally important for the prevention of synchronised, rhythmic burst firing of 
STN neurons and hence dysfunctional motor coding in PD.
 First, the decorrelated nature of the GPe and STN activity under normal 
conditions is in part attributed to the anatomical feature of GPe–STN network. In the 
rat, the GPe and STN consist of 46000 and 13600 neurons respectively (Oorschot, 
1996). However, each GPe–STN neuron is estimated to maximally only innervate 2% 
of STN neurons (Baufreton et al., 2009). This is probably an overestimation because 
individual GPe–STN terminal fields are clustered, suggesting multiple terminations 
onto individual STN neurons. Each STN neuron is also thought to receive only input 
from less than 2% of GPe neurons. Simultaneous recordings from STN neurons 
confirm that neighbouring STN neurons share little inputs from common GPe neurons 
(Baufreton et al., 2009). Therefore, single GPe neurons innervate a tiny, sparsely 
distributed, fraction of STN neurons, and each STN neuron receives input from a 
similarly limited and distinct set of GPe neurons.
 Another likely explanation is short-term plasticity of GABAergic synaptic 
transmission. Because synaptic depression occurs even during short period of intense 
stimulated transmission (Baufreton and Bevan, 2008), the strength of GPe–STN 
synaptic transmission may be heavily dependent on the recent firing history of GPe 
neurons. Indeed recent work from our research group showed that GPe–STN synaptic 
inputs exhibited a high probability and amplitude of transmission that declined 
dramatically within 2 s of stimulation at the mean rate of GPe activity in vivo (33 
Hz), due to limited supply of release-ready vesicles (not published). Furthermore, 
synchronous inhibition of tonically active GPe–STN neurons or phasic activity of GPe–
STN neurons was required to reliably pattern STN activity.
 Third, local actions of dopamine in the STN at a variety of pre- and post-
synaptic receptors are possibly a contributing factor. STN neurons express both D1-
like (D5) and D2-like (D2 and D3) receptors (Flores et al., 1999; Baufreton et al., 2003; 
Ramanathan et al., 2008), whereas the axon terminals of STN afferents express D2-
like receptors only (Shen and Johnson, 2000; Baufreton and Bevan, 2008). Dopamine 
acts on STN neurons directly through D1- and D2-like receptors, which overall 
depolarise the membrane potential and increase the frequency and irregularity of 
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their autonomous activity (Baufreton et al., 2003; Zhu et al., 2002a; Zhu et al., 2002b; 
Loucif et al., 2008; Ramanathan et al., 2008). This postsynaptic effect of dopamine 
could potentially reduce the impact of hyperpolarising GABAergic inhibition on STN 
firing. At inhibitory terminals, the synaptic GABA release is reduced by the activation 
of presynaptic D2 dopamine receptors (Shen and Johnson, 2000; Cragg et al., 2004; 
Baufreton and Bevan, 2008). Specifically, dopaminergic modulation suppresses the 
initial release probability of GABA but does not affect steady-state depression at GPe–
STN synapses (Baufreton and Bevan, 2008). Therefore, phasic bursts of GPe–STN 
input are dampened in transmission strength by dopamine, making them less capable 
to reset, synchronise autonomous firing, and evoke rebound bursting in the STN.
 Lastly, the complex interaction of inhibitory input with intrinsic properties 
of STN neurons could in part contribute to the decorrelation of GPe–STN network 
activity. In comparison to other major ion channels in STN neurons, the role of HCN 
channels is poorly understood, because they minimally contribute to autonomous 
firing and previously studied forms of synaptic integration (Bevan and Wilson, 1999; 
Beurrier et al., 2000; Do and Bean, 2003; Baufreton et al., 2005). Since they both 
require prolonged hyperpolarisation below voltages associated with spontaneous 
firing, the low-voltage-gated Ca2+ and Ih currents often occur together. This leads to 
the speculation that HCN channels are important to oppose GPe–STN inhibition that 
deinactivates Cav3 channels, thus reducing the propensity of rebound burst firing being 
generated in STN neurons.
1.7. Optogenetics
Optogenetics refers to the integration of optical and genetic methods to accomplish 
gain or loss of function of well-defined events within specific cell types of living tissue. 
It allows technologies for delivering light into tissues under investigation to control 
the activity of cells of interest and obtain readouts from the evoked activity (Deisseroth 
2010, 2011). This section will briefly discuss the significance of optogenetics, the 
tools currently available, the methods of optogenetic targeting, and relevance of the 
technology to the pathophysiological study of basal ganglia network in PD.
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1.7.1. Significance
The major challenge in the history of neuroscience research is the ability to control one 
cell type while leaving others unaltered as suggested by Francis Crick in 1979. Electrical 
stimulation has probably been the most common method to control neuronal activity, 
but is confounded by its non-specificity and heterogeneity of stimulation effects. 
Pharmacological manipulation resolves specificity issue, but is not temporally precise 
because drugs often act very slowly. Optogenetic control with spatial and temporal 
precision has been recently shown to be feasible in intact living mammalian tissue and 
even freely moving animals (Deisseroth et al., 2006; Adamanditis et al., 2007; Aravanis 
et al., 2007). This is achieved through the introduction of microbial opsin gene, which 
together with the expression of natural all-trans retinal – the cofactor necessary for 
photonic activation of microbial opsins, makes neurons precisely responsive to light 
(Deisseroth 2010, 2011). Optogenetics therefore enables us to causally dissect complex 
phenomena in the brain, from molecular, cellular, network to behavioural level. 
1.7.2. Optogenetic tools
Three main classes of microbial opsin genes have been identified thus far (Yizhar et al., 
2011). The first type is the haloarchaeal proton pump bacteriorhodopsins, which pumps 
protons from the cytoplasm into the extracellular medium as part of an alternative energy 
production system. The second class of microbial opsin genes encodes halorhodopsins. 
Instead of pumping protons, halorhodopsins pump chloride ions from the extracellular 
space into the cytoplasm. The third class identified is channelrhodopsins or ChRs. 
Unlike bacteriorhodopsins and halorhodopsins, ion-conducting activity of ChRs is 
largely uncoupled from photocycle - ion flux does not depend on retinal isomerisation 
but rather relies on the kinetics of channel closure (Feldbauer et al., 2009). ChRs, 
bacteriorhodopsins, halorhodopsins have all been demonstrated capable of activating 
or inhibiting neurons rapidly and safely in response to a diversity of light wavelengths. 
For fast optogenetic neuronal excitation, ChRs, particularly ChR2, is efficient in 
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depolarising and initiating action potentials with precise temporal control in response 
to time-locked light pulses (Zhang et al., 2006; Fenno et al., 2011).
1.7.3. Opsin targeting
Optogenetic tools are continuously being optimised for more efficient transcription, 
membrane expression and safety (Fenno et al., 2011). Additionally, specificity in vivo 
targeting of the optogenetic tools is also crucial for well-defined control of neuronal 
activity. Opsin targeting is generally performed through the use of viral expression 
system or generating genetically modified animal lines. Targeting with viruses (eg. 
lentiviral vector, adeno-associated viral vector) are advantageous in many aspects, 
including rapidity, flexibility, potency due to high expression levels, and genetic and 
anatomical specificity. It is still a challenge to design neuron-type-specific promoter 
fragments that are small enough to be carried by viral systems due to limited packaging 
capacity (Yizhar et al., 2011). This limitation can be overcome through the use of 
recombinase-dependent opsin-expressing viruses. Alternatively, cell-type specific 
opsin expression can also be achieved by generating mouse transgenic lines that 
express local promoter-driven opsin genes (Yizhar et al., 2011). Although producing 
and maintaining transgenic mouse lines require relatively more time, effort and cost, 
homogenous and consistent opsin expression between animals provides greater 
convenience and reliability.
1.7.4. Optogenetics and DBS
Thy1-ChR2-EYFP lines expressing ChR2 under control of the Thy1 promoter  are one 
of the early generated transgenic mouse strains that have been used in a variety of 
studies (Arenkiel et al., 2007). Many promoters including Thy1 do not completely 
define cell types and therefore the expression pattern of opsins often requires detailed 
characterisation. Thy1-driven expression is mainly restricted to projection neurons 
(Arenkiel et al., 2007). Recent optogenetic study using one of the Thy1-ChR2-EYFP 
lines found that DBS in the STN is most effective in correcting parkinsonian symptoms 
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when the direct target is afferent axons within the structure (Gradinaru et al., 2009). It 
is however not clear which afferent axons are involved because the expression pattern 
of ChR2 in the STN of the mouse line has not been characterised. Cell-specific control 
of neuronal activity with optogenetics as demonstrated in this study should help us 
dissect PD circuitry and identify the most effective therapeutic manipulation in DBS.
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1.8. Aims of the thesis
To conclude, the loss of midbrain dopamine in idiopathic and experimental PD results 
in not only changes in mean firing rates of the basal ganglia nuclei, but also changes in 
activity patterns that are critical for PD pathophysiology. Thus, GPe and STN exhibit 
hypo- and hyper-activity, respectively, and abnormal synchronous rhythmic burst 
firing at <30 Hz. Both acute and chronic loss of dopamine in the STN (in addition 
to striatum, GPe) may enhance the functional connectivity of GPe–STN input, hence 
strengthening its capability to synchronise firing in STN neurons and generate rhythmic 
burst firing.
 Suppression of the pathological oscillations in the STN (and associated nuclei) 
by local DBS is highly correlated with the relief from motor impairments in PD. 
However, the mechanisms of DBS are still unclear. The emergence of optogenetics 
allows us to dissect the relevant neuronal circuits responsible for the manifestation of 
parkinsonian motor symptoms. Indeed, recent application of the technique suggests 
that HFS of STN exerts its therapeutic effects through manipulation of afferent activity 
in the nucleus, although the involvement of GPe-STN input is unknown.
 Given the potency of GPe input to pattern and synchronise STN activity, the 
decorrelated nature of GPe–STN network under normal conditions is somewhat 
unexpected. The possible contributing factors include sparse and selective afferent 
connectivity, synaptic depression and dopaminergic modulation of the GPe–STN 
input. Intrinsic properties of STN neurons that affect inhibitory synaptic integration, 
such as HCN channels, might additionally be important, but yet to be characterised.
 To further elucidate the mechanisms that regulate the GPe–STN input in health 
and disease, three studies were carried out in accordance to the following objectives:
To define alterations in GPe–STN connectivity following chronic depletion of 1. 
dopamine in 6-OHDA-lesioned rodent models of PD. 
To examine ChR2 expression in the STN of 2. Thy1-ChR2-EYFP transgenic mice 
and hence elucidate the mechanisms underlying therapeutic effects of DBS.
To characterise the role of HCN channels in the STN neurons in integrating 3. 
GABAergic synaptic input.
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CHAPTER 2
PROLIFERATION OF GLOBUS PALLIDUS-
SUBTHALAMIC NUCLEUS SYNAPSES 
FOLLOWING DEGENERATION OF MIDBRAIN 
DOPAMINE NEURONS
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2.1. Introduction
The reciprocally connected GABAergic GPe and glutamatergic STN occupy pivotal 
positions in cortico-basal ganglia-thalamo-cortical networks necessary for action 
selection (Smith et al., 1998). In PD degeneration of SNc dopamine neurons leads 
to hyperactivity of D2-MSNs and hypo- and hyper-activity of GPe and STN neurons, 
respectively, which together contribute to the excessive inhibitory output of the 
parkinsonian basal ganglia (Gerfen and Surmeier, 2011; Wichmann et al., 2011). 
Abnormal hypersynchronous rhythmic (<30 Hz) burst firing may also contribute to 
motor symptoms because: 1) this activity pattern is prevalent in the parkinsonian basal 
ganglia; 2) reduction of hypersynchronous rhythmic activity through dopamine-based 
therapies or high frequency (>60 Hz) electrical stimulation is associated with the relief 
from motor symptoms; 3) electrical stimulation of the STN at <30 Hz exacerbates 
symptoms (Benabid et al., 2009; Zaidel et al., 2009; Jenkinson and Brown, 2011; 
Wichmann et al., 2011). 
 Although loss of dopaminergic neuromodulation directly contributes to 
abnormal STN activity in PD (e.g. Galati et al., 2009), alterations in cellular and network 
properties may also be significant because abnormal activity develops slowly over 2–3 
weeks following lesion of midbrain dopamine neurons (Vila et al., 2000; Mallet et al., 
2008a). During this period there are adaptive changes in elements of the “indirect” 
pathway. In D2-MSNs, corticostriatal axospinous synapses reduce and inhibitory 
inputs from fast spiking GABAergic interneurons remarkably increase in number, 
probably in response to reduced inhibition following loss of D2 receptor activation 
(Day et al., 2006; Gittis et al., 2011). In addition, autonomous firing activity of STN 
neurons is reduced (Zhu et al., 2002a; Wilson et al., 2006). These adaptations may 
reflect homeostatic compensatory processes triggered by hyperactivity of D2-MSNs 
and STN neurons but could also be maladaptive by contributing to the manifestation 
of abnormal firing patterns.
 The GPe is the main source of GABAergic input to the STN (Smith et al., 1998) 
and patterns activity predominantly through GABAA receptors (Hallworth and Bevan, 
2005). The hyperpolarised equilibrium potential of postsynaptic GABAA receptor 
current (Bevan et al., 2002) and the unitary and collective strength of GPe–STN inputs 
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(Baufreton et al., 2009) enable the GPe to: inhibit and synchronise STN activity through 
deactivation of pacemaker Nav channels (Baufreton et al., 2005, 2009); promote 
synaptic excitation through deinactivation of Nav channels (Baufreton et al., 2005); 
and generate rebound burst firing through deinactivation of Cav1 and Cav3 channels 
(Bevan et al., 2002; Hallworth and Bevan, 2005). Given the capability of GPe inputs 
to strongly pattern STN activity and evidence for enhanced functional connectivity 
between the parkinsonian GPe and STN in vivo (Mallet at al., 2008a, b; Cruz et al., 
2011; Moran et al., 2011), this study therefore sought to determine whether the loss of 
midbrain dopamine neurons leads to adaptations in GPe–STN synaptic properties that 
may compensate for and/or contribute to abnormal STN activity.  
2.2. Materials And Methods
Experiments were performed in accordance with institutional, NIH and Society for 
Neuroscience guidelines using male Sprague-Dawley rats (Charles River) except 
for quantitative PCR where male C57/B6 mice (Charles River) were used due to the 
availability of species specific primers.
2.2.1. Surgery and slice preparation
Under ketamine/xylazine anaesthesia unilateral, stereotaxic injections of 6-OHDA 
(mouse: 2.5 µl 3 mg/ml; rat: 4–5 µl 3–5 mg/ml at a rate of 0.5–1 µl/min) or vehicle were 
made in the substantia nigra or medial forebrain bundle (MFB). The animals were also 
treated with systemic injections of desipramine (25 mg/kg) and pargyline (50 mg/kg) 
to minimise the effect of 6-OHDA on noradrenergic fibres and to enhance the toxicity 
of the toxin, respectively. In order to assess the degree of associated motor impairment 
forelimb use asymmetry was assessed 1–2 weeks post-surgery, as described previously 
(Schallert et al., 2000). The number of spontaneous exploratory touches made by each 
forepaw on the wall of a clear plastic cylinder (18 cm wide for rats; 9 cm wide for mice) 
was recorded using a digital camcorder for 10–20 minutes over 2 sessions and scored 
using iMOVIE (Apple).
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Approximately 2–3 weeks post-surgery 6-OHDA- and vehicle-injected animals 
were perfused transcardially under ketamine/xylazine anesthesia with ice-cold modified 
artificial cerebrospinal fluid (ACSF).  6-OHDA-injected animals (n = 44) were perfused 
17.9 ± 4.2 days after surgery and vehicle-injected animals (n = 13) were perfused 19.4 ± 
3.8 days after surgery. Age-matched control animals (n = 23) were also transcardially 
pefused with the same solution. At the time of perfusion 6-OHDA-injected, vehicle-
injected and age-matched control animals were 55.3 ± 16.6, 67.3 ± 9.2 and 53.0 ± 
15.1 days old, respectively. Modified ACSF was equilibrated with 95% O2/5% CO2, and 
contained (in mM): 230 sucrose, 26 NaHCO3, 2.5 KCl, 1.25 NaH2PO4, 0.5 CaCl2, 10 
MgSO4 and 10 glucose. Each brain was sliced at 250–300 mm (for Electrophysiology/
quantitative PCR) or at 125 mm (for Immunocytochemistry for synaptic markers) in 
the sagittal plane using a vibratome (Vibratome 3000; Leica Microsystems). Slices 
containing the STN were stored in ACSF, which was equilibrated with 95% O2/5% 
CO2 and contained (in mM): 126 NaCl, 26 NaHCO3, 2.5 KCl, 1.25 NaH2PO4, 2 CaCl2, 2 
MgSO4 and 10 glucose, prior to further processing.
2.2.2. Electrophysiology
Slices were perfused with ACSF, which was heated to ~ 35°C, equilibrated with 95% 
O2/5% CO2 and contained (in mM): 126 NaCl, 26 NaHCO3, 3 KCl, 1.25 NaH2PO4, 1.6 
CaCl2, 1.5 MgSO4, 10 glucose, 0.05 d-(–)-2-amino-5-phosphonopentanoic acid (APV), 
0.02 6,7-dinitroquinoxaline-2,3-dione (DNQX) and 0.002 (2S)-3-[[(1S)-1-(3,4-
dichlorophenyl)ethyl]amino-2 hydroxypropyl](phenylmethyl)phosphinic acid (CGP 
55845). APV, DNQX and CGP55845 were used to block NMDA, AMPA/kainate and 
GABAB receptors, respectively, so that GABAA receptor-mediated currents could be 
studied in relative isolation (Bevan et al., 2002; Hallworth and Bevan, 2005). Miniature 
inhibitory postsynaptic currents (mIPSCs) were recorded in the additional presence of 
0.5 mM tetrodotoxin (TTX). In some cases sulpiride (2 mM) was added to block D2 
dopamine receptors. Drugs were purchased from Abcam except for sulpiride, which 
was obtained from Tocris. 
 Somatic patch clamp recordings were obtained under visual guidance 
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(Axioskop FS2, Zeiss) using computer-controlled manipulators (Luigs & Neumann) 
and a Multiclamp 700B amplifier and digidata 1440A digitizer controlled by PClamp 
10 (Molecular Devices). Pipettes contained (in mM): 135 CsCl, 3.6 NaCl, 1 MgCl2, 10 
HEPES, 10 QX-314, 0.1 Na4EGTA, 0.4 Na3GTP and 2 Mg1.5ATP (pH 7.2, 290 mOsm) 
or 130 Kgluconate, 3.6 Nagluconate, 1 MgCl2, 10 HEPES, 10 QX-314, TEA-Cl 5, 0.1 
Na4EGTA, 0.4 Na3GTP and 2 Mg1.5ATP (pH 7.2, 290 mOsm) for the recording of GABAA 
receptor-mediated mIPSCs and evoked currents, respectively. mIPSCs were recorded 
at –60 mV. Evoked IPSCs and isoguvacine-evoked current were recorded at –50 mV. 
Weighted decay kinetics of mIPSCs were calculated from t decay = (A1*t1 + A2*t2)/
(A1 + A2) where A and t refer to the amplitude and decay constants, respectively, of 
biexponential fits of mIPSCs. Data were analysed with Clampfit 10 (Molecular Devices), 
Igor Pro 6 (Wavemetrics) and Origin 8 (OriginLab).
2.2.3. Quantitative PCR
The STN was microdissected from 250 mm sagittal slices prepared as described above. 
STN RNA was first isolated using RNeasy Plus Mini Kit (Qiagen). STN cDNA was then 
synthesised using qScript cDNA Supermix (Quanta Biosciences) under the following 
conditions: 5 min at 25°C, 30 min at 42°C, 5 min at 85°C, and then held at 4°C. 
Quantitative PCR was run in triplicate, including negative controls, using SYBR Green 
I on a StepOnePlus thermocycler (Applied Biosystems) under the following conditions: 
95°C for 20 s, 40 cycles at 95°C for 3 s and 60°C for 30 s. The PCR cycle threshold (CT) 
values were set in StepOne Plus (Applied Biosystems) within the exponential phase of 
the PCR reaction. Custom synthesised primers (Invitrogen) were desalted and intron-
spanning. Melting curves verified amplification of single PCR products. Primers were 
further validated with PCR and gel electrophoresis of whole brain tissue samples 
to confirm the amplification of PCR products with the predicted molecular weight. 
After performing quantitative PCR, outliers were removed from triplicates if the SD of 
the PCR cycle was >0.3. Samples that showed an SD >0.3 after outlier removal were 
excluded from further analysis. 
A relative quantification approach, the DDCT method, was used to compare 
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transcript levels. Expression levels were normalised to 5 housekeeping genes: gapdh, 
atp5b, sdha, uchl1 and cyc1. The contribution of each gene was weighted to its relative 
stability, based on the integration of four algorithms: geNorm (Vandesompele et al. 
2002), Normfinder (Andersen et al. 2004), BestKeeper (Pfaffl et al. 2004) and the 
comparative ΔCt method (Silver et al. 2006; integration tool available at http://www.
leonxie.com/referencegene.php). Expression data are presented as fold difference 
relative to control.
2.2.4. Immunocytochemistry of synaptic markers
125 μm thick sagittal slices, prepared as described above, were immersion-fixed in 4% 
paraformaldehyde in phosphate buffer (PB; 0.1 M, pH 7.4) at room temperature for 
20 min. After washing in phosphate buffer saline (PBS; 0.01 M) slices were incubated 
in primary antibodies (Synaptic Systems), as indicated in Table 2.1, in PBS plus 0.3% 
Triton X-100 (Sigma-Aldrich) and 2% normal donkey serum (NDS) for 48 h at 4°C. 
After washing, slices were incubated in fluorescent secondary antibodies (Jackson 
Immunoresearch; Table 2.1) in the same diluent for 2 h at room temperature. Slices 
were then mounted in ProLong Gold (Invitrogen) on glass slides and coverslipped. 
 Immunofluorescent labelling was visualised using confocal laser scanning 
microscopy (Zeiss LSM 510). Image stacks (16 optical sections each) were acquired 
using a 63× oil immersion objective (NA 1.4) with a digital zoom of 1.5× (x, y: 1024 × 
1024 pixels, 93 nm per pixel; z-step: 0.3–0.4 μm). For multichannel image acquisition 
fluorophores were excited alternately [excitation wavelengths and corresponding 
emission filters (in nm): 488, 503-530; 543, >560]. Pinholes were set to the same airy 
unit for each laser in order to obtain identical optical section thickness. Images were 
acquired using the same settings and analysed without post-processing. The density, 
fluorescent intensity and dimensions of immunoreactive structures were assessed with 
Image J (National Institutes of Health, Bethesda, USA).
 The densities of gephyrin-, γ2-, vesicular GABA transporter(VGAT)- and 
bassoon-immunoreactive structures were quantified using the optical dissector method 
(West, 1999). Sample sites were chosen using a grid (frame size, 11.9 × 11.9 μm) that 
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was superimposed randomly on each image stack.  Stereological counting commenced 
at an optical section ~ 4 μm below the slice surface. Immunoreactive structures were 
counted if they appeared within the sample frame and in the reference but not the 
adjacent look up section. For gephyrin and γ2 colocalisation, gephyrin-immunoreactive 
structures were selected stereologically and colocalisation of these structures with γ2-
immunoreactive structures was then determined. For VGAT and bassoon colocalisation, 
VGAT -immunoreactive structures were first selected stereologically and colocalisation 
with bassoon-immunoreactive structures was subsequently determined. Removal or 
prior incubation of primary antibodies with their respective immunogenic synthetic 
peptides abolished specific labelling.
Antibody Species Primary 
Dilution
Secondary 
antibody
Secondary 
dilution
double 
labelling
GABAA 
receptor γ2 
subunit
Rabbit 1:1000 DyLight 594 
donkey anti-
rabbit IgG
1:250
Gephyrin Mouse 1:300 DyLight 488 
donkey anti-
mouse IgG
1:250
double 
labelling
VGAT Mouse 1:250 Cyanine Cy3 
donkey anti-
mouse IgG
1:250
Bassoon Guinea 
pig
1:1000 Alexa 488 
donkey anti-
guinea pig 
IgG
1:250
single 
labelling
VGAT Rabbit 1:1000 DyLight 594 
donkey anti-
rabbit IgG
Or 
Biotinylated 
donkey anti-
rabbit IgG
1:250
Table 2.1. Antibodies used for immunocytochemistry of GPe–STN synaptic markers
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2.2.5. Electron microscopy
Under ketamine/xylazine anaesthesia animals were transcardially perfused with 
~ 50 ml HEPES buffered ACSF, which was equilibrated with O2 and contained (in 
mM): 140 NaCl, 3 KCl, 1.6 CaCl2, 10 MgCl2, 23 glucose, and 15 HEPES followed by 
250 ml 0.1% glutaraldehyde and 4% paraformaldehyde in 0.1 M PB for 15 min, 4% 
paraformaldehyde in 0.1 M PB for 15 min, and finally 0.1 M PB for 15 min. 75 μm 
coronal sections were then prepared with a vibratome (VT1000s; Leica Microsystems). 
In order to permeabilise the tissue in a manner compatible with ultrastructural 
preservation, sections were equilibrated in cyroprotectant medium (25% sucrose, 15% 
glycerol in 0.05 M PB) rapidly frozen in cooled isopentane and liquid nitrogen and then 
thawed at room temperature. After washing in PBS, sections were incubated in rabbit 
anti-VGAT primary antibody (1:1,000) and 2% NDS in PBS for 48 h at 4°C. Sections 
were then washed and incubated in biotinylated donkey anti-rabbit IgG (1:500) in the 
same diluent for 2 h at room temperature. Sections were then washed and incubated 
in avidin–biotin–peroxidase complex  (1:100 ABC-Elite; Vector Laboratories) in the 
same diluent for 2 h at room temperature before further washing in PBS. Finally, 
VGAT immunoreactivity was revealed by incubation in 0.025% DAB and 0.0025% 
hydrogen peroxide in Tris buffer (0.05 M, pH 7.4) for 5–10 min.  Sections were then 
prepared for electron microscopy: sections were post-fixed with 1% osmium tetroxide 
in 0.1 M PB, dehydrated through a graded alcohol series, contrasted with 1% uranyl 
acetate and embedded in epoxy resin between coverslips and glass slides (Durcupan, 
Fluka). STN tissue was then re-sectioned at ~ 70 nm using an ultramicrotome (UCT, 
Leica Microsystems). Ultrathin sections were mounted on pioloform-coated slot 
grids, stained with lead citrate and examined using an electron microscope (Tecnai 
Spirit G2, FEI) equipped with a digital camera. Entire individual ultrathin sections 
were systematically scanned at ~ 10,000× for VGAT-immunoreactive structures. Each 
VGAT-immunoreactive structure was then imaged at higher magnification (20,000–
25,000×) and measurements were taken using Image J (National Institutes of Health, 
Bethesda, USA). The dimensions of VGAT-immunoreactive structures, postsynaptic 
structures and synapses were measured. Synapses were defined according to classical 
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criteria, i.e. the presence of synaptic vesicles associated with the presynaptic active 
zone, the presence of a synaptic cleft with cleft material and the presence of pre- and 
post-synaptic membrane specializations. 
2.2.6. Immunocytochemistry for tyrosine hydroxylase (TH)
Brain tissue was immersion-fixed in 4% paraformaldehyde in 0.1 M PB (see section 
2.2.1. Surgery and slice preparation) or perfusion-fixed in 0.1% glutaraldehyde and 
4% paraformaldehyde in 0.1 M PB (see section 2.2.5. Electron microscopy). Fixed 
tissue was then sectioned at 70 μm on a vibratome (VT1000s; Leica Microsystems) 
and processed for the detection of TH using immunofluorescent or immunoperoxidase 
techniques. For immunofluorescent detection, slices were incubated in 1:500 mouse 
anti-TH (Millipore) in PBS plus 0.3% Triton X-100 and 2% NDS for 48 h at 4°C. After 
washing, sections were incubated in 1:200 DyLight 488 donkey anti-mouse IgG in the 
same diluent for 2 h at room temperature.  For immunoperoxidase detection, slices 
were treated as above except that 1:100 biotinylated donkey anti-mouse IgG (Jackson 
Immunoresearch) was used as the secondary antibody and sections were subsequently 
incubated in avidin–biotin peroxidase complex (1:100 ABC-Elite; Vector Laboratories) 
before peroxidase was revealed with diaminobenzidine tetrahydrochloride (DAB) 
and hydrogen peroxide, as described above. Sections were mounted on glass slides, 
coverslipped and then imaged under epifluorescent or brightfield illumination using 
a microscope (Axioskop, Zeiss) equipped with a software controlled CCD camera 
(Axiovision/Axiocam, Zeiss).  Immunoreactivity was assessed from optical densities 
acquired with Image J (National Institutes of Health, Bethesda, USA). Specific 
immunoreactivity for TH was defined as immunoreactivity of the dorsal striatum 
minus immunoreactivity of the overlying motor cortex in the same section. 
2.2.7. Statistics
Data are reported as mean ± SD. Cumulative and box (central line, median; dot, mean; 
box, 25–75%; whiskers, 10–90%) plots are used to illustrate sample distributions. The 
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Kolmogorov-Smirnov test was used to test for significant differences in cumulative 
distribution (Prism 5, GraphPad Software). Mann-Whitney and Wilcoxon signed rank 
tests were used to test for significant differences between unpaired and paired data, 
respectively (Prism 5, GraphPad Software). The level of significance was set at an α 
value of 0.05.  Non significant differences are denoted as N.S.. 
2.3. Results
2.3.1. Impact of chronic dopamine depletion on miniature GABAergic 
events in STN neurons
In order to determine the impact of chronic dopamine depletion on GPe–STN 
transmission GABAergic transmission was compared in brain slices derived from 
animals that had received unilateral 6-OHDA injections in the substantia nigra or medial 
forebrain bundle ~ 2–3 weeks earlier (n = 44) and control animals that had received 
similarly timed vehicle injections (n = 13) or were age-matched (n = 23). Data derived 
from the control groups were similar and were therefore pooled. 6-OHDA-lesioned 
animals exhibited profound asymmetric forelimb use (forelimb ipsilateral to 6-OHDA 
injection normalised to total forelimb movement = 75.0 ± 15.7 %, n = 44), which is a 
faithful marker of substantial dopamine depletion ipsilateral to the preferred forelimb 
(Schallert et al., 2000). Indeed, TH immunoreactivity of the striatum ipsilateral to 
the injection of 6-OHDA and forelimb preference was found to be profoundly reduced 
compared to the contralateral striatum in each 6-OHDA-injected animal (ipsilateral = 
1.7 ± 5.5% of contralateral immunoreactivity, n = 44).
 Because the GPe is the principal source of GABAergic inputs to STN neurons 
(Smith et al., 1998) and these inputs are mediated largely through GABAA receptors 
(Baufreton et al., 2005, 2009; Hallworth and Bevan, 2005), GABAA receptor-mediated 
transmission and its associated molecular and anatomical markers in the STN were 
used as measures of GPe–STN transmission. The impact of chronic dopamine depletion 
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on GPe–STN transmission was first assessed by whole-cell patch clamp recording. The 
frequency of AP-independent transmission, measured in the presence of 0.5 μM TTX, 
was significantly increased by dopamine depletion (Fig. 2.1; control = 1.05 ± 0.36 Hz, n 
= 26; 6-OHDA = 1.80 ± 1.59 Hz, n = 35; p < 0.05). The decay time constant of mIPSCs 
was also increased by dopamine depletion (control = 6.48 ± 1.92 ms, n = 26; 6-OHDA = 
7.78 ± 2.40 ms, n = 35; p < 0.05). However, the mean conductance underlying mIPSCs 
was unaltered (Fig. 2.1; control = 0.70 ± 0.24 nS, n = 26; 6-OHDA = 0.76 ± 0.23 nS, 
n = 35; N.S.). Application of the D2-like dopamine receptor antagonist sulpiride (2 
μM) to control slices had no effect on the frequency, conductance or decay kinetics 
of mIPSCs (sulpiride data normalised to control: frequency = 0.95 ± 0.17, n = 7, NS; 
conductance = 0.86 ± 0.18, n = 7, NS; kinetics = 1.2 ± 0.12, n = 7; N.S.) confirming that 
basal activation of presynaptic D2-like dopamine receptors (Shen and Johnson, 2000; 
Baufreton and Bevan, 2008) does not underlie the relatively low frequency and rapid 
kinetics of mIPSCs in control slices compared to those derived from 6-OHDA-treated 
animals. 
2.3.2. Chronic dopamine depletion augments GPe–STN transmission 
through postsynaptic mechanisms
In order to further address the contribution of pre- and/or post-synaptic mechanisms 
to the alteration in GPe–STN transmission, the effect of chronic dopamine depletion 
on IPSCs evoked by bipolar electrical stimulation of the internal capsule (IC) rostral 
to the STN at 10 or 50 Hz was studied. Electrical stimulation intensity was increased 
until the maximum IPSC was evoked. Although the intensity of stimulation required 
to generate the maximum IPSC was not significantly different in control and 6-OHDA 
lesion groups (control = 706 ± 78 mA, n = 20; 6-OHDA = 719 ± 69 mA, n = 15; N.S.), 
dopamine depletion significantly increased the conductance underlying evoked IPSCs 
(Fig. 2.2; Table 2.2). Dopamine depletion had no effect on  the short-term synaptic 
plasticity of GPe–STN transmission (Fig. 2.2; Table 2.2). Application of the D2-like 
dopamine receptor antagonist sulpiride (2 μM) to control slices also had no effect 
on the conductance underlying evoked IPSCs (sulpiride data normalised to control: 
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Figure 2.1. Chronic dopamine depletion increased the frequency and prolonged the 
decay kinetics of mIPSCs 
A, representative recordings of mIPSCs in STN neurons derived from control and 
6-OHDA-treated animals.  The frequency but not the amplitude of mIPSCs was 
greater following dopamine depletion. B, Cumulative probability (cum. prob.) plots of 
the sample populations confirmed that dopamine depletion significantly reduced the 
intervals between mIPSCs but had no effect on the conductance underlying mIPSCs. 
C, The mean frequency of mIPSCs was significantly enhanced by dopamine depletion, 
whereas the mean conductance underlying mIPSCs was unaltered. D, The decay of 
mIPSCs was prolonged by chronic dopamine depletion, as evidenced by representative 
mean peak-scaled mIPSCs and box plots. * p < 0.05.
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Figure 2.2. Chronic dopamine depletion increased the magnitude of evoked GABAA 
receptor-mediated synaptic transmission but had no effect on short-term synaptic 
plasticity
Following chronic dopamine depletion the magnitude of synaptic transmission 
evoked at 10 Hz (A–C) and 50 Hz (E–H) was enhanced with no alteration in short-
term synaptic plasticity. A, E, representative recordings. B, F, Peak and normalised 
conductances plotted against IPSC number. Chronic dopamine depletion significantly 
increased the conductances underlying IPSC1 and 25 (C, G) but had no effect on the 
ratio of conductances underlying IPSC2 to IPSC1 nor IPSC25 to IPSC1 (D, H). *, p < 
0.05.
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IPSC1 = 0.98 ± 0.21, n = 7, NS; IPSC 25 = 1.00 ± 0.37, n = 7, N.S.) nor the short-term 
plasticity of evoked IPSCs (sulpiride data normalised to control: 10 Hz IPSC2/IPSC1 = 
1.03 ± 0.14, n = 4; 10 Hz IPSC25/IPSC1 = 0.98 ± 0.12, n = 4, NS; 50 Hz IPSC2/IPSC1 
= 0.99 ± 0.09, n = 7; 50 Hz IPSC25/IPSC1 =1.01 ± 0.21 , n = 7, N.S.) confirming that 
basal activation of presynaptic D2-like dopamine receptors (Shen and Johnson, 2000; 
Baufreton and Bevan, 2008) does not underlie the relatively small amplitude of evoked 
IPSCs in control slices compared to those derived from 6-OHDA-treated animals. 
Together these data suggest that the augmentation of GPe–STN synaptic transmission 
following loss of dopamine is not mediated by an alteration in the probability of 
transmission.
control 6-OHDA significance
IPSC1 7.03 ± 3.10 nS (n = 20) 11.17 ± 5.41 nS (n = 15) p < 0.05
IPSC25 
(10 Hz)
5.59 ± 2.58 nS (n =20) 8.62 ± 4.42 nS (n = 15) p < 0.05
IPSC2:IPSC1 
(10 Hz)
0.94 ± 0.06 (n = 20) 0.96 ± 0.04 (n = 15) NS
IPSC25:IPSC1 
(10 Hz)
0.79 ± 0.10 (n = 20) 0.77 ± 0.09 (n = 15) NS
IPSC2:IPSC1 
(50 Hz)
0.86 ± 0.18 (n = 20) 0.89 ± 0.16 (n = 14) NS
IPSC25:IPSC1 
(50 Hz)
0.56 ± 0.18 (n = 20) 0.64 ± 0.21 (n = 14) NS
Table 2.2.  Chronic dopamine depletion increases the maximum evoked GABAA- 
receptor-mediated synaptic conductance but has no effect on short-term synaptic 
plasticity. The frequency of electrical stimulation (10 Hz or 50 Hz) and number of the 
evoked IPSC (IPSC1, IPSC2 etc) are denoted.  
 In order to further address the contribution of postsynaptic mechanisms to 
the augmentation of GPe–STN transmission following depletion of dopamine, the 
magnitude of GABAA receptor conductance evoked by perfusion of 20 μM isoguvacine, 
a slowly desensitising GABAA receptor agonist, was examined. Chronic dopamine 
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Figure 2.3. Chronic dopamine depletion increased the conductance evoked by the 
GABAA receptor agonist isoguvacine
A, Representative traces of isoguvacine-evoked currents in STN neurons derived from 
control and 6-OHDA treated animals. B, The conductance evoked by isoguvacine was 
significantly increased by chronic dopamine depletion. *, p < 0.05.
46
depletion significantly increased the peak amplitude of the isoguvacine-evoked 
conductance (Fig. 2.3; control = 4.61 ± 1.84 nS, n = 6; 6-OHDA = 7.80 ± 1.10 nS, n = 
5; p < 0.05). This observation suggests that the expression of GABAA receptors by STN 
neurons is increased following the loss of dopamine. Together the electrophysiological 
data demonstrate that GPe–STN synaptic transmission is greatly enhanced by chronic 
dopamine depletion and that postsynaptic alterations contribute to this enhancement. 
Furthermore, the increased frequency of mIPSCs and amplitude of ensemble but not 
miniature GABAA receptor-mediated currents suggest that the collective rather than the 
individual strength of GPe–STN synapses is increased following the loss of dopamine.
2.3.3. Upregulation of gene transcriptions encoding GABAA receptor 
subunits in the STN following chronic dopamine depletion
In order to address molecular mechanisms underlying the enhancement of GPe–
STN transmission by chronic dopamine depletion, the relative abundance of mRNA 
transcripts encoding the most commonly expressed GABAA receptor subunits in 
the STN (Wisden et al., 1992) were compared using quantitative PCR analysis. Data 
are expressed as fold change relative to median control values. Dopamine depletion 
significantly elevated the level of each transcript (Fig. 2.4; α1: control = 1.04 ± 0.21, n = 
15; 6-OHDA = 1.20 ± 0.12, n = 12, p < 0.05; b2: control = 1.02 ± 0.21, n = 15; 6-OHDA 
= 1.34 ± 0.22, n = 12, p < 0.05; g2: control = 1.05 ± 0.178, n = 15; 6-OHDA = 1.24 ± 
0.15, n = 12, p < 0.05). In contrast the less abundantly expressed α3 subunit (Wisden 
et al., 1992), which is associated with relatively slow GABAA receptor-mediated IPSCs 
in neurons (Eyre et al., 2012), was unchanged following dopamine depletion (α3: 
control = 1.02 ± 0.18, n = 15; 6-OHDA = 1.14 ± 0.19, n = 12, N.S.). Together these data 
suggest that GPe–STN transmission is enhanced, at least in part, through persistent 
increases in the transcription of genes encoding the usually expressed GABAA receptor 
subunits.
2.3.4. Immunocytochemical analysis of markers for GABAergic synapses 
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Figure 2.4. Chronic dopamine depletion increased the transcription of genes encoding 
commonly expressed GABAA receptor subunits 
Quantitative PCR of the STN derived from control and 6-OHDA-lesioned animals 
revealed that the abundance of mRNA encoding GABAA α1, β2, and γ2 receptor subunits 
was significantly increased by chronic dopamine depletion. *, p < 0.05.
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in the STN
In order to further address the molecular (and structural) mechanisms contributing to 
the enhancement of GPe–STN transmission by chronic dopamine depletion the density 
of postsynaptic structures expressing gephyrin and both gephyrin and g2 GABAA 
receptor subunits and the density of presynaptic structures expressing VGAT and 
bassoon were estimated stereologically using immunofluorescent confocal microscopy. 
The inhibitory postsynaptic scaffold protein gephyrin and g2 GABAA receptor subunits 
are critical for the clustering and retention of functional GABAA receptors at many 
GABAergic synapses (Smith and Kittler, 2010; Tyagarajan and Fritschy, 2010; Luscher 
et al., 2011), whereas VGAT is a transporter responsible for the concentration of GABA 
in synaptic vesicles (McIntire et al., 1997) and bassoon is an active zone protein at 
both inhibitory and excitatory synapses (tom Dieck et al., 1998; Micheva et al., 2010). 
Dopamine depletion significantly increased the density of immunoreactive structures 
expressing gephyrin and both gephyrin and g2 GABAA receptor subunits (Fig. 2.5; 
gephyrin: control = 59.78 ± 22.40 million mm-3, n = 14; 6-OHDA = 80.92 ± 24.65 
million mm-3, n =  15, p < 0.05; gephyrin plus g2: control = 50.90 ± 22.80 million mm-3, 
n = 14; 6-OHDA = 72.78 ± 22.58 million mm-3, n = 15, p < 0.05) but had no effect on the 
absolute or relative densities of presynaptic structures expressing VGAT or both VGAT 
and bassoon (Fig. 2.6; VGAT: control = 65.46 ± 7.12 million mm-3, n = 16; 6-OHDA = 
68.47 ± 10.53 million mm-3, n = 16, N.S.; VGAT plus bassoon: control = 44.53 ± 19.57 
million mm-3; 6-OHDA = 47.15 ± 17.8 million mm-3, n = 16).  The fluorescence intensity 
and dimensions of gephyrin-, g2-, VGAT- and bassoon-immunoreactive structures were 
unaltered by dopamine depletion (data not shown). Together these data indicate that 
the density of postsynaptic markers is increased by chronic dopamine depletion but 
this is not matched by an increased density of axon terminals. Therefore one possibility 
is that the number of synapses per GPe-STN axon terminal increases following 
dopamine depletion. However the number of bassoon-immunoreactive structures per 
VGAT immunoreactive terminal was also apparently unaltered by dopamine depletion 
(control = 1.29 ± 0.56, n = 108; 6-OHDA = 1.39 ± 0.64, n = 105, N.S.). Given the 
resolution limit of standard confocal microscopy it is likely that distinct bassoon-
immunoreactive structures were not fully resolved. In order to mitigate this confound 
further analysis was restricted to large VGAT-immunoreactive structures > 0.5 mm2 
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Figure 2.5. Chronic dopamine depletion increased the densities of postsynaptic 
gephyrin- and γ2 GABAA receptor subunit-immunoreactive structures
 Representative confocal micrographs of gephyrin (A1, B1: green), γ2 GABAA 
receptor subunit (A2, B2: red) and gephyrin plus γ2 GABAA receptor subunit 
immunoreactivity (A3, B3: yellow) in the STN of a control (A) and 6-OHDA-treated 
(B) animal. The densities of immunoreactive structures in the STN was increased by 
chronic dopamine depletion compared to control both in representative micrographs 
and across the sample population (C). The scale bar in A1 applies to each micrograph. 
*, p < 0.05. 
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Figure 2.6. Chronic dopamine depletion did not alter the densities of presynaptic 
VGAT- and bassoon-immunoreactive structures
Representative confocal micrographs of bassoon (A1, B1: green), VGAT (A2, B2: red) 
and bassoon plus VGAT immunoreactivity (A3, B3: yellow) in the STN of a control 
(A) and 6-OHDA-depleted (B) animal. The densities of immunoreactive structures in 
the STN were not altered by chronic dopamine depletion compared to control in the 
representative micrographs nor across the sample population (C). The scale bar in A1 
applies to each micrograph. *, p < 0.05.
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in their maximal cross-sectional area where bassoon-immunoreactive larger axon 
terminals the number of bassoon-immunoreactive structures per terminal was found 
to be significantly greater in dopamine-depleted tissue (Fig. 2.7; control = 1.56 ± 0.71, 
n = 48; 6-OHDA = 2.0 ± 0.70, n = 34, p < 0.05) suggesting that the number of active 
zones per GPe–STN axon terminal does indeed increase following loss of dopamine.
2.3.5. Ultrastructural analysis of GABAergic synapses in the STN
In order to investigate the structural basis for augmented GPe–STN synaptic 
transmission, the ultrastructural properties of VGAT-immunoreactive structures 
were analysed through electron microscopy. VGAT-immunoreactive structures were 
identified by the presence of an electron dense DAB reaction product, which adhered 
to the cytoplasmic face of the membrane of organelles including synaptic vesicles 
and mitochondria (Fig. 2.8). The cross-sectional area of VGAT-immunoreactive axon 
terminals in the STN of control and dopamine-depleted animals were similar (Fig. 2.8; 
control = 0.76 ± 0.54 mm2, n = 63; 6-OHDA = 0.64 ± 0.34 mm2, n = 61, N.S.) as were 
the diameter of postsynaptic dendrites (control = 0.83 ± 0.63 mm, n = 28; 6-OHDA = 
0.81 ± 0.43 mm, n = 43, N.S.) and the proportion of STN somata postsynaptic to VGAT-
immunoreactive axon terminals (control = 12.5 %, 4 of 32 postsynaptic structures; 
6-OHDA = 14%, 7 of 50 postsynaptic structures). The synaptic contacts of VGAT-
immunoreactive terminals were invariably symmetric and were therefore assumed to 
arise from the GPe (Smith et al., 1998; Baufreton et al., 2009). Although the dimensions 
of GPe–STN synapses were unaltered by dopamine depletion (length of synapses: 
control = 0.18 ± 0.06 mm, n = 41; 6-OHDA = 0.18 ± 0.67 mm, n = 78), the number 
of symmetric synapses per GPe–STN terminal was significantly greater in dopamine-
depleted tissue (Fig. 2.8; number of synapses per terminal: control = 0.63 ± 0.75, n = 
63; 6-OHDA = 1.26 ± 0.98, n = 61, p < 0.05).  Taken together with electrophysiological 
and molecular data these findings suggest that chronic dopamine depletion enhances 
GPe–STN transmission through an increase in the number of GPe–STN synaptic 
connections. Furthermore, the enhancement in GPe–STN synaptic connectivity is 
mediated, at least in part, through an increase in the number of synapses per GPe–STN 
terminal.
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Figure 2.7. Chronic dopamine depletion increased the number bassoon-
immunoreactive structures associated with large VGAT-immunoreactive axon 
terminals
Representative through-focus confocal micrographs of bassoon (green) and VGAT (red) 
co-immunoreactive (yellow) axon terminals in the STN of control (A–C) and 6-OHDA-
lesioned (D–E) animals. 3 examples (A–C and D–F) per condition are illustrated. 
The number of bassoon-immunoreactive structures per VGAT-immunoreactive axon 
terminal (arrows) was significantly increased by chronic dopamine depletion compared 
to control both in the representative examples and across the sample population (G). 
The scale bar in A applies to each micrograph. *, p < 0.05
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Figure 2.8. Chronic dopamine depletion increased the number synapses per VGAT-
immunoreactive axon terminal
Representative electron micrographs of VGAT-immunoreactive axon terminals in the 
STN of control (A–C) and 6-OHDA-lesioned (D–F) animals. VGAT-immunoreactive 
axon terminals were characterized by the presence of flocculent, electron dense DAB 
reaction product, which adhered to intracellular organelles, particularly synaptic 
vesicles. 3 examples per condition are illustrated (A–C and D–F). VGAT immunoreactive 
structures formed synapses (arrows) with the dendrites (d) and somata (s) of STN 
neurons. In some cases VGAT-immunoreactive structures did not form a synaptic 
connection in the ultrathin section that was examined (A). Although the dimensions 
of VGAT-immunoreactive structures, synapses and synaptic targets were similar 
in control and dopamine-depleted tissue, individual VGAT-immunoreactive axon 
terminals formed significantly more synapses (A–G). Scale bar in A applies to each 
micrograph. *, p < 0.05. 
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2.4. Discussion
Following lesion of substantia nigra dopamine neurons hypersynchronous, <30 Hz 
rhythmic burst activity in the GPe, STN and associated brain nuclei gradually emerges 
and intensifies until it reaches a stable maximum after ~ 2–3 weeks. At this time point 
this study demonstrates through a variety of experimental approaches that loss of 
midbrain dopamine neurons leads to a substantial increase in the synaptic strength 
of the GPe–STN projection. The data are therefore concordant with studies, which 
reported increased GABAA receptor current and binding in the STN ipsilateral to 
dopamine depletion relative to the STN in the intact hemisphere (Yu et al., 2001; Shen 
and Johnson, 2005). However in these studies STN ipsilateral to dopamine lesions 
was compared to the STN from the intact hemisphere, which is a less satisfactory 
control than used here due to the existence of contralateral dopaminergic innervations 
(Fass and Butcher, 1981). Results from this study are also consistent with in vivo 
electrophysiological studies, which imply that the functional connectivity between the 
GPe and STN is strengthened by dopamine depletion (Mallet at al., 2008b; Cruz et 
al., 2011; Moran et al., 2011). Presented here are convergent but independent lines of 
evidence, which support the conclusion that following loss of dopamine the STN–GPe 
projection is strengthened through an increase in the number of GPe–STN synapses 
per axon terminal. The electrophysiological data demonstrated that 1) the frequency 
but not the amplitude of mIPSCs increased; 2) the amplitude of evoked IPSCs 
increased with no alteration in short-term plasticity; 3) current evoked by application 
of an exogenous GABAA receptor agonist increased. Thus, strengthening was mediated 
by an increase in GPe–STN synaptic connections with properties similar to those 
in control tissue. Quantitative PCR data demonstrated that transcription of usually 
expressed GABAA receptor subunits also increased, presumably to supply the newly 
formed synapses with receptors. Immunocytochemical data revealed that the density 
of pre- and postsynaptic synaptic markers was elevated but the density of GABAergic 
axon terminals was unaltered implying an increased number of synapses per GPe–
STN terminal. Finally, electron microscopy confirmed that the number of synapses 
per GPe–STN axon terminal increased with no alteration in the dimensions of GPe–
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STN terminals or their individual synapses or their postsynaptic target preference. 
The correspondence of the datasets both in terms of magnitude and mechanism is 
compelling, e.g. the frequency but not the amplitude of mIPSCs increased, which is 
concordant with both the increased density but not intensity of immunocytochemically 
visualised synaptic markers and the increase in the number but not the size of synapses 
per GPe-STN axon terminal at the electron microscopic level (cf. Nusser et al., 1997).
 A homeostatic regulation of the excitatory and inhibitory balance has been 
proposed as preserving the structure and the function of neuronal networks (Turrigiano, 
1999). Regulation of GPe–STN synaptic transmission through dynamic modification of 
GPe–STN connectivity may represent a homeostatic process for fine-tuning GPe–STN 
interactions. Specifically, the strengthening of the GPe–STN projection might occur 
in response to the hypoactivity of GPe neurons in PD. This process may be recruited 
excessively by profound alterations in pre- and postsynaptic activity, which follows 
the loss of dopamine. However strengthening the GPe–STN projection, aside from 
restricting hyperactivity of the parkinsonian STN, may also increase the capability of 
the GPe to generate synchronous, rhythmic burst firing in the STN and in that respect 
be maladaptive. Indeed, ex vivo and in vivo electrophysiological studies (Baufreton 
et al., 2005, 2009; Hallworth and Bevan, 2005; Mallet et al., 2008b; Tachibana et al., 
2011) and computational modelling (Holgado et al., 2010; Moran et al., 2011) suggest 
that strengthening the GPe–STN projection will enhance the capability of the GPe 
(and cortical inputs) to synchronise STN neurons and generate rhythmic burst firing. 
Furthermore, in the non-human primate model of PD silencing the GPe with muscimol 
abolished hypersynchronous rhythmic burst firing in the STN (Tachibana et al., 2011), 
which implies a crucial role for GPe–STN synaptic transmission in the manifestation 
of parkinsonian STN activity.
 Together with synaptic adaptations in D2-MSNs (Day et al., 2006; Gittis et 
al., 2011), reductions in the autonomous activity of STN neurons (Zhu et al., 2002a; 
Wilson et al., 2006) and downregulation of HCN channels in GPe neurons (Chan et 
al., 2011), this study suggests that loss of dopamine leads to adaptations in elements of 
the indirect pathway. In idiopathic PD it is possible that such adaptations are initially 
homeostatic and delay the symptomatic expression of the disease until the scale of 
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neurodegeneration and resulting adaptation is sufficiently severe that abnormal activity 
such as hypersynchronous firing is generated.  Thus in the basal ganglia and other brain 
regions intrinsic cellular and synaptic plasticity mechanisms may ultimately contribute 
to rather than ameliorate brain dysfunction if the scale of neuronal degeneration or 
disruption is sufficiently extreme (Zhu et al., 2002a; Day et al., 2006; Wilson et al., 
2006; Chan et al., 2011; Gittis et al., 2011; Lewis and Chetkovich, 2011). 
 The processes that regulate the strength of GPe–STN synaptic transmission 
both under normal conditions and following the loss of dopamine are unknown. Apart 
from dopamine’s direct actions on the probability of GPe–STN transmission and the 
frequency and pattern of autonomous STN activity dopamine has also been shown 
to reduce the expression of synaptic GABAA receptors in the nucleus accumbens and 
MSNs through dephosphorylation of beta subunits leading to receptor endocytosis 
(Chen et al., 2006; Goffin et al., 2010).  Although exogenous dopamine does not reduce 
whole-cell GABAA receptor current in STN neurons (Shen and Johnson, 2000) more 
prolonged receptor activation may be required to trigger/detect G protein-coupled 
receptor-dependent removal of receptors.
 In addition, intracellular Ca2+ signalling is likely to be important due to its 
influence on protein kinases and phosphatases, which in turn regulate the translation, 
exocytosis, endocytosis, recycling, degradation and molecular interactions of synaptic 
receptors and associated molecules. In cortical pyramidal neurons the strength of 
GABAergic connections is regulated bidirectionally through postsynaptic activity 
pattern-dependent activation of Cav2.3 and Cav1 channels (Kurotani et al., 2008). 
Activation of Cav1 channels can also enhance the strength of GPe–STN synaptic 
transmission but this effect is mediated through increased extrusion of intracellular 
Cl- (Wang et al., 2006) and cannot therefore account for (but could augment) the 
plasticity described here. Another potential source of postsynaptic Ca2+ is the NMDA 
receptor, which triggers an increase in the number and/or strength of some GABAergic 
synapses (Ouardouz and Sastry, 2000; Marsden et al., 2007). Hyperactivity of STN 
neurons and increased patterning by cortical inputs (Mallet et al., 2008b; Wichmann 
et al., 2011) suggest that activation of both STN Cav channels and NMDA receptors will 
be profoundly enhanced in the parkinsonian STN.  
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 The plasticity described here is presumably mediated, in part, through activation 
of transcription factors e.g. cAMP response element-binding (CREB) and c-fos, which 
upregulate sufficient gene expression for the construction and maintenance of additional 
GPe–STN synapses. Indeed quantitative PCR confirmed that transcription of GABAA 
receptor subunits increased following loss of dopamine. Altered trafficking may also 
contribute to plasticity because NMDA receptor stimulation leads to activation of GABA 
receptor accessory protein (GABARAP) and N-ethylmaleimide-sensitive factor (NSF), 
which chaperone and position GABAA receptors in preparation for exocytosis (Marsden 
et al., 2007). Indeed, exocytosis of GABAA receptors rather than alterations in recycling 
is required for the potentiation of GABAergic synaptic transmission (Ouardouz and 
Sastry, 2000; Marsden et al., 2007; Kurotani et al., 2008). 
 Following export to the cell surface, the mechanisms responsible for the 
positioning of GABAA receptors and associated molecules at synapses are complex and 
connection specific. Tethering of GABAA receptors at synapses is often dependent on 
their interaction with the scaffolding protein gephyrin, whose positioning is in turn 
regulated by cell adhesion molecules such as neuroligin 2 and regulatory proteins like 
collybistin (Smith and Kittler, 2010; Tyagarajan and Fritschy, 2010; Luscher et al., 
2011; Papadopoulos and Soykan, 2011). Indeed, the dynamic expression pattern of 
gephyrin and g2 GABAA receptors in the STN argues that gephyrin is critical for both 
GPe–STN synaptic transmission and plasticity.
 GPe–STN axon terminals are large (Smith et al., 1998; Baufreton et al., 2009) 
and thus provide readily available sites for the addition of synapses in the absence of 
axonal sprouting. Thus, the prolonged decay timecourse of mIPSCs following loss of 
dopamine may reflect cross-activation of receptors at neighbouring synapses rather 
than de novo expression of slowly gating GABAA receptor subunits. The processes 
that mediate coordinated remodelling of GABAergic pre- and postsynaptic machinery 
are poorly understood but presynaptic alterations accompany and often precede 
postsynaptic changes (Dobie and Craig, 2011). Therefore, retrograde messaging and 
cell-to-cell molecular interactions are likely to be critical for coordinated regulation 
of the pre- and post-synaptic elements of GPe–STN synapses both under normal 
conditions and in disease states.
62
CHAPTER 3
CHARACTERISATION OF 
CHANNELRHODOPSIN-2 EXPRESSION IN THE 
SUBTHALAMIC NUCLEUS OF THY1-CHR2-EYFP 
TRANSGENIC MOUSE LINE 18
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3.1. Introduction
PD is a neurodegenerative disease clinically characterised by bradykinesia, akinesia, 
and resting tremor (Samii et al., 2004). The motor symptoms usually manifest 
when more than 60% of dopaminergic neurons in the SNc are degenerate (Dauer 
and Przedborski, 2003). Loss of dopaminergic neuromodulation in the striatum, 
GPe, and STN leads to changes in firing rate and activity pattern within the basal 
ganglia. The abnormal activity pattern appears to be crucial for the manifestation of 
the parkinsonian symptoms because HFS of the STN (DBS) at >100 Hz suppresses 
the pathological rhythmic burst firing and improves motor symptoms, whereas LFS 
makes the symptoms worse (Brown, 2007; Hammond et al., 2007).
 However, the mechanism(s) of STN DBS is still not clear. A deep cellular and 
circuit-level understanding of PD circuitry and DBS mechanism has been challenging 
because of the limitations of traditional methods. Optogenetics is a recently 
pioneered approach involving the use of photosensitive microbial opsins that can be 
stimulated upon illumination to control neuronal activity with spatial and temporal 
precision (Deisseroth, 2010; Deisseroth, 2011). Therefore replacement of electrical 
stimulation with photostimulation allowing selective excitation or inhibition of 
specific cell types could facilitate precise interrogation and correction of abnormal 
neuronal microcircuits in PD. In spite of the ever-expanding optogenetic toolbox for 
more refined manipulations (Fenno et al., 2011), early optogenetic tools, particularly 
ChR2, are still useful for time-locked trigger of AP in response to light pulses. 
 For dissecting neural circuitries, it is important to target optogenetic 
constructs to specific neuronal subsets. A range of ChR2 gene delivery approaches 
have been in use, but they are often labour-intensive and technically challenging.  
Every experimental mouse requires stereotaxic surgery to deliver viral constructs 
encoding the ChR2 transgene. Not every injected mouse expresses the transgene, 
and those that do have variable spread of the viral infection, gradients of transgene 
expression in infected brain regions or potential tissue damage. These potential 
issues are eliminated in cell type-specific ChR2 transgenic mouse lines.
 Thy1-ChR2-EYFP line 18 generated by Feng group (Arenkiel et al., 2007) is 
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one of the early transgenic mouse strains that has been used in a variety of studies. 
This mouse line has been proven to be useful for dissecting the PD circuitry and 
the therapeutic effects of DBS in STN. Using this mouse line, optogenetic driving 
of the cortical–STN connections at high frequency was shown to reverse motor 
impairments in parkinsonian animals (Gradinaru et al., 2009), suggesting that the 
therapeutic effects of DBS could at least in part be attributed to manipulation of this 
pathway.
 Thy1-ChR2-EYFP line 18 is so far known to express high levels of ChR2 in 
multiple brain regions including the motor cortex, hippocampus, thalamus, midbrain 
and brainstem, cerebellum and the olfactory bulb under the Thy1 promoter (Arenkiel 
et al., 2007). Because the STN receives both excitatory and inhibitory inputs from 
various brain regions, the sources of ChR2 expression in the STN is still undefined. 
Identifying and quantifying the sources of ChR2 expression will optimise the 
utility of this mouse strain to investigate and correct the PD circuitry. The objective 
of this study is therefore to characterise the expression of ChR2 from different 
input sources within the STN of Thy1-ChR2-EYFP line 18, using a combination of  
electrophysiological and immunocytochemical approaches.
3.2. Materials and Methods
Experiments were performed in accordance with institutional, NIH and Society for 
Neuroscience guidelines using (Tg(Thy1-COP4/EYFP)18Gfng (Thy1-ChR2-EYFP) 
mice (line 18) obtained from The Jackson Laboratory (Sacramento, USA). Embryo 
rederivation of the animals was performed by Charles River. Thy1-ChR2 mice were 
genotyped following the protocol from The Jackson Laboratory to ensure that they 
were homozygotes. Mice used in this study were adult males aged 2 to 5 months old.
3.2.1. Immunocytochemistry
Animals were perfused transcardially under ketamine/xylazine anaesthesia with 
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room-temperature HEPES-buffered simulated intestinal fluid (SIF), equilibrated 
with O2 and contained (in mM): 140 mM NaCl, 3 mM KCl, 1.6 mM CaCl2∙2H2O, 
1.5 mM MgCl2∙6H2O, and 23 mM glucose, and 15 mM HEPES. Following blood 
clearance, animals were perfused with 4% paraformaldehyde in 0.1 M PB at pH 7.4 
for 25 minutes, then with 0.1 M PB, pH 7.4, for 25 minutes. Each brain was sliced on 
a vibratome at 70 μm in the coronal plane in 0.01 M PBS. Slices were incubated with 
primary antibodies as shown in Table 3.1 in PBS, plus 0.3% Triton X-100 and 2% NDS 
for 48 h at 4°C. After washing, slices were incubated in fluorescent or biotinylated 
secondary antibodies (Jackson Immunoresearch; see Table 4.1) in the same diluent for 
2 h at room temperature. Immunofluorescent slices were mounted in Prolong Gold or 
Prolong Gold with 4‘,6-diamidino-2-phenylindole (DAPI; Invitrogen) and coverslipped. 
Biotin-labelled slices were further reacted with avidin–biotin–peroxidase complex 
(1:100 ABC-Elite; Vector Laboratories) for 2 h at room temperature. Peroxidase linked 
to the EGFP-tagged ChR2 channels by the avidin-biotin bridge was revealed by placing 
the sections in Tris buffer (0.05 M, pH 7.4) containing 0.025% DAB and 0.0025% 
hydrogen peroxide for 5 min. The reaction was terminated by rinsing several times in 
Tris buffer. 0.5% Cresyl Violet Acetate was used as a counterstain to reveal neuronal 
structures. The slices were then mounted on Vectabond-treated (Vector Laboratories) 
slides and dehydrated with alcohol and xylene before being coverslipped in Entellan 
New (Electron Microscopy Sciences, Hatfield, USA).
 Immunofluorescent labelling was visualised using confocal laser scanning 
microscopy (Zeiss LSM 510 or Nikon A1R). Image stacks of immuno (16 optical sections 
each) were acquired using a 63× oil immersion objective (NA 1.4) with a digital zoom 
of 1.5× (x, y: 892 × 892 pixels, 93 nm per pixel; z-step: 0.4 μm) and analysed with 
Image J (National Institutes of Health, Bethesda, USA) or Nikon Elements (Nikon, 
Tokyo, Japan). Sample sites were randomly determined from a grid (frame size 11.9 
× 11.9 μm) superimposed on each image stack captured from STN slices. Vesicular 
glutamate transporter(VGLUT)1, VGLUT2 and VGAT-immunoreactive puncta were 
stereologically selected  ~ 4 μm below the slice surface, using the optical dissector 
method (West, 1999). Colocalisation of the counted puncta with EGFP-positive 
terminals was then determined.
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Antibody Source Species Primary 
dilution
Secondary 
antibody
Secondary 
dilution
double 
labelling
EGFP Clontech Mouse 1:2500 DyLight 488 
donkey anti-
mouse IgG
1:250
VGLUT1
    or
Synaptic 
Systems
Guinea 
pig 
1:1500 DyLight 594 
donkey anti-
guinea pig 
IgG
1:250
VGLUT2
    or
Synaptic 
Systems
Guinea 
pig
1:1500 Dylight 594 
donkey anti-
guinea pig 
IgG
1:250
VGAT Synaptic 
Systems
Rabbit 1:1000 Dylight 594 
donkey anti-
rabbit IgG
1:250
single 
labelling
EGFP Clontech Mouse 1:2500 Biotin-SP 
donkey anti-
mouse
        or
1:500
DyLight 488 
donkey anti-
mouse IgG
1:250
Table 3.1. Antibodies used for immunocytochemical analysis of ChR2 expression in 
the STN
3.2.2. Electrophysiology
Slice preparation. Animals were deeply anaesthetised by intraperitoneal injection of a 
mixture of ketamine (87 mg kg−1) and xylazine (13 mg kg−1) and perfused transcardially 
with ice-cold modified ACSF equilibrated with 95% O2 and 5% CO2 and contained: 230 
mM sucrose, 26 mM NaHCO3, 2.5 mM KCl, 1.25 mM Na2HPO4, 0.5  mM CaCl2, 10 mM 
MgSO4 and 10 mM glucose. The brain was then removed, blocked in the sagittal plane, 
glued to the stage of a vibrating microtome (Vibratome 3000; Leica Microsystems), 
and submerged in ice-cold modified ACSF. Slices of 300 μm thick through STN were 
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cut and transferred to a holding chamber at room temperature containing ‘traditional’ 
ACSF that was equilibrated with 95% O2 and 5% CO2 and contained: 126 mM NaCl, 26 
mM NaHCO3, 2.5 mM KCl, 1.25 mM Na2HPO4, 2 mM CaCl2, 2 mM MgSO4 and 10 mM 
glucose. 
Recording. Brain slices were transferred to a recording chamber that was perfused 
at a rate of 3–5 mlmin-1 with ACSF that was modified to more closely match rodent 
brain interstitial fluid.  ACSF contained 126 mM NaCl, 3 mM KCl, 1.25 mM NaH2PO4.
H2O, 1.6 mM CaCl2.2H2O, 1.5 mM MgSO4.7H2O, 10 mM glucose, and 26 mM NaHCO3 
(equilibrated with 95 % O2 and 5 % CO2) and was heated to ~ 35˚C. Somatic recordings 
were made using borosilicate glass micropipettes containing (in mM): 135 CsCl, 3.6 
NaCl, 1 MgCl2, 10 HEPES, 10 QX-314, 0.1 Na4EGTA, 0.4 Na3GTP, and 2 Mg1.5ATP (pH 7.2, 
290 mOsm). For the recording of evoked glutamatergic currents, 2-(3-Carboxypropyl)-
3-amino-6-(4 methoxyphenyl)pyridazinium bromide (GABAzine; 20 μM) and CGP 
55845 (2 µM) were used to block GABAA and GABAB receptors respectively. To isolate 
NMDA current, DNQX (20 µM) was also applied to block AMPA/Kainate receptors. 
AMPA current trace was relatively isolated by recording in the absence of DNQX and 
substracting it from the NMDA current trace. For the recording of evoked GABAergic 
currents, APV (50 µM) and DNQX (20 µM) were used to block NMDA and AMPA/
Kainate receptors. Photostimulation was generated from 470 nm laser wavelength 
(Polychrome V monochromator; TILL Photonics), by gradually increasing the laser 
output power until a physiological response was elicited (~ < 10 mW), 
3.2.3. Statistics
Data are reported as mean ± SD. Cumulative and box (central line, median; dot, mean; 
box, 25–75%; whiskers, 10–90%) plots are used to illustrate sample distributions. 
Mann-Whitney and Kruskal-Wallis tests were used to test for significant differences 
between two and more than two independent samples respectively. The level of 
significance was set at an α value of 0.05. Non significant differences are denoted as 
N.S..
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3.3. Results
3.3.1. ChR2 expression in glutamatergic and GABAergic afferents in the 
STN
STN receives substantial glutamatergic projections from multiple cortical and 
subcortical regions (Bevan et al., 1995). In order to determine the expression of 
ChR2 in glutamatergic afferents in the STN immunocytochemistry was performed 
on fixed brain sections of adult Thy1-ChR2-EYFP line 18 mice, using VGLUT1 
and VGLUT2 antibodies as cortical and subcortical terminal markers respectively 
(Fujiyama et al., 2004, 2006; Hur and Zaborszky, 2005; Kubota et al., 2007). 
Strong immunofluorescence of EGFP-tagged ChR2-EYFP (EYFP is recognized by 
EGFP antibody) can be observed along afferents and within terminal structures, 
with more intense labelling along the membrane structures. Both VGLUT1 (Fig. 
3.1 A1) and VGLUT2 (Fig. 3.1 A2) immunoreactive structures in the STN showed 
colocalisation with ChR2. Many of the VGLUT2-immunoreactive structures, however, 
were not seen ChR2-positive in comparison with VGLUT1 terminals. Because STN 
also receives GABAergic projections, VGAT antibody was used as a GABAergic 
terminal marker (McIntire et al., 1997) to determine the expression of ChR2 in these 
inhibitory afferents. A large proportion of VGAT puncta colocalised with ChR2-EYFP 
immunofluorescence (Fig. 3.1 A3). Putative somata of STN neurons were devoid of 
ChR2-EYFP (Fig. 3.1), consistent with observations from single EGFP-labelled STN 
sections counterstained with nuclear marker DAPI (data not shown).
 To quantify the proportion of glutamatergic and GABAergic afferents 
expressing ChR2, VGLUT1, VGLUT2 and VGAT immunoreactive structures were first 
selected using stereological method, and their colocalisations with ChR2 were then 
determined.  The percentage of VGLUT1  (76.7 % ± 22.37, n = 16) that colocalised 
with ChR2-EYFP was significantly higher than that of VGLUT2 (19.8% ± 21.3, n = 
16; p < 0.05), but not VGAT (70.6% ± 21.27, n = 16; N.S.; Fig. 3.1 B). The absolute 
densities of the three immunoreactive structures were not significantly different from 
each other (VGLUT1 = 44.6 ± 20.4 million mm-3; VGLUT2 = 43.8 ± 21.1 million mm-3 
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Figure 3.1. Anatomical and functional characterisation of ChR2 expression in the 
STN
A1–3, colocalisation of ChR2-EYFP (green) with terminal markers (red) for cortical 
(VGLUT1) and subcortical (VGLUT2) glutamatergic afferents and GABAergic (VGAT) 
afferents. ChR2-EYFP immunofluorescence colocalised mostly with VGLUT1 (A1) 
and VGAT (A3), and to a much less extent VGLUT2 (A2) immunoreactive-puncta 
(indicated by yellow arrows). Putative neuronal somata (denoted by the white symbol 
*) were largely devoid of ChR2-EYFP fluorescence. B, quantification of colocalisation 
percentage of VGLUT1, VGLUT2 and VGAT immunoreactive structures with ChR2-
EYFP immunofluorescence. The percentage of VGLUT1 puncta (n = 16) positive for 
ChR2-EYFP was similar was significantly higher than that of VGLUT2 puncta (n = 16 ) 
(but not VGAT puncta; n = 16). C1–2, Brief single photostimulation (denoted by arrow) 
of an STN neuron evoked AMPA, NMDA (C1) and GABA (C2) currents at different 
holding potentials. *, p < 0.05.
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; VGAT = 46.5 ± 17.2 million mm-3; N.S.).
 To confirm that ChR2 expressed in the glutamatergic and GABAergic afferents 
was functional, whole-cell patch clamp recordings of evoked synaptic currents were 
performed in acute brain slices from young adult mice. In the presence of GABAzine 
(GABAA receptor antagonist) and CGP 55845 (GABAB receptor antagonist), single 
photostimulation (1 ms) over an STN neuron triggered excitatory AMPA but not 
NMDA current respectively at –65 mV holding potential (Fig. 3.1 C1; for methods 
see section 4.2.2. Electrophysiology). NMDA current was revealed when the cell was 
held at +20 mV (Fig. 3.1 C1), consistent with its known voltage-dependent activation 
due to ion channel block by Mg2+ (Mayer et al., 1984). In the presence of APV (NMDA 
receptor antagonist) and DNQX (non-NMDA receptor antagonist), inhibitory GABA 
current was evoked at –1o mV holding potential (Fig. 3.1 C2). These results suggest 
that the both glutamatergic and GABAergic afferents STN express functional ChR2 
channels sufficient to elicit postsynaptic response upon photoactivation.
3.3.2. Sources of ChR2-expressing projections to the STN
 The possible sources of ChR2-expressing afferents in the STN were examined 
using enzyme immunohistochemistry through DAB staining of ChR2-EYFP. The STN 
is known to receive substantial projections from several regions of the cerebral cortex, 
including prefrontal regions, primary motor cortex and primary somatosensory cortex 
(Canteras et al., 1990; Feger et al., 1994). Intense and widespread cellular labelling of 
layer V cortical neurons was seen throughout the cerebral cortex of the Thy1-ChR2 
transgenic mice, including the primary M1 motor regions (Fig. 3.2 A). GABAergic 
projection to the STN predominantly arises from the GPe (Smith et al., 1998). Indeed, 
intense staining of many neuronal somata and their processes was observed throughout 
the GPe (Fig. 3.2 B).
 In contrast to the cortex, no cellular staining was detected in parafascicular 
thalamic nucleus (PF; Fig. 3.3 A), which is the main subcortical glutamatergic input to 
the STN (Feger et al., 1994; Bevan et al., 1995). Other known subcortical input sources 
(Bevan and Bolam, 1995; Coizet et al., 2009) were also examined, including the 
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Figure 3.2. Neuronal expression of ChR2 in the cerebral cortex and GPe
A–B, DAB staining of ChR2-EYFP revealed cell body and dendritic expression of 
ChR2 in the cerebral cortex and GPe, the main glutamatergic and GABAergic inputs 
respectively to the STN. A1, Cerebral cortex (shown here primary motor area), displayed 
abundant ChR2-EYFP staining in Layer V cortical neurons. High power image from 
the Layer V is shown in A2. B1, GPe, was also labelled strongly in many neurons over 
distributed regions of the nucleus.  High power image from the dorsolateral area of the 
GPe is shown in B2. All scale bars represent 50 μm in length.
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GPe striatum
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Figure 3.3. Subcortical sources of ChR2-expressing glutamatergic and GABAergic 
projections to the STN
A–D, ChR2-EYFP DAB staining in subcortical regions that project to the STN. No 
cellular labelling of ChR2-EYFP was observed in parafascicular thalamic nucleus or 
PF (A1, A2). Labelled cell bodies was detected in the superior colliculus or SC (B1, B2). 
Laterodorsal tegmental nucleus or LTDg did not display any cellular labelling (C). A 
very small number of cells was faintly labelled in the pedunculopontine nucleus or PPN 
(D1, D2). In contrast, midbrain extrapyramidal area or MEA (D1, D3) showed strong 
labelling within both cell bodies and neuronal processes. All scale bars represent 50 
μm in length.
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superior colliculus (SC; Fig. 3.3 B) and three divisions of the mesopontine tegmentum 
(MTg): the laterodorsal tegmental nucleus (LDTg; Fig. 3.3 C) the cholinergic neurons 
from pedunculopontine nucleus (PPN; Fig. 3.2 D), the noncholinergic midbrain 
extrapyramidal area (MEA; Fig. 3.3 D) and. Cell body immunostaining of ChR2-EYFP 
in these midbrain structures was not observed, except for minor labelling in the SC 
and MEA (Fig. 3.3 D). Faint DAB staining in the PPN was also observed in a very small 
number of cell bodies (Fig. 3.3. D).
 Animals of Thy1-ChR2-EYFP line 18 used in this study were embryo-rederived 
due to pathogen contamination of the original mutant strain. To eliminate the 
possibility of spontaneous genetic or epigenetic changes of the embryonic stem cell 
genome (Nagy et al., 1993; Fedorov et al., 1997) causing alterations in ChR2 expression 
pattern, animals of the original line were also subject to anatomical characterisation of 
ChR2 expression in the STN. The percentages of VGLUT1, VGLUT2, and VGAT puncta 
colocalising with ChR2 were not significantly different from the values obtained from 
embryo-derived individuals (VGLUT1 = 81.5% ± 16.6, n = 16; VGLUT2 = 22.2% ± 17.2, 
n = 16; VGAT = 70.6% ± 17). The densities of these immunoreactive structures were 
also similar to those obtained from embryo-derived individuals (VGLUT1 = 41.5 ± 14.6 
million mm-3; VGLUT2 = 43 ± 21.9 million mm-3; VGAT = 45.1 ± 15.5 million mm-3). 
In addition, ChR2 expression patterns in various brain regions (i.e. motor cortex, GPe, 
PF, SC, PPN, MEA, and LTD) projecting to the STN were also qualitatively similar (not 
shown). These results suggest that the embryo-derived animals are a reliable substitute 
to the original Thy1-ChR2-EYFP line with quantitatively similar ChR2 expression 
pattern in the VGLUT1, VGLUT2 and VGAT terminals within the STN.
3.4. Discussion
Immunocytochemical data in this study revealed that EYFP-tagged ChR2 is expressed 
in both glutamatergic and GABAergic afferents within the STN of the embryo-derived 
animals from Thy1-ChR2-EYFP line 18, with similar expression pattern to that 
observed in the original line. Using VGLUT1 and VGLUT2 as cortical and subcortical 
glutamatergic terminal markers respectively, analysis of ChR2-EYFP colocalisation 
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suggested that most of the cortical afferents (~ 4 out of 5) but to a much less extent 
the subcortical afferents (~ 1 out of 5) in the STN expressed ChR2. Considering that 
the densities of VGLUT1 and VGLUT2 immunoreactive terminals were similar, the 
ratio of ChR2-positive glutamatergic afferents in the STN of Thy1-ChR2-EYFP line 
18 of cortical origins to that of subcortical origins is about 4:1. In addition, ChR2 is 
also expressed by GABAergic afferents, as suggested by colocalisation of ChR2-EYFP 
with VGAT, a marker for GABAergic terminals. Similar density of VGAT and VGLUT1 
immunoreactive puncta and the percentage of VGAT and VGLUT1 puncta colocalised 
with ChR2-EYFP suggest that as many GABAergic afferents in the STN express ChR2 
as glutamatergic cortical afferents. Functional expression of ChR2 in glutamatergic 
and GABAergic afferents was confirmed by electrophysiological recordings that 
demonstrated the capability of photostimulation to evoke AMPA, NMDA and GABA 
currents in the STN neurons.
 Electrophysiological studies (Paz et al., 2005), retrograde (Canteras et al., 1990; 
Feger et al., 1994) and anterograde labelling (Kita and Kita, 2012) in rodents suggest 
that cortical–STN innervations largely originate from layer V pyramidal neurons in 
motor cortex. In this and previous studies (Arenkiel et al., 2007) substantial ChR2 
expression was observed in the layer V cortical neurons of Thy1-ChR2-EYFP mouse 
line 18, consistent with results presented here showing high proportion of VGLUT1-
immunoreactive terminals in the STN was ChR2-positive. Subcortical excitatory 
projections in the STN predominantly arise from the intralaminar thalamus, 
particularly the centro-median parafascicular complex (Feger et al., 1994; Bevan et 
al., 1995). However, minimal somatic expression of ChR2 was detected within the 
PF of the transgenic ChR2-EYFP mouse line. Within other subcortical midbrain 
structures that project to the STN (Bevan and Bolam, 1995; Coizet et al., 2009), cellular 
immunostaining of ChR2-EYFP was similarly absent except for minor labelling in the 
SC and MEA (presumably also PPN to a much lesser extent). Although both GABAergic 
and glutamatergic projection neurons are found in the SC, GABAergic neurons mostly 
innervate locally within the nucleus (Lee and Hall, 2006; Sooksawate et al., 2011). 
MEA is largely noncholinergic and may also give rise to glutamatergic (and GABAergic) 
projections to the STN (Bevan and Bolam, 1995). Therefore these data suggest that the 
small proportion of ChR2-positive VGLUT2 terminals may largely originate from the 
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SC and/or MEA.
 Since STN predominantly receives GABAergic projection from the GPe (Smith 
et al., 1998), most of VGAT terminals that were ChR2-positive are likely to arise from 
the nucleus. Indeed, ChR2-EYFP DAB staining was detected in many neuronal cell 
bodies across distributed regions of the GPe, suggesting that these neurons are the main 
origin of GABAergic projections to the STN. Although STN also receives GABAergic 
projection from the ventral pallidum, the innervation is known to be restricted only 
to the very medial pole of STN (Bevan et al., 1997). However, minor ChR2-positive 
GABAergic projection from the immunoreactive MEA remains a possibility (Bevan 
and Bolam, 1995).
 The results from this study have several implications. First,  the current study 
could be the first rigorous quantification of the relative abundance of different cortical 
and subcortical inputs to STN. Selectivity in stimulation of cortical-STN input, which 
has been difficult with traditional stimulation electrodes, is particularly important 
considering the unexpected finding that subcortical glutamatergic inputs to STN 
are just as numerous as cortical inputs to STN. Multiple sources of glutamatergic 
afferents often cause difficulty in interpreting results from various studies of synaptic 
phenomena in the STN. Although not exclusive, the abundant expression of ChR2 in 
cortical afferents compared to subcortical afferents in the STN of Thy1-ChR2-EYFP 
line 18 will significantly improve the specificity of cortical input stimulation. 
 Second, characterisation of ChR2 expression in the STN will facilitate more 
precise interrogation of the mechanisms underlying DBS. Previous study using Thy1-
ChR2-EYFP line 18 mice demonstrated that optogenetic HFS of motor cortex and of 
afferents in the STN improved motor impairments in parkinsonian animals, suggesting 
that DBS exerts its effect through driving the cortical–STN input (Gradinaru et 
al., 2009). This study however reveals abundant expression of ChR2 in GABAergic 
terminals within the STN, implying that manipulation of GPe–STN input could in part 
contribute to the reversal of parkinsonian symptoms during DBS. This speculation is 
consistent with the observation that LFS of STN worsened motor symptoms in these 
parkinsonian animals similar to observations in PD patients, whereas LFS of motor 
cortex did not produce such effect (Gradinaru et al., 2009). 
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 Indeed growing body of evidence suggests that abnormal GPe–STN 
transmission following dopamine depletion is critical for the manifestation of activity 
rate and pattern changes of extrastriatal basal ganglia in experimental PD due to its 
pivotal position in the GPe–STN reciprocal network and in the indirect pathway of 
basal ganglia circuitry, as well as its interaction with glutamatergic input in the STN 
(Bevan et al., 2007; Wilson and Bevan, 2011). The Thy1-ChR2-EYFP mouse line will be 
a useful transgenic model to probe into the cellular principles regulating cortical and 
GPe–STN inputs and their modulation by dopamine in health and experimental PD.
 Despite the non-exclusive specificity of ChR2 expression in cortical afferents 
within the STN, long-term use of this transgenic mouse strain will be a highly efficient 
alternative to costly and labour-intensive methods for repeated ChR2 delivery to the 
same specific classes of neurons. Although variants of ChR2, such as ChETA or ChiEF, 
have been developed to address some of the issues associated with ChR2 (eg. relatively 
slower kinetics and minor calcium permeability), they have not been extensively tested 
and wild-type ChR2 remains a robust choice for highly specific method to manipulate 
neuronal activity (Gunaydin et al., 2010; Berndt et al., 2011; Lin et al., 2011).
79
CHAPTER 4
THE IMPACT OF HCN CHANNELS ON 
INHIBITORY SYNAPTIC INTEGRATION IN 
NEURONS OF THE SUBTHALAMIC NUCLEUS
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4.1. Introduction
The firing patterns of STN neurons are highly correlated with normal movement 
and abnormal movement in PD and are generated through the dynamic, non-linear 
interplay between intrinsic and synaptic conductances (Crossman, 2000; Brown, 
2003; Wichmann and Delong, 2003; Bevan et al., 2006). Apart from glutamatergic 
projections from the cortex and intralaminar thalamus (Bevan et al., 1995), the STN is 
innervated by GABAergic afferents that predominantly arise from the GPe (Smith et 
al., 1998). Although GPe neurons fire at relatively high frequency in vivo (Urbain et al., 
2000) and their inputs can potently pattern the frequency and synchronisation of the 
STN activity (Bevan et al., 2002; Baufreton et al., 2005,2009), GPe and STN neuronal 
activities are rarely correlated under normal conditions (eg. Hallworth and Bevan, 
2005; Mallet et al., 2008b). The intrinsic conductances that actively oppose inhibitory 
conductances might therefore play an important role. One potential candidate is the 
HCN channels because their role in the STN neurons is still poorly understood. Despite 
high levels of expression (Santoro et al., 2000; Notomi and Shigemoto, 2004), the 
channels do not contribute to the characteristic autonomous activity of STN neurons 
and their role in (certain forms of) synaptic integration appears minimal (Bevan and 
Wilson, 1999; Beurrier et al., 2000; Do and Bean, 2003; Baufreton et al., 2005). Thus, 
blockade of HCN channel function has no effect on firing rate or rhythmicity of STN 
cells or on the resetting of firing by single GABAergic synaptic inputs. The duration 
and degree of hyperpolarization produced by individual IPSPs are apparently not 
enough to strongly activate HCN channels (and deinactivate Cav3 channels; Baufreton 
et al., 2005). In contrast, in many classes of nerve cell HCN channels underlie a key 
conductance that contributes to intrinsic activity and sculpts the integration of synaptic 
inputs (Robinson and Siegelbaum, 2003; Baruscotti and DiFrancesco, 2004; Biel et 
al., 2009).
 The molecular and biophysical properties of native HCN channels have been 
extensively characterised (Robinson and Siegelbaum, 2003; Baruscotti and DiFrancesco, 
2004; Biel et al., 2009). Native HCN channels comprise homo- or hetero-tetramers 
of up to 4 subunits (HCN1–4), activate progressively with hyperpolarisation and are 
modulated directly by cyclic AMP. HCN channels invariably mediate depolarisation 
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because the equilibrium potential of their mixed cation current is ~ –30 mV. HCN 
channels subserve a range of neuronal functions. Thus, HCN channels contribute 
oscillatory properties to neurons and neuronal networks (Lüthi and McCormick, 1998; 
Bennett et al., 2000; Ludwig et al., 2003; Chan et al., 2004; Garden et al., 2008), 
regulate the location dependence of synaptic potential magnitude and time course 
(Magee, 1998, 1999; Williams and Stuart, 2000; Angelo et al., 2007), oppose bistability 
and Ca2+ channel-mediated electrogenesis (Pape and McCormick, 1989; Lüthi and 
McCormick, 1998; Williams et al., 2002; Tsay et al., 2007) and mediate homeostatic 
adjustments in intrinsic excitability (Fan et al., 2005).  
 In STN neurons, HCN channel currents can be readily detected upon prolonged 
hyperpolarization of the membrane potential by current pulses (Nakanishi et al., 1987; 
Bevan and Wilson, 1999; Beurrier et al., 2000). Upon removal of the hyperpolarization, 
prominent rebound bursts are seen in all STN neurons due to the deinactivation of low-
voltage-gated Cav3 channels (Bevan et al., 2002; Hallworth et al., 2003). Therefore, 
these Ca2+ and non-specific cation currents are often present together, and their 
interaction may be functionally relevant to PD which involves excessive burst firing in 
the STN. Indeed, HCN channel dysregulation has been linked to certain neurological 
disorders including epilepsy and PD (Shah et al., 2004; Kole et al., 2007; Shin et al., 
2008; Meurers et al., 2009; Chan et al., 2011).
 The functional roles of HCN channels are related to a variety of factors including 
their subunit composition, compartmental expression pattern, voltage-dependence, 
kinetics and interaction with intrinsic and synaptic conductances (Robinson and 
Siegelbaum, 2003; Baruscotti and DiFrancesco, 2004; Biel et al., 2009). Therefore, 
in order to address the specific roles of HCN channels in STN neurons, following 
techniques were applied: 1) single cell molecular profiling to determine the subunit 
expression pattern 2) immunocytochemistry to determine the plasma membrane 
expression pattern 3) patch clamp recording to determine the biophysical properties 
of HCN channels and their role in burst firing 4) dynamic clamp to determine their role 
in the integration of inhibitory inputs, and 5) computational modelling to examine the 
interaction of HCN and other ion channels.
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4.2. Materials and methods
This study utilised tissue prepared from male Sprague Dawley or Wistar rats (p16-adult) 
and adult C57BL/6 HCN2 wildtype and deficient mice (Ludwig et al., 2003).  Procedures 
were performed in accordance with the policies of the Society for Neuroscience, the 
National Institutes of Health, the 1986 UK Animals (Scientific Procedures) Act and 
the Institutional Animal Care and Use Committees of Bordeaux, Northwestern and 
Sheffield Universities and the Graduate University for Advanced Studies, Okazaki, 
Japan.
4.2.1. Single cell molecular profiling
STN neurons (p16-25) were acutely isolated and subjected to molecular profiling using 
the single cell reverse transcription polymerase chain reaction technique (scRTPCR), 
as described previously (Tkatch et al., 2000; Ramanathan et al., 2008). The results 
of scRTPCR were expressed as a fraction of cells with detectable mRNA levels. The 
detection of mRNA was based on the presence of a clearly visible band of the appropriate 
size in an ethidium bromide-stained gel. In order to ensure consistent efficacy of 
reverse transcriptase all experiments were carried out with the same batch of enzyme. 
HCN1 mRNA (GenBank accession AF247450) was detected with a pair of primers 
ATGCCTCTCTTTGCTAACGC (position 1458) and TATTCCTCCAAGACCTCGTTGAA 
(position 1476), which gave a PCR product of 311 bp. HCN2 mRNA (GenBank accession 
AF247451) was detected with a pair of primers TTCCGCCAGAAGATCCACGATTA 
(position 1318) and GAACACGTGCGACTTACTCATAA  (position 832), which 
gave a PCR product of 185bp. HCN3 mRNA (GenBank accession AF247452) was 
detected with a pair of primers GTCGGAGAACAGCCAGTGTAA (position 1496) and 
TGAGCGTCTAGCAGATCGAG (position 1928), which gave a PCR product of 452 bp. 
HCN4 mRNA (GenBank accession AF247453) was detected with a pair of primers 
ATCAACGGCATGGTGAATAACTC (position 1584) and TGCCCTGGTAGCGGTGTTC 
(position 1893), which gave a PCR product of 328 bp. 
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4.2.2. Immunohistochemical analysis of HCN2 subunit expression
The rabbit polyclonal HCN2 antibody used in this study was raised against glutathione 
S-transferase fusion proteins containing the C-terminus of rat HCN2 (amino acid 
residues 797-862), as described previously (Notomi and Shigemoto, 2004). For 
immunization, HCN2 fusion protein was purified by sodium dodecyl sulphate-
polyacrylamide gel electrophoresis. The gel fragments containing the purified fusion 
protein were emulsified with Freund’s complete (first immunization) or incomplete 
(second immunization) adjuvant (Nacalai tesque, Kyoto, Japan) and injected 
subcutaneously into rabbits (500 mg fusion protein per animal) at intervals of 4 
weeks. From antisera collected 2 weeks after the second injection, HCN2 antibody 
was affinity purified, first using Protein G-Sepharose (Amersham Pharmacia Biotech, 
Uppsala, Sweden) and then CNBr-activated Sepharose 4B (Amersham Pharmacia 
Biotech) coupled to the HCN2 fusion protein. The specificity of immunostaining with 
the HCN2 antibody was verified using an HCN2 gene-deficient mouse (Ludwig et 
al., 2003) (Fig. 4.1). Adult wild-type and HCN2 gene-deficient (Ludwig et al., 2003) 
mice were deeply anaesthetised with pentobarbital, perfused with phosphate buffered 
saline (PBS; 0.01 M phosphate, pH 7.4) for 1 minute, followed by fixative containing 
4% paraformaldehyde, 0.05% glutaraldehyde, and 15% saturated picric acid in 0.1 M 
phosphate buffer (PB; pH 7.4) for 15 minutes. Brains were removed and sections cut on 
a vibratome (VT1000s; Leica Microsystems) at a thickness of 50 μm. Sections were then 
incubated at 4oC with the HCN2 antibody (1.0 μg/ml) in PBS containing 0.1% Triton 
X-100, 0.25% -carrageenan, and 0.5% normal goat serum (NGS). After several washes 
in PBS the sections were incubated with biotinylated goat anti-rabbit IgG antibody 
(1:200, Vector Laboratories; Burlingame, USA) at room temperature for 1 hour and then 
with avidin–biotin–peroxidase complex (1:100 ABC-Elite in PBS; Vector Laboratories) 
at room temperature for 1 hour. Finally, sections were incubated in DAB (Dojindo, 
Kumamoto, Japan) and hydrogen peroxide to reveal immunoreactivity. Sections were 
then mounted on glass slides and prepared for light microscopic analysis.
Rats (p20-adult; Charles River) were deeply anaesthetised with ketamine and 
xylazine and perfused via the ascending aorta with PBS, followed by 300 ml of 4% 
paraformaldehyde and 0.05% glutaraldehyde in PB followed by 200 ml of PB. Brains 
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were then removed and sectioned in the sagittal plane on a vibratome (VT1000s; 
Leica Microsystems) at 70 μm. Sections were freeze-thawed, washed in PBS and then 
incubated in PBS containing 10% NGS for 2 h prior to antibody incubations in PBS 
containing 2% NGS. Sections were incubated in the HCN2 antibody described above 
at 0.5 µg/ml, for 48 h at 4°C. Sections for immunoperoxidase labelling were incubated 
in biotinylated goat anti-rabbit IgG (1:200; Vector Laboratories) for 2–3 h, followed 
by 2 h in avidin–biotin–peroxidase complex (1:100 ABC-Elite; Vector Laboratories), 
at room temperature. Bound peroxidase was then revealed by incubating the sections 
in DAB in the presence of hydrogen peroxide (Vector Laboratories). Sections for 
immunogold labelling were incubated in goat anti-rabbit IgG coupled to 1.4 nm gold 
particles (1:100; Nanoprobes, Yaphank, USA) for 3–4 h at room temperature. Bound 
gold particles were silver-enhanced using the HQ Silver kit (Nanoprobes). Sections 
were then postfixed in 1% osmium tetroxide in PB for 25 min (immunoperoxidase) or 
10 min (immunogold) and dehydrated through a graded series of alcohol dilutions and 
embedded in resin (Durcupan ACM Fluka; Sigma-Aldrich) on glass slides. 
Immunoreactive structures in the STN were examined using a light microscope 
equipped with 40–100× oil immersion objectives (Zeiss Axioskop, Zeiss, Oberkochen, 
Germany) and images were captured using a high-resolution digital camera (Zeiss 
Axiocam). The dimensions of immunoreactive neuronal somata and putative glial 
cell bodies were quantified from the digital images using Image J (National Institutes 
of Health, Bethesda, USA) and compared statistically using the Mann-Whitney U 
test (Prism 5, GraphPad Software). An α value of 0.05 was used as the criterion for 
determining statistically significant differences. Following light microscopic analysis, 
areas of the STN were excised, re-sectioned at 50–70 nm on an ultramicrotome (UCT, 
Leica Microsystems) and collected on pioloform-coated, single-slot copper grids. 
Ultrathin sections were then stained with 1 % uranyl acetate for 30 min followed by 
lead citrate for 2–3 min before being imaged and analysed with a Jeol 1200 (Jeol 
USA, Peabody, USA) or Tecnai G2 Spirit (FEI, Hillsboro, USA) transmission electron 
microscope. Electron microscopic analysis of structures expressing HCN2 was 
performed on rat DAB and immunogold labelled tissue. Tissue close to the surface of 
the block was analysed to minimise false negative labelling due to limited penetration 
of immunoreagents. The densities of immunogold particles overlying somatic and 
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dendritic compartments were quantified using Reconstruct (http://synapses.clm.
utexas.edu/tools/reconstruct/reconstruct.stm). Given that the dendrites of STN 
neurons tend to decrease in diameter with distance from the soma (Kita et al., 1983; 
Afsharpour, 1985), proximal dendrites were defined arbitrarily as having a diameter > 
1 µm and distal dendrites as having a diameter < 1 µm (two perpendicular diameters 
were measured for each dendrite and the minimum diameter was used for analysis). 
The distance of immunogold particles from the middle of the plasma membrane to the 
middle of the particle was measured. The best Gaussian fit to the data showed a peak 
position at 23.3 nm from the membrane with an SD of 9.9 nm. A gold particle was thus 
considered to be associated with the plasma membrane if it was located within an area 
that was up to 43 nm (peak + 2SD) of the cytoplasmic side of the plasma membrane. 
Immunoparticle densities were measured by calculating the number of gold particles 
per unit area.  Nonspecific labelling was considered to be the density of nuclear labelling. 
The compartmental distribution of HCN2 labelling was compared statistically using 
the Kruskal-Wallis test with Dunnett’s post hoc analysis (Prism 5, GraphPad Software) 
An α value of 0.05 was used as the criterion for determining statistically significant 
differences.
4.2.3. Electrophysiology
Slice preparation and recordings. Brain slices were prepared, maintained and then 
transferred to recording chamber as described previously (refer to section 3.2.2. 
Electrophysiology). Somatic recordings, made using borosilicate glass micropipettes, 
were obtained under visual guidance (Axioskop FS2, Zeiss) using computer-controlled 
manipulators (Luigs & Neumann) and a Multiclamp 700B amplifier and digidata 
1440A digitizer controlled by PClamp 10 (Molecular Devices). Recording pipettes 
contained 135 mM K-MeSO4, 3.8 mM NaCl, 1 mM MgCl2.6H2O, 10 mM HEPES, 0.1 
mM Na4EGTA, 0.4 mM Na3GTP, and 2 mM Mg1.5ATP. The resistance of filled pipettes 
(as measured in the bath) was 3–4 MΩ for voltage clamp experiments, and 5–12 MΩ 
for current clamp experiments.  
 Recordings were acquired using Clampex 10 software (Molecular Devices, Palo 
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Alto, CA) running on a PC connected to a Multiclamp 700B amplifier (Molecular 
Devices) via a Digidata 1322A digitizer (Molecular Devices). Recordings were low-pass 
filtered online at 10 kHz and sampled at 50 kHz. For current clamp recordings electrode 
capacitance was compensated on-line and voltage errors due to series resistance were 
either compensated on-line or corrected off-line. For voltage clamp recordings, electrode 
capacitance and series resistances of ~ 10–20 MΩ were electrically compensated. A 
liquid junction potential correction of 9 mV was subtracted from whole-cell recordings. 
Synthetic GABAAR-mediated IPSPs were generated through the patch pipette using 
a synaptic module (SM-1) conductance injection amplifier (Cambridge Conductance, 
Cambridge, UK), as previously described (Baufreton et al., 2009). 
Drugs. All drugs used were prepared as concentrated stock solutions and stored at 
–20˚C. On the day of the experiment drugs were diluted and applied either through 
the bath or local perfusion system. GABAergic and glutamatergic synaptic transmission 
was blocked for all experiments. NMDA, AMPA, GABAA and GABAB receptors were 
blocked with 50 µM APV (Ascent Scientific, Princeton, NJ), 20 µM DNQX (Ascent 
Scientific), 20 µM GABAzine (Ascent Scientific; SR 95531) and 2 µM CGP 55845 
(Tocris Bioscience, Ellisville, USA), respectively. Nav and HCN channels were blocked 
with 1 mM TTX (Ascent Scientific) and 20 µM 4-ethylphenylamino-1,2-dimethyl-6-
methylaminopyrimidinium chloride (ZD7288; Ascent Scientific), respectively. Because 
ZD7288 may have non-specific effects (Chevaleyre and Castillo, 2002; Do and Bean, 
2003; Felix et al., 2003), 2 mM Cs was also applied in some experiments to block HCN 
channels (Halliwell and Adams, 1982).
Data analysis. Data were analysed using Clampfit 10 (Molecular Devices), IgorPro 6 
(Wavemetrics, Portland, OR), and Prism 5 (GraphPad Software). Line scan images were 
analysed with IgorPro 6. Maximum intensity projections of Z-series were generated 
with Image J (National Institutes of Health, Bethesda, USA). Numerical data are 
presented as mean ± SD. An α value of 0.05 was used as the criterion for determining 
statistically significant differences.
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4.2.4. Computational modelling
In order to further investigate the impact of HCN channels on synaptic integration, a 
simplified compartmental model consisting of a single spherical somatic compartment 
and a four-compartment dendrite, of which each compartment was represented by a 
cylinder was constructed. The suffix i represents the location of each compartment, 
with 0 for the somatic compartment and 1–4 for each dendritic compartment. The 
diameter (di) and length (li) of each compartment are listed in Table 4.1. The membrane 
potential of the i-th compartment Vi was calculated from the following equation:
	  
where cm is unit membrane capacitance (cm = 1 μF cm
–2) and Ai is the surface area of the 
i-th compartment (πdili). g
axis is the axial conductance between adjacent compartments 
and was determined from the cytoplasmic resistance Ra (150 Ωcm) (Gillies and 
Willshaw, 2006) and the dimensions of adjacent compartments according to the 
following equation:
	  
Iion, Isyn and Iapp are ionic current density, synaptic current and applied current, 
respectively. The ionic current density Iion was determined by currents flowing through 
several ion channels including leak, Nav, class 3 voltage dependent K
+ (Kv3), small 
conductance Ca2+-dependent K+ (SK), class 3 and 2.2 voltage dependent Ca2+ (Cav3 and 
Cav2.2, respectively) and HCN channels:
	  
Gating variables for each ion channel were described by an activation function and a 
time constant:
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where x represents the gating variable and u is membrane potential for a voltage-
dependent channel or intracellular Ca2+  concentration for the SK channel.  Intracellular 
calcium concentration obeyed the following equation (Otsuka et al., 2004):
	  
where Z is the valence of calcium ion (2), F is the Faraday constant, KCa is the 
Ca2+ removal rate (2 ms) and γi is the ratio of surface area to volume for the i-th 
compartment. Parameters for Nav, Kv3, Cav3 and SK channels were adopted from the 
model of Otsuka and colleagues (2004) with voltage-dependent functions shifted by 
–7.1 mV for Nav and –5 mV for the others (θx, φx
1
 and φx
2 are changed). Parameters 
for Cav2.2 channels were adopted from Tsay and colleagues (2007) except for a shift 
in voltage-dependence of –5 mV. The activation function of HCN channels was based 
on experimental data.  The voltage-dependent time constant of Angelo et al. (2007) 
was adopted except that the time constant τ x
1 was increased from 1600 ms to 2400 
ms. Parameters for each channel are detailed in Table 4.2. Equilibrium potentials (E) 
were set as follows: Eleak= –67 mV, ENa= 50 mV, EK= –90 mV and Ecation= –35 mV for the 
HCN channel. ECa was determined by the Nernst equation. To determine the impact of 
HCN channel expression and compartmental distribution 3 models were investigated: 
somatic, somatodendritic and deficient.  Respectively, HCN conductance was restricted 
to the soma, uniformly expressed in each compartment or entirely absent. The total 
HCN conductance for each model (Σi AigHCN,i) was equivalent for the somatic and 
somatodendritic models. The initial magnitude of conductances in each compartment 
are detailed in Table 4.1 and were chosen so that 1) model neurons exhibited typical 
membrane properties of STN neurons i.e., autonomous activity of ~ 10 Hz, voltage sag 
in response to hyperpolarising current injection (for models in which HCN channels 
were expressed) and rebound burst activity; 2) the impact of channel removal was 
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similar to that observed experimentally (Bevan et al., 1999; Beurrier et al., 2000; 
Hallworth et al., 2003); 3) APs were generated in the soma before propagating into 
the dendritic compartment, as observed experimentally (Atherton et al., 2008). The 
maximum conductance of each ion channel in each compartment is indicated in Table 
4.1. Isyn represents excitatory and inhibitory synaptic currents. EPSCs were modelled as 
a compound of AMPA receptor-mediated and NMDA receptor-mediated components. 
The AMPA receptor-mediated EPSC was described by the model of Tsodyks and 
Markram (1997):
	  
where e and r represent effective and recovered ratios of neurotransmission, 
respectively. The decay constant of the EPSC τ and the recovery time constant τrec were 
set to 2.5 ms and 200 ms, respectively. The presynaptic release probability U was 0.2. 
tAP represents the timing of the presynaptic AP. 
The NMDA receptor-mediated EPSC was described by the model of Destexhe and 
colleagues (1998):
	  
where α–1 and β–1 are rise and decay time constants of the open ratio of receptors (s) and 
were set to 2.0 ms and 142.8 ms, respectively. The variable T represents presynaptic 
neurotransmitter release, which was set to 1 ms after the occurrence of an AP, and is 
otherwise 0. F(V) is a postsynaptic-voltage-dependent function that represents voltage 
dependent Mg2+ block. The inhibitory postsynaptic current mediated by GABAA 
receptors was modelled similarly to AMPA receptors except that a decay time constant 
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of 8.0 ms was employed. Finally, simulation codes were written in C and numerical 
integration was carried out with the fourth order Runge-Kutta method. An integration 
time step of 0.05 ms was used although similar results were obtained with a time step 
of 0.01 ms.
soma 0 dend 1 dend 2 dend 3 dend 4
diameter	[μm] 10.0 2.0 1.5 1.0 0.5
length 10.0 100.0 100.0 100.0 100.0
gleak [mScm
–2] 0.08 0.08 0.08 0.08 0.08
gNav 33.0 0.01 0.01 0.01 0.01
gKv3 69.0 0.01 0.01 0.01 0.01
gSK 0.1 0.1 0.1 0.1 0.1
gCav3 0.6 0.6 0.6 0.6 0.6
gCav2.2 1.0 1.0 0.1 0.1 0.1
GHCN (somatic) 1.2 0.0 0.0 0.0 0.0
GHCN (uniform) 0.2 0.2 0.2 0.2 0.2
GHCN	(deficient) 0.0 0.0 0.0 0.0 0.0
Table 4.1. Morphological and electrical properties of the STN neuron model
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Channel Parameters Values Channel Parameters Values
Nav θ­m , km –47.1, –8.0 Cav2.2 θw , kw –64.0, 10.0
Nav τm
0, τm
0 0.2, 3.0 Cav2.2 τw
0
, τw
1 121.0, 0
Nav φm , σm –58.0, –0.7 Cav3 θp , kp –61.0, –6.7
Nav θh , kh –50.5, 6.4 Cav3 τp
0, τp
1 5.0, 0.33
Nav τh
0, τh
1 0, 24.5 Cav3 φp
1, σp
1 –32.0, –10.0
Nav φh
1, σh
1 –55.0, –15.0 Cav3 φp
2, σp
2 –107.0, 15.0
Nav φh
2, σh
2 –55.0, 16.0 Cav3 θq , kq –95.0, 5.8
Kv3 θn , kn –46.0, –14.0 Cav3 τq
0, τq
1 0, 400.0
Kv3 τn
0
, τn
0 0, 11.0 Cav3 φq
1, σq
1 –55.0, –15.0
Kv3 φn
1
, σn
1 –45.0, –40.0 Cav3 φq
2, σq
2 –55.0, 16.0
Kv3 φn
2
, σn
2 –45.0, 50.0 HCN θf , kf -90.0, 8.0
SK θr , kr 0.17, –0.08 HCN τf
0, τf
1 0, 2400.0
SK τr
0, τr
1 2.0, 0.0 HCN φf
1, σf
1 –68.0, –22.0
Cav2.2 θv , kv –7.0, –10.0 HCN φf
2, σf
2 –68.0, 7.0
Cav2.2 τv
0
, τv
1 3.0, 0
Table 4.2. Channel parameters of the STN neuron model
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4.3. Results
4.3.1. STN neurons express multiple HCN subunits
scRTPCR analysis was carried out to determine the pattern of HCN channel subunit 
mRNA expression in individual acutely isolated STN neurons (Fig. 4.1 A, B). Of 16 
cells tested, 8 (50.0%) expressed detectable levels of HCN1 channel subunit mRNA, 
13 (81.3%) expressed HCN2 and HCN3 subunit mRNA and 4 (25%) expressed HCN4 
subunit mRNA (Fig. 4.1 B). 
 The STN has previously been shown to most strongly express HCN2 (Monteggia 
et al., 2000; Santoro et al., 2000; Notomi and Shigemoto, 2004). Light microscopic 
analysis confirmed that the rat and mouse STN was immunoreactive for HCN2 and 
demonstrated that STN immunoreactivity was abolished in HCN2 deficient mice (Fig. 
4.1 C–E; Ludwig et al., 2003). Immunoreactivity was present in the somata of STN 
neurons, smaller diameter putative glial cells (minimum diameter of STN neurons = 
9.6 ± 1.5 μm, n = 54; minimum diameter of putative glial cells = 6.6 ± 1.0 μm, n = 40; 
Mann-Whitney U test, p < 0.05) and fine dendritic- and axonal-like structures (Fig. 4.1 
C, D). HCN2 immunoreactivity in other brain regions was also consistent with earlier 
reports (Monteggia et al., 2000; Santoro et al., 2000; Notomi and Shigemoto, 2004; 
data not shown). 
 Given that axons, terminals and perineuronal oligodendrocytes also express 
HCN2 subunits (Notomi and Shigemoto, 2004; Boyes et al., 2007) electron microscopic 
analysis of DAB labelled tissue was employed to determine the expression pattern of 
HCN2 in the somatodendritic compartment of STN neurons. Small and large diameter 
dendrites and neuronal somata were immunoreactive (Fig. 4.2 A). Labelled glial cells 
(putative perineuronal oligodendrocytes) were readily distinguished from the somata 
of STN neurons on the basis of their well-characterised ultrastructural properties 
including round/ovoid nuclei with relatively dense clumps of heterochromatin, 
electron dense cytoplasm filled with ribosomes and short strands of Golgi apparatus 
and endoplasmic reticulum (Ludwin et al., 1979; data not shown).
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Figure 4.1.  Expression of HCN channels
A, Gel from a single STN neuron that expressed HCN1, 2 and 3 mRNA. B, scRT-PCR 
detection rate of HCN1–4 subunits in STN neurons (n = 16). C, Light micrograph of 
rat STN HCN2 immunoreactivity visualised with DAB and intensified by post-fixation 
with osmium tetroxide. Arrowheads point to small immunoreactive elements in the 
neuropil. Neuronal somata (s) and small glial cells (g) were also weakly and strongly 
labelled, respectively. D–E, STN HCN2 immunoreactivity (as revealed by DAB without 
post-fixation with osmium tetroxide) in a wild type (WT) and HCN2 knockout (HCN2 
KO) mouse. The pattern of labelling in the rat and WT mouse STN (labelled as for 
C) are similar. However, specific labelling was abolished in the STN of the HCN2 KO 
mouse. 
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Figure 4.2. HCN2 immunoreactivity is expressed across the somatodendritic axis of 
STN neurons
A, Electron micrograph of STN HCN2 immunoreactivity visualised with DAB. 
Reaction product (arrowheads) was observed in the soma (s) of a STN neuron and 
dendrites (d) of varying diameters. B, The density of HCN2 immunogold particles 
overlying the somatodendritic membrane (M) was similar across the somatodendritic 
axis and significantly higher than the densities overlying cytoplasmic (C) or nuclear 
compartments. This sample was taken from p41 tissue. C–D, Selective association of 
HCN2 immunogold particles (arrowheads) with the plasma membrane of small (< 1 
μm) and large (> 1 μm) diameter dendritic (d; C) and somatic (s; D) compartments of 
STN neurons. In C, a terminal (*) with the morphology of a globus pallidus terminal 
forms symmetrical synaptic contacts (arrows) with a large diameter immunoreactive 
dendrite. In these examples immunoreactivity was absent from myelinated axons (a) 
*, p < 0.05; box plot: box, 25%, 50% and 75%; whiskers, 10–90%.
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 In order to more precisely quantify the relative expression of HCN2 in each 
compartment of STN neurons immunogold labelling of HCN2 was analysed (c.f. 
Lörincz et al., 2002; Holderith et al., 2003; Boyes et al., 2007). Material from p20, p41 
and p82 rats were studied to ensure that the expression patterns of HCN2 in juvenile 
animals (in which physiological measurements were mostly made) were similar to 
those associated with later stages of development. The pattern of HCN2 expression 
at the electron microscopic level was similar for material derived from each animal. 
Thus, the density of HCN2 expression overlying the somatic, large and small diameter 
dendritic plasma membrane of STN neurons was significantly higher than background 
labelling over neuronal nuclei in each sample (Fig. 4.2 B–D); Kruskal-Wallis and Dunn’s 
multiple comparison tests, p < 0.05). In contrast the density of HCN2 expression 
overlying the cytoplasmic component of each compartment was not significantly 
different from background nuclear labelling (Fig. 4.2 B–D). In order to compare the 
specific membranous expression pattern of HCN2 across the somatodendritic axis 
background labelling was subtracted. The pattern of specific HCN2 expression in the 
somatic and large/small diameter dendritic membrane was not significantly different 
and this pattern was consistent for each sample [specific density of HCN2 labelling, 
particles per square micrometer; p20: soma = 6.3 ± 3.9 (n = 16), dendrite > 1.0 mm = 
6.7 ± 7.2 (n = 20), dendrite < 1.0 mm = 9.2 ± 9.4 (n = 28); p41: soma = 10.5 ± 9.5 (n 
= 20), dendrite > 1.0 mm = 12.0 ± 9.1 (n = 21), dendrite < 1.0 mm = 18.5 ± 21.7 (n = 
62); p82: soma = 6.9 ± 4.7 (n = 15); dendrite > 1.0 mm = 8.3 ± 5.7 (n = 11); dendrite 
< 1.0 mm = 9.0 ± 7.9 (n = 31); Kruskal-Wallis and Dunn’s multiple comparison tests, 
N.S.)]. Together these data suggest that HCN2 subunits are expressed throughout the 
somatodendritic membrane of STN neurons and this expression pattern is stable over 
the developmental period of interest.
4.3.2. Voltage-dependence of HCN channel activation
Previous studies have suggested that HCN channels contribute minimally to 
autonomous activity of STN neurons or integration of single IPSPs emanating from the 
GPe (Bevan and Wilson, 1999; Beurrier et al., 2000; Do and Bean, 2003; Baufreton et 
al., 2005).  In order to further characterise the activation of HCN channels at voltages 
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associated with and more hyperpolarised than the resting membrane potential (~ 70 
mV), the voltage dependence of HCN channels was characterised under voltage clamp 
(Fig. 4.3). TTX was applied to improve voltage control. STN cells were held at –50 
mV for 2 s before stepping to voltages between –50 mV and –120 mV. The cells were 
held at the test potential for 5 s and then stepped to –120 mV for 1 s to evoke a tail 
current (Fig. 4.3 A). In order to isolate HCN channel current, the experiments were 
repeated in the presence of ZD7288. Analysis of ZD7288-sensitive tail currents for the 
cell shown in Fig. 4.3 A revealed a small inward current that activated at membrane 
potentials hyperpolarised to ~ –60 mV. The half-maximal activation voltage (V½) was 
estimated by sigmoidal fit to be –87.5 mV. Overall, for 8 cells tested, the ZD7288-
sensitive current displayed minimal activation at –60 mV (1.1 ± 16.8 %) and a V½ of 
–87.1 ± 4.2 mV (Fig. 4.3 B). Steady state currents (measured immediately prior to the 
step to –120 mV to measure tail currents) ranged from –13.4 ± 10.3 pA at –70 mV to 
–130.1 ± 98.6 pA at –120 mV (n = 8). The activation kinetics of HCN current were 
best fit by a double exponential (–90 mV: A1 = 35.7 ± 12.3 %; t1 = 430.9 ± 261.6 ms; 
A2 = 64.3 ± 12.3 %; t2 = 2270.0 ± 866.1 ms; n = 6). Together these data suggest that: 
1) inputs that hyperpolarise the voltage below the range associated with autonomous 
activity lead to the activation of HCN channels; 2) STN HCN channels activate slowly 
with time constants ranging from several hundred ms to several secs.
4.3.3. HCN channels are recruited by and oppose GABAA receptor-
mediated inhibition 
In many types of neuron HCN channels are active at the resting membrane potential 
and participate in the integration of synaptic inputs (Lüthi and McCormick, 1998; 
Magee, 1999; Bennett et al., 2000; Williams and Stuart, 2000; Williams et al., 
2002; Williams and Stuart, 2003; Ludwig et al., 2003; Chan et al., 2004; Shah et 
al., 2004; Fan et al., 2005; Angelo et al., 2007; Garden et al., 2008). Although STN 
HCN channels are apparently not active during autonomous activity, these neurons 
receive continuous and powerful GABAA receptor-mediated inhibition from the GPe 
(DeLong, 1990; Crossman, 2000; Hallworth and Bevan, 2005; Tachibana et al., 2008; 
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Figure 4.3. Voltage-dependence of HCN channel activation
A, representative example. A1, voltage clamp waveform used to measure voltage 
dependence of HCN channel activation. A2–4, currents measured under control 
conditions (A2), in the presence of ZD7288 (A3) and ZD7288-sensitive (A4) currents 
(inset shows tail currents evoked at –120 mV). A5, ZD7288-sensitive tail currents 
increased with progressive hyperpolarisation from –60 mV. B, Absolute and normalised 
(norm) ZD7288-sensitive tail currents for the sample population. Vm, membrane 
potential.
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Karachi et al., 2009).  Given that the maximum instantaneous conductance arising 
from this pathway in rats is estimated to be several hundred nS and the equilibrium 
potential of GABAA receptor current is < –80 mV (Bevan et al., 2000, 2002; Baufreton 
et al., 2009), HCN channels may be strongly and dynamically recruited by GABAergic 
inhibition. Indeed at –80 mV HCN channels are 30.2 ± 12.6% activated and contribute 
approximately –30.6 ± 22.9 pA at steady state (n = 8). To test this hypothesis STN 
neurons were injected with a GABAA receptor mediated conductance derived from a 10 
s voltage clamp record of a minimally stimulated GPe–STN axon (Fig. 4.4). Minimal 
stimulation was performed as described previously (Baufreton et al., 2009). The 
temporal pattern of minimal stimulation was derived from a GPe neuron recorded 
extracellularly in an awake restrained rat (Urbain et al., 2000). The record was chosen 
because the frequency and pattern of activity of the GPe neuron was close to the 
population mean (frequency = 33 Hz; CV = 0.65). Application of ZD7288 significantly 
reduced the number of APs generated (control = 14.0 ± 9.2; ZD7288 = 9.3 ± 8.3; n = 6; 
WSR test, p < 0.05) and significantly hyperpolarised the membrane potential (control 
= –71.9 ± 2.2 mV; ZD7288 = –74.5 ± 2.5 mV; n = 6; WSR test, p < 0.05) during the 
period of conductance injection. Both the peak and decay time course of IPSPs were 
clearly increased by blockade of HCN channels. Similar results were also obtained 
when HCN channels were blocked with 2 mM Cs+ in each of 3 neurons tested (APs: 
control = 29.0 ± 14.0; Cs+ = 18.7 ± 10.1; n = 3) (Vm: control = –71.2 ± 3.2 mV; Cs+ = 
–73.5 ± 3.1 mV). 
 In order to determine how the distribution of HCN channels might influence the 
integration of inhibitory inputs across the somatodendritic axis, the effect of the same 
inhibitory conductance waveform was analysed for models in which HCN channel 
conductance was present at the soma or across the somatodendritic axis or was absent. 
The inhibitory conductance waveform was applied to the soma (not shown) or most 
distal dendritic compartment (Fig. 4.5). In either case the somatodendritic model 
was associated with greater spiking activity and was slightly more depolarised than 
the somatic model (somatic conductance injection; somatic HCN model: spikes = 59, 
mean V0 = –71.0 mV, mean V4 = –69.9 mV; somatodendritic HCN model: spikes = 65, 
mean V0 = –70.7 mV, mean V4 = –69.2 mV) (dendritic conductance injection; somatic 
HCN model: spikes = 41, mean V0 = –67.8 mV, mean V4 = –72.7 mV; somatodendritic 
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Figure 4.4. The impact of GABAA receptor-mediated inhibition is enhanced by 
blockade of HCN channels
A1, Response of a STN neuron under control conditions (black) and in the presence 
of ZD7288 (red) to an in vivo-like GABAA receptor-mediated synaptic conductance 
waveform (blue). A2, Zoom of epoch highlighted by blue rectangle in A1. Blockade 
of HCN channels increased inhibition of autonomously generated action potentials 
(control example 31 action potentials; ZD7288 example 25 action potentials) and 
the degree of hyperpolarisation produced by the GABAA receptor-mediated synaptic 
conductance both in the representative example (A) and sample population (B; 
individual cells denoted by distinct colours; sample mean and SD also indicated). Vm, 
membrane potential; *, p < 0.05.
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Figure 4.5. HCN channels distributed across the somatodendritic axis most effectively 
counteract GABAergic inhibition
A, Somatic (black) and 4th (most distal) dendritic compartment (gray) responses of each 
STN neuron model to a GABAA receptor mediated-synaptic conductance (upper panel) 
applied to the 4th dendritic compartment. The number of action potentials generated 
during GABAergic inhibition was 41, 54 and 30 for the somatic, somatodendritic and 
deficient models, respectively. B, Zoom of the epoch 2–2.4 s from the traces in A. 
During the period of inhibition the somatic and 4th dendritic compartments of the 
somatodendritic model (blue) were relatively depolarised compared to the somatic 
(green) and deficient (red) models. Whole-cell HCN and Nav channel currents were 
also greatest for the somatodendritic model. Vm, membrane potential.
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HCN model: spikes = 54, mean V0 = –67.4 mV, mean V4 = –71.9 mV). As predicted, 
the deficient model was relatively inhibited and more hyperpolarised than either of 
the models expressing HCN channels (somatic conductance injection; HCN deficient 
model: spikes = 51, mean V0 = –71.8 mV, mean V4 = –70.6 mV) (dendritic conductance 
injection; HCN deficient model: spikes = 30, mean V0 = –68.6 mV, mean V4 = –73.1 
mV).
 In order to determine how HCN channels interact with other channels to 
oppose synaptic inhibition and promote AP generation, the magnitude of HCN, Nav 
and Cav3 channel currents were compared for each model during the somatic (not 
shown) or dendritic (Fig. 4.5 B) application of the GABAA receptor-mediated inhibitory 
conductance. In each case the somatodendritic model was associated with larger 
depolarising Nav and HCN channel currents than the somatic model and similar Cav3 
channel currents (somatic conductance injection; somatic model: INav = –17.0 pA, IHCN 
= –2.0 pA, ICav3 = –3.7 pA; somatodendritic model: INav = –18.5 pA, IHCN = –2.8 pA, 
ICav3 = –3.8 pA) (dendritic conductance injection; somatic model: INav = –14.6 pA, IHCN 
= –1.3 pA, ICav3 = –2.4 pA; somatodendritic model: INav = –17.7 pA, IHCN = –2.7 pA, 
ICav3 = –2.4 pA). Nav and to a lesser extent Cav3 channel current was also smallest for 
the HCN deficient model presumably due to weaker activation of the channels at the 
relatively hyperpolarised voltages associated with the HCN deficient model (somatic 
conductance injection; deficient model: INav = –14.9 pA, IHCN = 0 pA, ICav3 = –3.5 pA) 
(dendritic conductance injection; deficient model: INav = –11.5 pA, IHCN = 0 pA, ICav3 = 
–2.3 pA).
One reason for larger HCN channel current in the somatodendritic model 
appears to be the effect of APs, which more effectively reduce the electrochemical 
gradient for HCN channel current and deactivate somatic compared to dendritic 
HCN channels. The effect on HCN channel current was further augmented by the 
slow kinetics of HCN channel activation following spike-generated deactivation (Fig. 
4.5 B). Indeed, when back propagation of APs into dendritic compartments was 
enhanced by increasing dendritic Nav channel conductance from 0.01 to 1.0 mS.cm
–2 
in each dendritic compartment (while reducing somatic conductance to 28 mS.cm–2 to 
maintain the same whole-cell Nav channel conductance) the relative capability of the 
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somatodendritic model compared to the somatic model to counteract inhibition was 
eliminated (somatic conductance injection; somatic HCN model: spikes = 54, mean V0 
= –70.9 mV, mean V4 = –69.2 mV; somatodendritic HCN model: spikes = 54, mean 
V0 = –71.0 mV, mean V4 = –69.1 mV) (dendritic conductance injection; somatic HCN 
model: spikes = 36, mean V0 = –67.8 mV, mean V4 = –72.2 mV; somatodendritic HCN 
model: spikes = 36, mean V0 = –67.8 mV, mean V4 = –72.0 mV).  However, the relative 
susceptibility of the HCN deficient model to inhibition was not abolished (somatic 
conductance injection; HCN deficient model: spikes = 47, mean V0 = –71.7 mV, mean 
V4 = –70.0 mV) (dendritic conductance injection; HCN deficient model: spikes = 26, 
mean V0 = –68.7 mV, mean V4 = –72.8 mV).
Together the data demonstrate that 1) HCN channels distributed throughout the 
somatodendritic compartment (similar to the distribution observed experimentally) 
most effectively opposed synaptic inhibition directed to the somatic or dendritic 
compartment 2) the relative capability of somatodendritic HCN channels to counteract 
inhibition was associated with larger Nav and HCN channel currents.
4.3.4. HCN channels limit the deinactivation of Cav3 channels in STN 
neurons
Several studies suggest that HCN channels play a pivotal role in the regulation of Cav 
channel mediated electrogenesis (Pape and McCormick, 1989; Lüthi and McCormick, 
1998; Kole et al., 2007; Tsay et al., 2007). In STN neurons hyperpolarisation below the 
voltages associated with autonomous activity can lead to the deinactivation of Cav3, 
which at the offset of hyperpolarisation can trigger rebound burst activity (Beurrier et 
al., 1999; Bevan and Wilson, 1999; Otsuka et al., 2001; Bevan et al., 2002; Hallworth 
et al., 2003; Hallworth and Bevan 2005; Kass and Mintz, 2006). By opposing 
hyperpolarisation HCN channels may therefore limit the propensity for low-voltage-
activated Ca2+ channel-mediated rebound burst firing.
 The response of STN neurons to the offset of 500 ms moderate hyperpolarising 
current under control conditions and in the presence of ZD7288 was characterised 
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(Fig. 4.6). Rebound activity was compared for both matching voltage at the end of the 
current step (~ –85 mV) and matching hyperpolarising current (~ –15 pA). The latency 
to the generation of the first AP following the offset of hyperpolarising current was 
greatly increased for both comparisons following blockade of HCN channels (Fig. 4.6; 
latency following –15 pA injection: control = 85.5 ± 16.9 ms; ZD7288 = 364.4 ± 342.3 
ms; n = 6; WSR test, p < 0.05) (Fig. 4.6; latency following hyperpolarisation to –85 
mV: control = 57.1 ± 23.6 ms; ZD7288 = 364.4 ± 342.3 ms; n = 6; WSR test, p < 0.05). 
The duration and frequency of rebound activity, defined as activity exceeding the mean 
autonomous firing frequency + 3 SD, was also significantly increased by ZD7288 for 
matching current (Fig. 4.6; duration of rebound activity following –15 pA injection: 
control = 453.6 ± 461.4 ms; ZD7288 = 1537.6 ± 990.1 ms; n = 6; WSR test, p < 0.05) 
(Fig. 4.6; maximum frequency of rebound activity following –15 pA injection: control 
= 30.9 ± 47.8 Hz; ZD7288 = 98.3 ± 61.4 Hz; n = 6; WSR test, p < 0.05) (Fig. 4.6; 
mean frequency of rebound activity following –15 pA injection: control = 14.6 ± 17.4 
Hz;  ZD7288 = 38.1 ± 26.1 Hz; n = 6; WSR test, p < 0.05) but not for voltage (data not 
shown). Rebound activity following the termination of –15 pA current injection was 
also delayed (control = 244.7 ± 72.8 ms; Cs+ = 360.0 ± 44.9 ms; n = 4) but enhanced 
in intensity (maximum frequency; control = 7.8 ± 10.4 Hz; Cs+ = 92.4 ± 39.3 Hz; n = 
4) (mean frequency: control = 7.8 ± 9.9 Hz; Cs+ = 34.2 ± 4.6 Hz; n = 4) and duration 
(control = 138.9 ± 173.2 ms; Cs+ = 2553.0 ± 3306 ms; n = 4) by application of 2 mM Cs+ 
in a manner similar to that produced by ZD7288 in each of 4 neurons tested. Together 
these data confirm that HCN channels accelerate depolarisation following the offset of 
hyperpolarising current and by restricting hyperpolarisation during current application 
reduce the intensity of rebound burst activity.
 In order to determine the impact of HCN channels on the specific contribution of 
Cav3 channels a synaptic GABAA receptor conductance (peak conductance of 80 nS at 
40 Hz for 5 seconds) was applied to the soma of the original somatic, somatodendritic 
and deficient models and the Cav3 channel conductance following the termination of 
inhibition was studied (Fig. 4.7). Simulations supported experimental observations 
that deficiency of HCN channels causes GABAergic inhibition to more effectively 
hyperpolarize STN neurons, which in turn leads to more complete deinactivation of Cav3 
channels and thus relatively powerful Cav3 channel-mediated rebound burst firing at 
107
Figure 4.6. Blockade of HCN channels increases the intensity of rebound burst 
firing 
A, Response of a STN neuron under control conditions (black) and in the presence of 
ZD7288 (red) to hyperpolarising current injection. A1, from top to bottom, responses 
to –15 pA, –25 pA and –15 pA, respectively. A2, Instantaneous frequency plots for each 
trace. Dashed line represents the mean instantaneous frequency + 3 SD associated with 
autonomous activity. The degree of hyperpolarisation and frequency of subsequent 
rebound activity in response to –15 pA were greatly enhanced by ZD7288. Application 
of –25 pA and–15 pA under control conditions and in the presence of ZD7288 produced 
similar degrees of hyperpolarisation and rebound activity, respectively. B, Population 
data. Individual cells are represented by distinct colours. Population mean and SD 
are also indicated. Action potentials truncated at 0 mV; fq, frequency; Vm, membrane 
potential; *, p < 0.05.
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Figure 4.7. HCN channels reduce the propensity for Cav3 channel-mediated rebound 
burst firing
A, Somatic responses of the somatic, somatodendritic and deficient STN HCN models 
at the end and offset of somatic GABAA receptor synaptic conductance injection. The 
effectiveness of GABAA receptor-mediated hyperpolarization and subsequent rebound 
burst firing is enhanced by deficiency of HCN channels. B, Conductance (expressed 
as % g/gmax) of Cav3 channels for the 3 models at the end and offset of somatic 
GABAA receptor synaptic conductance injection. During inhibition the conductance 
of Cav3 channels is smallest in the HCN deficient model. At the offset of inhibition the 
conductance of Cav3 channels is largest in the HCN deficient model. Vm, membrane 
potential.
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the offset of inhibition (Fig. 4.7). This effect was amplified by hypothetically increasing 
Cav3 channel conductance to 2–5 times of the original (not shown). Together, the 
experimental and modelling data suggest that STN HCN channels limit the capability 
of GABAA-receptor mediated inhibition to generate low-voltage-activated Ca
2+ channel-
mediated rebound burst firing in STN neurons.
4.4. Discussion
Cellular and subcellular expression of HCN subunits
Regional mRNA and protein expression studies have shown that the STN is associated 
with a high level of HCN2 and 3 and lower levels of HCN1 and 4 expression (Monteggia 
et al., 2000; Santoro et al., 2000; Notomi and Shigemoto, 2004). Using single cell 
molecular profiling, this study showed that the detection rates of HCN subunit 
expression in individual neurons approximated the regional pattern. Thus, individual 
STN (and other) neurons express a variety of HCN subunits, which could underlie 
homomeric channels with heterogenous, distinct biophysical properties and/or 
heteromeric channels with homogenous, intermediate properties (Robinson and 
Siegelbaum, 2003; Baruscotti and DiFrancesco, 2004; Biel et al., 2009).
 Immunocytochemical detection of HCN2 subunits revealed that STN neurons 
express HCN2 channel subunits across their somatodendritic plasma membrane. 
However, the sampling approach used here (and in most studies) might fail to detect 
heterogeneous cellular and/or subcellular expression patterns. Uniform (Angelo et al., 
2007), decreasing (Bullis et al., 2007) and increasing (Magee, 1998, 1999; Williams 
and Stuart, 2000; Lörincz et al., 2002) somatodendritic expression with distance from 
the soma have been reported in other neurons using high resolution immunoelectron 
microscopy (Notomi and Shigemoto, 2004; Lörincz et al., 2002) and/or cell-attached 
patch clamp recording (Magee, 1998, 1999; Williams and Stuart, 2000; Angelo et 
al., 2007; Bullis et al., 2007). In pyramidal cells where both approaches have been 
applied, the data were concordant implying that immunocytochemical detection of 
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HCN channels is highly correlated with functional expression. Distinct compartmental 
expression patterns of HCN channels may confer neuron specific cellular and subcellular 
computational properties (London and Häusser, 2005).
Voltage dependence and kinetics of STN HCN channels
In order to determine the voltage range at which STN HCN channels are activated 
the response of STN neurons to current and voltage steps were compared before and 
during application of ZD7288 or Cs+. In contrast to other autonomously active [eg. 
GPe neurons (Chan et al., 2004) and striatal cholinergic interneurons (Bennett et 
al., 2000)] and inactive neurons [e.g. cortical pyramidal neurons (Magee 1998, 1999; 
Shah et al., 2004; Kole et al., 2007; Tsay et al., 2007)], STN HCN channels are barely 
activated at the resting membrane potential and contribute little to their intrinsic 
activity or excitability. Thus loss of HCN channel function was not accompanied by 
a reduction in the frequency of spontaneous firing (Bennett et al., 2000; Chan et al., 
2004), hyperpolarisation (Magee 1998, 1999; Shah et al., 2004; Kole et al., 2007; Tsay 
et al., 2007), emergence of bistable states (Williams et al., 2002) or an enhancement in 
excitability (Magee 1998, 1999; Shah et al., 2004; Kole et al., 2007; Tsay et al., 2007), 
as reported for other neurons. Only hyperpolarisation below the peak of single spike 
afterhyperpolarisation sufficiently activated HCN channels to modify the integrative 
properties of STN neurons. 
 Although the half activation voltage of STN HCN channel current overlaps 
that reported for homo- and/or hetero-meric HCN1–4 subunit-containing channels 
the slow kinetics of activation are consistent with slower gating homo- and/or hetero-
meric channels containing HCN2–4 subunits and inconsistent with more rapidly 
gating homomeric HCN1 channels (Robinson and Siegelbaum, 2003; Baruscotti and 
DiFrancesco, 2004; Biel et al., 2009).
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STN HCN channels counteract GABAergic inhibition and reduce the 
propensity­of­rebound­burst­firing
Studies which maintained natural chloride homeostasis have shown that GABAA 
receptor-mediated inhibition can hyperpolarise STN neurons 20 mV below the voltage 
range of autonomous STN activity, which in turn leads to deinactivation of low-voltage-
activated Ca2+ channels and rebound burst firing (Bevan et al., 2000, 2002; Hallworth 
and Bevan, 2005). By using hyperpolarising current injection or the dynamic clamp 
technique to impose physiologically relevant patterns of GABAergic inhibition, blockade 
of HCN channels greatly enhanced inhibition of autonomous activity, the degree of 
hyperpolarisation and thus the propensity for rebound burst firing. Computational 
modelling revealed that somatodendritic HCN channel expression, similar to that 
observed experimentally, most effectively counteracted inhibition directed either 
towards the soma or dendrite.
 Previous studies have shown that dendritic HCN channels may be positioned 
to reduce local temporal summation of synaptic potentials and/or local regenerative 
potentials engaged by synaptic input (Magee 1998, 1999; Shah et al., 2004; Angelo et 
al., 2007; Bullis et al., 2007; Kole et al., 2007; Tsay et al., 2007).  Findings described 
here further suggest that dendritic HCN channels may be protected from deactivation 
by back propagating APs compared to somatic channels closer to the initiation site. 
This protective effect may be particularly critical in STN neurons, which express HCN 
channels that activate slowly following AP-driven deactivation. The degree to which 
APs attenuate in the extensive small caliber dendrites of STN neurons is unknown 
but may be considerable: 1) dendritic, in contrast to axosomatic, Nav channels do not 
contribute to autonomous firing implying their density is relatively low (Atherton et al., 
2008); 2) the velocity of back propagation is slow implying that it is relatively passive 
in nature (Atherton et al., 2008); 3) AP-associated dendritic Ca2+ transients decline 
precipitously with distance from the soma implying that the amplitude of dendritic 
potentials is small (unpublished observations). 
 The depolarisation produced by HCN channels was supplemented by increased 
activation of Nav and Cav3 channels. Nav channels are the primary driver of autonomous 
firing in STN neurons (Bevan and Wilson, 1999; Beurrier et al., 2000; Do and Bean, 
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2003) and although Cav3 channels were largely inactivated a small fraction of channels 
may contribute a tiny window current that promotes activity (Dreyfus et al., 2010).
 Computational modelling further suggested that the impact of HCN channel 
currents on rebound burst firing is due to its limitation of the deinactivation of Cav3 
channels. Previous studies showed that about 75% of STN neurons display short (<100 
ms) rebound burst driven by Cav3 channels (Bevan and Wilson, 1999; Beurrier et al., 
2000; Song et al., 2000; Do and Bean, 2003; Hallworth et al., 2003). Some neurons, 
however, exhibit longer rebound bursts (>100 ms) due to the additional recruitment 
of low-voltage-gated Cav1.2–1.3 channels. Therefore, the effect of HCN channels on 
rebound bursts possibly also includes similar interaction with Cav1.2–1.3 channels in a 
proportion of STN neurons.
Functional implications
At rest, tonically active GPe neurons inhibit the somatodendritic domain of STN 
neurons largely through the synaptic activation of GABAA receptors (Hallworth and 
Bevan, 2005; Tachibana et al., 2008; Baufreton et al., 2009; Karachi et al., 2009). Data 
from this study suggest that the compartmental distribution and biophysical properties 
of STN HCN channels are conformed to maintain STN neurons in a voltage range where 
autonomous spiking activity is promoted and low-voltage-activated Ca2+ channels 
are largely inactivated. By opposing GABAA-receptor-mediated synaptic inhibition, 
which predominantly arises from the GPe, HCN channels may reduce the capability 
of GPe-STN to inhibit, reset, and synchronise firing in STN neurons (Baufreton et 
al., 2009). This interaction between intrinsic and synaptic conductances is a possible 
factor contributing to the decorrelated nature of GPe-STN network observed both ex 
vivo and in vivo (Baufreton et al., 2009). By maintaining STN activity, HCN channels 
may help to prevent involuntary movements that are produced by interruptions in 
STN activity (Crossman et al., 1984; DeLong, 1990; Wichmann et al., 1994; Baunez 
et al., 1995). By reducing low-voltage-activated Ca2+ channel-dependent burst firing 
STN HCN channels may help to prevent tremor, akinesia and bradykinesia that are 
associated with excessive burst firing in PD (Bergman et al., 1994; Magill et al., 2001; 
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Levy et al., 2002; Brown, 2003). However, it is possible that a small proportion of STN 
neurons are not capable of generating low-voltage-activated Ca2+ channel-dependent 
rebound burst firing (Bevan et al., 2000). The functional implication of HCN channel 
expression in these neurons remain to be determined. Although there is no direct 
evidence thus far suggesting that burst firings in parkinsonian STN in vivo is mediated 
by classical rebound bursts mediated by low-voltage-activated Ca2+ channels, the loss 
of depolarising effect of postsynaptic dopamine action (Baufreton et al., 2003; Zhu 
et al., 2002a; Zhu et al., 2002b; Loucif et al., 2008; Ramanathan et al., 2008) could 
lead to more hyperpolarised membrane potential of STN neurons that promotes the 
deinactivation of these calcium channels. 
 The mechanisms through which the distribution, number and gating of STN HCN 
channels are dynamically regulated are unknown but data from thalamic and cortical 
neurons suggest that intrinsic homeostatic signalling pathways and neuromodulatory 
tone are critical for maintenance of normal thalamocortical HCN channel function 
(Pape and McCormick, 1989; Lüthi  and McCormick, 1998; Shah et al., 2004; Fan et 
al., 2005). It is therefore speculated that in PD, aberrant afferent activity together with 
alterations in dopaminergic neuromodulation (Bergman et al., 1994; François et al., 
2000; Raz et al., 2000; Magill et al., 2001; Levy et al., 2002; Brown, 2003; Shen and 
Johnson, 2005; Baufreton and Bevan 2008; Ramanathan et al., 2008) could represent 
conditions for the dysregulation of STN HCN channels and thus the emergence of 
pathological burst firing in STN neurons. The pathophysiological role of HCN channels 
has indeed been recently demonstrated in the parkinsonian GPe, in which excessive 
burst firing occurs due to the loss of HCN channel pacemaking function (Chan et al., 
2011). Whether the acute loss of dopaminergic neuromodulation, or chronic adaptive 
changes in the PD network could lead to the dysregulation of HCN channels, remain to 
be determined.
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CHAPTER 5
GENERAL DISCUSSION
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5.1. Summary and concluding remarks
The overall objective of the research presented in this thesis was to further elucidate 
the mechanisms underlying the regulation of GABAergic inhibition in the STN in 
health and PD. To accomplish this objective, complementary molecular and cellular 
electrophysiological, imaging, computational and optogenetic approaches were applied 
to the rat and mouse STN.
 In idiopathic and experimental PD, the GPe and STN exhibit hypo- and 
hyper-activity, respectively, and abnormal synchronous rhythmic burst firing. Motor 
symptoms are intimately related to changes in the frequency and pattern of neuronal 
activity in the reciprocally connected GPe and STN as well as associated brain 
networks. Following lesion of midbrain dopamine neurons beta band synchronisation 
emerges slowly  before reaching its peak in the STN at 2 to 3 weeks later (Mallet et al., 
2008a). This process suggests that adaptive changes in cellular and network properties 
contribute to the evolution of parkinsonian STN activity.
 The primary objective of my thesis  therefore focused on the possibility of altered 
GPe–STN connectivity following chronic dopamine depletion. GPe–STN transmission 
in control and 6-OHDA-lesioned rodents was compared 2–3 weeks post-operative. 
Electrophysiological recordings showed that 1) the frequency (but not the amplitude) 
of mIPSCs increased by ~ 70%; 2) the amplitude of evoked IPSCs and isoguvacine-
evoked current increased by ~ 60% and ~ 70%, respectively. Quantitative PCR analysis 
revealed that levels of mRNA encoding α1, β2 and γ2 GABAA receptor subunits 
increased by 15–30%. In addition, immunocytochemical approach demonstrated the 
increase in the density of postsynaptic gephyrin and γ2 subunit co-immunoreactive 
structures by ~ 40%, whereas the density of VGAT and bassoon co-immunoreactive 
axon terminals was unchanged. The number of ultrastructurally defined synapses 
per GPe–STN terminal doubled with no alteration in terminal/synapse size or target 
preference. Therefore, loss of dopamine leads, through an increase in the number of 
synaptic connections per GPe–STN terminal, to substantial strengthening of the GPe–
STN pathway.  This alteration may be a homeostatic response to oppose hyperactivity 
but could also maladaptively contribute to the manifestation of hypersynchronous 
rhythmic burst firing in the parkinsonian STN.
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 Suppression of the abnormal hypersynchronous activity pattern by STN 
DBS at high frequency (>100 Hz) has been a highly effective treatment for motor 
symptoms in PD. The mechanisms of DBS action are, however, poorly defined. The 
first study described in this thesis suggests that the generation and/or exacerbation of 
pathological oscillations in the STN could in part be attributed to the strengthening of 
GPe–STN transmission, which makes it a plausible therapeutic target of DBS. Indeed 
recent optogenetic studies using Thy1-ChR2 transgenic mice (line 18; Gradinaru et al., 
2009) suggests that DBS exerts its effect through manipulating cortical activity and 
undefined afferents within the STN.
  The following objective of this thesis was hence to characterise the ChR2 
expression in the STN of this mouse line, in which ChR2 is expressed in multiple 
brain regions. Immunocytochemical analysis revealed that the majority (~ 80%) of 
ChR2-expressing glutamatergic afferents in the STN are from the cortex. Stereological 
quantification estimated that the ratio of ChR2-expressing cortical afferents to 
subcortical afferents is about 4:1. In addition, as many GABAergic afferents as cortical 
afferents also express ChR2. Consistent with the expression pattern in STN, strong and 
widespread cellular labelling of ChR2-EYFP was observed within Layer V motor cortex 
and GPe. Electrophysiological recordings confirmed functional ChR2 expression by 
glutamatergic and GABAergic afferents in the STN. Together these data suggested 
that DBS might exert its therapeutic effect through disrupting not just cortical input 
as previously suggested but presumably also through manipulating GABAergic input 
arising from the GPe. In addition, Thy1-ChR2 mouse line 18 is a useful optogenetic tool 
to study the regulation of cortical and GPe input and their interaction in normal and 
parkinsonian STN.
 Given that the GPe potently regulates the frequency and pattern of STN activity, 
the basis of decorrelation between GPe and STN activity under normal conditions 
requires further characterisation. The third study in my thesis, investigated the poorly 
understood role of HCN channels in inhibitory synaptic integration within STN 
neurons. Molecular profiling using single-cell PCR technique showed that individual 
STN neurons express mRNA encoding multiple HCN subunits, with HCN2 and HCN3 
being the most abundant. Light and electron microscopic analysis showed that HCN2 
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subunits are strongly expressed and uniformly distributed across the somatodendritic 
plasma membrane. Voltage- and dynamic-clamp analysis and computational modelling 
demonstrated that HCN channels are activated by GABAA receptor-mediated inputs 
and thus limit synaptic hyperpolarisation and deinactivation of low-voltage-activated 
Ca2+ channels. Consistent with the subcellular pattern of HCN expression observed 
experimentally, computational modelling also showed that uniform distribution of 
HCN channels across the somatodendritic axis most effectively counteracts GABAergic 
inhibition. Together the data demonstrate that HCN channels in STN neurons oppose 
GABAA receptor-mediated inhibition arising from the GPe and thus maintain single-
spike autonomous activity rather than rebound burst firing. 
 In conclusion, the first study in the thesis proposed that abnormally synchronous 
rhythmic bursting activity in the STN may at least in part arise from strengthening 
of the GABAergic inhibition due to augmentation in GPe–STN synaptic connectivity. 
Although loss of dopaminergic neuromodulation in PD directly contributes to the 
abnormal activity in the basal ganglia, long-term alterations in cellular and network 
properties could also be important. This study demonstrated that adaptive changes 
in synaptic connectivity following chronic dopamine depletion does not only occur at 
the level of striatum as previously shown, but also in the STN within the “indirect” 
pathway. Given that GPe neurons that project to the STN exhibit anti-phase rhythmic 
activities (<30 Hz) in relation to STN neurons (Mallet et al., 2012) and that GPe–STN 
input may enhance the sensitivity of STN neurons to cortical idling rhythms (Baufreton 
et al., 2005) in PD, strengthening of these GPe inputs is likely to cause or reinforce 
pathological oscillations in the STN. Together with disruptions in autonomous firing 
reported in STN neurons (Zhu et al., 2002a; Wilson et al., 2006), these adaptations 
appear to reflect homeostatic compensatory response to STN hyperactivity that 
ultimately may be maladaptive by contributing to abnormal activity patterns.
 If enhanced GPe–STN transmission is a key underlying pathophysiological 
cause of abnormal activity pattern in the STN and its target nuclei in the basal ganglia, 
correcting or abolishing the maladaptive output may potentially be beneficial for 
improving motor symptoms in PD. The second study identified a transgenic ChR2 
mouse model that will facilitate precise interrogation of the neuronal circuits underlying 
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motor dysfunction in PD. The abundant presence of ChR2-expressing GABAergic 
(besides cortical) afferents in the STN suggests that the recently reported therapeutic 
benefit of STN HFS in this model of PD (Gradinaru et al., 2009) could not be solely 
due to driving of cortical–STN connections. Considering the critical role of GPe–STN 
synaptic transmission in pathological condition as implied in the first study of the 
thesis, optogenetic manipulation of GPe–STN input presumably in part accounted for 
the correction of motor impairments upon STN photostimulation in the previous study 
(Gradinaru et al., 2009). In the future, hypotheses regarding the interactions between 
GPe and cortical inputs and intrinsic properties of STN in health and experimental 
PD can be tested using this mouse line. Combined with the use of other optogenetic 
tools, various manipulation strategies can be employed to identify the most relevant 
mechanisms underlying DBS therapeutic effect on motor impairments in PD.
 Finally, the last study of the thesis provides us insights on the underlying 
instrinsic mechanism of STN neurons that actively opposes the impact of GABAergic 
inhibition  under normal conditions. The selective role of HCN channels in regulating 
inhibitory synaptic input in part explains why GPe–STN network activity is often not 
seen correlated. In other brain regions, non-uniform distribution of HCN channels 
is thought to be important for cellular and subcellular computation of glutamatergic 
input integration. Work from the third study here shows that uniform distribution 
of the channels across the somatodendritic axis also serves important computational 
function in synaptic integration, i.e. to most effectively counteract GABAergic inhibition 
(arising from the GPe). As a result, HCN channels may act to reduce the capability of 
GPe input to inhibit, synchronise and/or generate rebound burst firing in the STN 
neurons. In PD, abnormal afferent activity or altered dopaminergic neuromodulation 
could potentially represent conditions for disruption of the channel function, thereby 
contributing to the emergence of rhythmic, synchronised burst firing in the STN.
5.2. Technical considerations
The experimental results presented in this thesis should be interpreted with 
consideration of a number of technical issues arising from the methods employed.
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6-OHDA-treated model of Parkinson’s Disease
6-OHDA is a neurotoxin that has been intensively used to generate rodent model of 
PD associated with SNc dopaminergic cell death for more than 40 years (Ungerstedt, 
1968). The most common model involves unilateral 6-OHDA injection into the nigra 
or MFB, resulting in rapid cell death. Syndrome that develops following dopamine 
depletion shares many similarities with PD, although some pathological features are 
not reproduced (Schwarting and Huston 1996, Dauer and Przedborski, 2003; Yuan et 
al., 2005). Prominent pathophysiological characteristics of PD and primate PD models, 
including changes in the firing rates and patterns within the cortex and basal ganglia 
have however been reproduced in 6-OHDA-treated models (Magill et al., 2001; Mallet 
et al., 2008a,b). Although the unilateral 6-hydroxydopamine (6-OHDA) model is more 
frequently used in rats, substantial and stable unilateral 6-OHDA-induced lesions that 
are functionally assessable can also be established in mice (Iancu et al., 2005). Thus, 
mice were also utilised as experimental PD models in this thesis (Chapter 2) where use 
of rats was not practical.
 A main difference between nigral and MFB 6-OHDA lesion models is that the 
latter also causes destruction of dopaminergic neurons in the ventral tegmental area 
(VTA), which does not closely mimic PD pathology. However, inaccurate/incomplete 
nigral targeting of the 6-OHDA injection sometimes results in the sparing of a 
proportion of dopaminergic neurons. The axons of residual dopaminergic neurons in 
the midbrain might undergo sprouting and reinnervate the striatum, thereby causing 
a behavioural recovery (Perese et al., 1989; Carman et al., 1991). Considering these 
factors, both nigral and MFB 6-OHDA-lesioned rodents were employed in current 
studies.
 6-OHDA-induced toxicity is relatively selective for monoaminergic neurons 
because it is preferentially taken up by dopamine and noradrenergic transporters 
(Luthman et al., 1989). To target specifically the death of dopaminergic neurons 
in these studies, 6-OHDA was used in conjunction with desipramine, a selective 
noradrenaline reuptake inhibitor. Because SNc dopaminergic neurons are known to 
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innervate contralateral basal ganglia structures (Fass and Butcher, 1981), the use of 
non-lesion side of the unilateral 6-OHDA-treated animals as control was avoided. 
However, quantification of dopaminergic denervation in the ipsilateral STN and GPe 
was not performed and therefore it is not known to what extent the loss of direct 
dopamine innervation is correlated with the enhancement of GPe–STN transmission 
in 6-OHDA-lesioned animals.
Electrophysiology
Patch clamp recordings were performed in our studies to examine the properties of 
synaptic input to STN neurons. Theoretical and experimental studies have suggested 
that a typical problem associated with somatic voltage clamp is that it exerts limited 
control over the dendritic arbor (Bar-Yehuda and Korngreen, 2008; Williams and 
Mitchell, 2008; Poleg-Polsky and Diamond, 2011). HCN currents recorded from the 
soma (Chapter 4) may therefore arise mostly from somatic HCN channel activity. The 
fine caliber dendrites of STN neurons nonetheless prevented local access for patch 
clamp recording. Because voltage clamp does not uniformly control voltage across the 
somatodendritic axis, electrical measurement of dendritic synaptic ion channel activity 
might be restricted. For this reason measurement of kinetics and voltage-dependence 
of instrinsic HCN channels were inevitably compromised, but the voltage-dependent 
contribution of STN HCN channels was shown to be similar under current (data not 
shown) and voltage clamp.
 Additionally, the expected poor space clamp cannot avoid synaptic inputs 
distant from the soma from driving the membrane potential away from the holding 
potential. Measurements of the amplitude, kinetics, slope conductance and reversal 
potential of synaptic inputs are distorted in a dendritic distance-dependent manner 
(Williams and Mitchell, 2008). In Chapter 2, the incomplete voltage control of synaptic 
events at the dendrites might partially mask augmentation of the GPe–STN inputs 
following chronic dopamine depletion. This possibility is consistent with the electron 
microscopic studies revealing a greater fold of increase in GABAergic synapses than that 
suggested by electrophysiological recordings. However, because GPe–STN projections 
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are predominantly targeted to the somata (31%) and the proximal dendrites (39%) 
of STN neurons (Smith et al., 1990), the space clamp problem in the measurement 
of GABAA-receptor mediated currents was relatively less severe. Since the recording 
conditions were consistent in each experiment, issues related to space clamp would 
be the same across recordings and hence not affect the qualitative results of these 
experiments. 
Confocal Microscopy
The use of fluorescent and confocal microscopy in immunocytochemical studies 
is accompanied by several technical limitations (Semwogerere and Weeks, 2005; 
Pawley, 2006). Since confocal microscopy employs focused laser beam and pin-
hole to minimise light diffraction, the optical resolution achieved by high numerical 
aperture (NA) objective lens is improved compared to conventional epifluorescence 
microscopy, but still considerably limited. With 63× and 1.4 NA objective lens used in 
Chapter 3 study, the maximum xy resolution achieved was above ~ 200 nm, whereas 
the distance between two adjacent synapses can be as close as 50 nm as observed in 
electron microscopy. Therefore, in determining the density of pre and post-synaptic 
immunoreactive puncta, some of the closely positioned synapses might not have been 
resolved as separate structures. Because the increase in GPe–STN transmission is 
mediated by upregulation of functional synapses without proliferation of presynaptic 
terminals, new synapses might be formed in close proximity to existing synapses. It is 
possible that the increase in GABAergic synaptic density observed was underestimated 
due to the limited optical resolution.
 Furthermore, the optical z-resolution is relatively worse than the lateral xy 
resolution. With the same 63× and 1.4 NA objective lens, z resolution obtained was 
above ~ 800 nm. This could potentially confound the colocalisation studies described 
in either Chapter 2 or 3, because structures that are physically separate might be 
observed as overlapping in the xy plane of an image. Additionally, because refractive 
index is different for different wavelengths, chromatic shift occurs when lights travel 
through the specimen, although this problem was largely corrected by the objectives 
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used. To address these issues, specimens were imaged in small step size (0.3–0.4 μm) 
and immunoreactive structures were examined throughout their z-axis spanning to 
assure reliable pattern of colocalisation.
 Another confocal microscopy issue concerns with photobleaching of fluorescent 
molecules tagging structures of interest. Photobleaching is a process in which molecular 
structure of a dye is altered due to absorption of excitation light, thus rendering this 
dye less or non-fluorescent. This potentially results in apparent reduction in the size/
intensity of immunofluorescent structures. In worse situation, structures with weaker 
fluorescence fail to be detected. However, the visibility of immunofluorescent structures 
remained stable across a broad range of excitation wavelength intensity. In order to 
minimise bleaching, 1) Prolong Gold antifade reagent (Invitrogen) was used; 2) image 
acquisition settings were optimised such that: the power of confocal lasers that emit 
excitation wavelengths and the laser scanning dwell time on each pixel was minimised, 
whereas photomultiplier gain was maximised, while maintaining high signal-to-noise 
ratio. No apparent fluorescent fading of specimens was observed after imaging was 
completed.
 Last but not least, spherical aberration is a typical problem in confocal imaging. 
It occurs mainly because light passing through the periphery of the lens is not brought 
into focus at the same plane as that travelling through lens centre, due to different 
degree of refraction. This problem can be worsened by the use of thin coverslips that 
individually have uneven thickness. To minimise loss of resolution due to spherical 
aberration, high-precision coverslips (170 ± 5 μm) were used in studies involving 
imaging of fine synaptic structures.
Electron microscopy
Electron microscopy offers much higher resolution images than confocal microscopy 
and the ability to observe ultrastructural details. Although state-of-the-art super-
resolution microscopy system (eg. structured illumination microscopy, SIM) that can 
produce up to two times the resolution of confocal microscopes has been recently 
developed (Sigrist and Sabatini, 2012), the thickness of fixed tissue sections often 
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greatly diminishes the resolving power of the system due to high degree of light 
diffraction passing through the specimens (Gustafsson et al., 2008). Because of this 
issue my attempt to better resolve immunofluorescent synaptic structures in the STN 
slice (Chapter 2) using super-resolution microscopy (Nikon SIM; Nikon, Tokyo, Japan) 
did not yield significantly improved results (not shown). Immunoelectron microscopy 
was therefore performed, but also not without its caveats. Due to a common problem 
in tissue penetration of antibodies, the identification of immunoreactive structures is 
limited to the superficial layer of ultrathin sections. At this depth stereological counting 
could be performed to quantify the number of terminals and synapses within these 
structures (Chapter 2). However, GPe–STN terminals are often large in size (Smith 
et al., 1998; Baufreton et al., 2009) and spans many sections beyond that held by a 
grid, making the quantification very difficult and labour-intensive. Consequently, 
semi-quantitative method was used instead, by analysing the number of synapses per 
identified GPe terminals on single sections. Although this method is confounded by 
the fact that larger structures are more likely to be counted and hence oversampled, 
the similar length of GABAergic synapses in control and parkinsonian STN samples 
(Chapter 2) suggests that their size is not altered by chronic dopamine depletion.
 In Chapter 4, because immunoperoxidase DAB labelling can variably diffuse 
over long distances and difficult to quantify (Courtoy et al., 1983), immunogold labelling 
was used to characterise the quantitative distribution of HCN channels. Given that gold 
particles (~ 30 nm) are bound to secondary antibodies but not the antigen itself, they 
appear 15–30 nm away from the antigen (Hermann et al., 1996). This poses a problem 
when determining whether the immunoreactive HCN channels are membranous or 
not. Thus, mean distance of the structures from the membrane + 2SD was used to 
define their subcellular localisation (i.e. membranous versus cytoplasmic) (Lörincz et 
al., 2002). Absolute density of HCN channels was determined because 1) the binding 
of immunogold may not be linear to channel density 2) silver enhancement of gold 
particles for enhanced detection causes variation in particle size and coagulation 
(Robinson et al., 2000).
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Reverse transcriptase PCR
Two types of reverse transcriptase PCR were employed to gauge the levels of gene 
expression in the STN: real-time quantitative PCR and single-cell end-point PCR. The 
former technique described in Chapter 2 is relatively much more sensitive and precise 
(Valasek and Repak, 2005), but considerable starting material for the reaction process 
is required and hence microdissected STN tissue was used instead of single isolated 
neurons. Because glial cells are often known to express GABAA receptors (Vélez-
Fort et al., 2011), expression of the same RNAs of interest in the glia might cause 
underestimation of expression level changes in STN neurons. Relative quantification 
was performed using a comparative quantification (ΔΔCT) method because absolute 
RNA levels were not of interest. The method is based on the assumption that the 
difference in threshold cycles (ΔCT) between the gene of interest and the housekeeping 
gene is proportional to the relative expression level of the gene of interest. To optimise 
the accuracy of the obtained data, the reaction efficiencies of different primers were 
tested so that they were similar. Additionally, because not all proposed housekeeping 
genes may retain constant expression levels after chronic dopamine depletion, the 
weighted average of 5 housekeeping genes based on their relative stability was used. In 
Chapter 4, single cell PCR was used instead because previous studies have examined 
HCN subunit expressions in the whole STN (Monteggia et al., 2000; Santoro et al., 
2000; Notomi and Shigemoto, 2004). Although relative quantification of HCN subunits 
would be desirable, the amount of RNA materials collected from isolated single neurons 
was not sufficient for quantitative PCR procedure.
5.3. Future studies
There is a number of investigations that can be further pursued based on the findings 
detailed in this thesis.
 Even though substantial dopaminergic neurodegeneration occurs within 
few hours of 6-OHDA injection into the nigra (Jeon et al., 1995; Zuch et al., 2000), 
pathological synchrony at beta band in the STN emerges 3 days afterward and 
intensifies to its peak at 2–3 weeks (Mallet et al., 2008a). At this time point, the 
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number of functional GPe–STN synapses is significantly upregulated, without 
presynaptic terminal proliferation (Chapter 2). However, the precise timecourse of 
aberrant GPe–STN connectivity in experimental PD has not been defined and is likely 
to be functionally relevant to the manifestation of abnormal activity frequency and 
pattern within the GPe–STN network. It would be interesting to see if the alterations 
in GPe–STN connectivity are correlated with the evolution of beta band activity in 
experimental PD. If the upregulation of GPe-STN synapses directly contributes to 
emergence of the abnormal activity pattern, the maladaptive alteration should occur 
gradually over 2 to 3 weeks and stabilise after that time point. However, it is possible 
that different mechanisms are employed at different time points of increased GPe–
STN transmission, including enhanced synaptic release probability, increased C1-1 
extrusion, increased number of GABAA receptors per synapse, altered GABAA receptor 
subunit composition, and proliferation of GPe–STN synaptic terminals. Defining the 
timecourse and nature of altered GPe–STN transmission will help us focus on relevant 
underlying mechanisms for the treatment of parkinsonism.
 In addition, determining the pathophysiological events that trigger the 
enhancement of GPe–STN synaptic transmission will enable us to lay down the 
principles regulating GPe–STN interactions in health and disease.  GABAergic synaptic 
plasticity is often triggered by elevated intracellular Ca2+ through NMDA receptors 
and/or intrinsic Cav channels (Maffei, 2011). In PD, STN neurons are hyperactive 
and more strongly entrained by cortical inputs (Mallet et al., 2008a; Moran et al., 
2011), suggesting that hyperactivation of STN NMDA receptors and/or Cav channels 
potentially leads to upregulation of GPe–STN synaptic transmission. Rectifying these 
triggers might therefore reverse alteration in GPe–STN connections and diminish 
pathological activity in the STN. 
 Defining the molecular mechanisms underlying the increased GPe–STN 
transmission are also of future research interests. Most forms of synaptic plasticity 
are triggered by changes in intracellular Ca2+ that regulate a variety of signalling 
pathways in neurons. Excessive activation of NMDA receptors and/or hyperactivity of 
STN neurons in PD may lead to elevation of intracellular Ca2+, which in turn activates 
signalling cascades that upregulate synaptic number/strength. Whether the increase 
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in postsynaptic Ca2+ are indeed necessary for plasticity should be determined. Current 
literature suggests that synaptic potentiation is typically mediated through the Ca2+-
dependent activation of protein kinases (in some cases phosphatases) (Mayford, 2007; 
Tretter and Moss, 2008). Notably, NMDA receptor activation can lead to enhanced 
trafficking and exocytosis of GABA receptor subunits into the plasma membrane 
mediated through Ca2+ calmodulin-dependent kinase II (CAMKII) (Marsden et al., 
2007). Gephyrin clustering of GABA receptors to form functional synapses is dependent 
on phosphorylation by glycogen synthase kinase 3β (Tyagarajan et al., 2011). Using 
specific activators and inhibitors of these kinases/phospathases, their role in mediating 
increased GPe–STN transmission in the STN can be determined.
 In addition, downstream intracellular signalling cascades that regulate a 
variety of cellular processes including transcription, translation, trafficking, exocytosis, 
endocytosis, recycling, and degradation of molecules involved, are also potential 
intervention points for preventing synaptic plasticity (Smith and Kittler, 2010). 
In particular, interaction of GABARAP with NSF, a protein critical for intracellular 
membrane trafficking events, may be important for the increased production of 
GABAergic synapses (Kittler et al., 2001; Luscher et al., 2011). Reduced endocytosis 
of GABA receptor subunits may also contribute to their increased surface expression. 
In addition, formation and maintenance of GABAA receptors clusters at inhibitory 
synapses could be augmented. This is possibly mediated through the binding of synaptic 
adhesion molecule neuroligin 2 that activates collybistin’s clustering of gephyrin-
dependent GABAA receptors at the membrane (Poulopoulos et al., 2009). At different 
time points of activity pattern changes in PD, presynaptic mechanisms might be involved 
in enhancement of GPe–STN transmission, such as changes in vesicle pool properties, 
proliferation of presynaptic terminals, and regulation by presynaptic NMDA or GABAB 
receptor (Takesian et al., 2010; Fioravante and Regehr, 2011; Maffei, 2011; Mathew 
and Hablitz, 2011). In long term, maintenance of potentiated transmission also often 
involve enhancement of gene transcription and translation mediated by transcription 
factors like c-fos and CREB (Loebrich and Nedivi, 2009). Phosphorylation of CREB 
in response to membrane depolarisation and elevated intracellular Ca2+ level can lead 
to c-fos gene activation which regulates activity-dependent transcription in neurons 
(Sheng et al., 1990). Taken together, defining the role of postsynaptic Ca2+ increase, 
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the relevant signalling cascades, and the molecular processes underlying GABAergic 
plasticity in experimental PD, using a combination of ex vivo electrophysiological 
and molecular approaches, should enable us to more precisely and effectively correct 
aberrant GPe–STN transmission in experimental PD.
 In addition, findings in this thesis (Chapter 3) suggest that the Thy1-ChR2 
mouse line 18 is a useful optogenetic tool to investigate the phenomenon of enhanced 
GPe–STN transmission in experimental PD. By specifically manipulating the activity 
of predominantly cortical afferents ex vivo and in vivo, this model can be used to 
test the hypothesis that hyperactivation of NMDA receptor due to enhanced cortical-
STN transmission triggers the synaptic plasticity of GPe–STN input. The molecular 
mechanisms underlying the NMDA receptor-mediated GABAergic plasticity can also 
subsequently be probed in this model.
 Once the triggers (or molecular processes) underlying enhancement of GPe–
STN transmission are identified ex vivo, in vivo studies will be useful to investigate 
the interventions leading lead to prevention/reversal of motor symptoms in PD. For 
instance, the effect of blocking NMDA receptor hyperactivation before, during or after 
6-OHDA injection into the nigra, on GPe–STN transmission and motor behaviours 
can be studied. This can be achieved by conditional knockout of NR1 subunit (required 
to form functional NMDA receptor channel; Traynelis et al., 2010) in the STN neurons, 
through viral gene delivery combined with Cre/LoxP recombination system in 
transgenic mice (Kühn and Torres, 2002).
 Understanding the neuronal principles underlying the pathophysiology 
of motor symptoms in PD will also help us define the therapeutic mechanisms of 
DBS. Despite advanced knowledge of HFS impact on neural activity (eg. Deniau et 
al., 2010), it is still not clear how the effects induced by stimulation contribute to its 
beneficial outcome. One possibility is that that DBS exerts therapeutic effect through 
manipulating afferent activities in the STN. Particularly, high frequency driving of 
synaptic transmission may attenuate its capability to pattern pathological activity due 
to heavy synaptic depression (Baufreton and Bevan, 2008). Thus, GABAA-receptor-
mediated transmission in the STN exhibit activity-dependent depression, such that 
even brief period (1–2 s) of high frequency stimulation (50 Hz) heavily reduced IPSC 
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amplitude (Baufreton and Bevan, 2008). The synaptic depression is predicted to be 
enhanced in the absence of dopamine because presynaptic dopamine action reduces 
phasic GABAergic transmission in the STN (Baufreton and Bevan, 2008). The ChR2 
transgenic mouse line will allow us to specifically probe into the activity-dependent 
plasticity of GPe–STN (or predominantly cortical inputs) at HFS and LFS in ex vivo 
recordings. Given the proliferation of GPe–STN transmission may be a maladaptive 
alteration that promotes synchronised, rhythmic neuronal discharge in the STN, 
abolishing this input (through synaptic depression) is predicted to suppress the 
emergence of pathological activity pattern in the STN during DBS. This could in part 
explain recent report demonstrating that HFS of GPe improves motor symptoms in 
PD patients (Vitek et al., 2004) and reduces bursting in the STN and GPi (Vitek et al., 
2012). Therefore, direct high-frequency photoactivation of GPe neurons in the Thy1-
ChR2 transgenic mice should deliver similar beneficial motor outcome. Considering 
the heterogenous effect of STN DBS, it would also be interesting to study the way in 
which STN neurons, under the effect of DBS, integrate beta-band rhythms from the 
GPe. The ChR2 mouse line 18 should enable us to explore this question, by specifically 
stimulating GPe–STN input at low frequency while recording response in the STN 
neurons under electrical HFS of the nucleus. In combination with the use of other 
micro-opsins, viral vectors and transgenic mouse lines, ex vivo and in vivo optogenetic 
approaches will facilitate our search for the most effective mechanisms for correcting 
symptoms in experimental PD.
 The selective role of HCN channels in opposing the impact of GABAergic 
inhibition on STN activity (Chapter 4) suggests that dysregulation of the channel 
function may potentially promote the emergence of abnormal activity patterns. 
Indeed, loss of HCN channels in the parkinsonian GPe pathologically enhances 
burst firing (Chan et al., 2011). Therefore, our research group has probed into the 
possibility of altered HCN channel function in 6-OHDA-lesioned rodents. Although 
preliminary electrophysiological and anatomical data suggest downregulation of HCN 
channel function, a larger number of observations from current and voltage clamp 
recordings did not reveal significant difference from normal animals (unpublished). 
Several reasons might explain the negative results: 1) the magnitude of HCN currents 
varies considerably from one cell to another 2) somatic voltage-clamp recordings 
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might not sufficiently reveal changes in channel function in the dendritic structures of 
STN neurons due to poor space clamp 3) alteration in HCN currents could be masked 
by changes in other overlapping conductances 4) whole-cell patch clamp results in 
intracellular dialysis due to the relatively much larger volume of internal recording 
solution, therefore perturbing the internal ionic and/or messenger components 
important for normal HCN channel function. 
 For more robust characterisation of HCN (dys)regulation in the parkinsonian 
STN, perforated patch clamp technique, which does not involve rupture of the patch 
membrane, could be performed to minimise the dialysis of the cell. HCN currents 
should also be isolated through the use of specific channel blocker such as ZD7288. 
Furthermore, electron microscopic studies (eg. immunogold labelling of HCN subunits) 
will help to define the ultrastructural changes, if any, of the subcellular distribution and 
expression level of HCN channels across the somatodendritic axis of STN neurons. The 
loss of HCN channel function in the STN could potentially represent a novel therapeutic 
target for PD. In that case, restoring normal function of HCN channels, or suppressing 
the enhanced function of low-voltage-gated Cav3 channels (deinactivated by more 
powerful GPe-STN patterning due to reduced opposing HCN currents), is predicted to 
diminish excessive synchronous burst firing in the STN and alleviate motor symptoms 
in PD.
 Considering that HCN channels participate minimally in autonomous firing of 
STN neurons (Bevan and Wilson, 1999; Beurrier et al., 2000; Do and Bean, 2003; 
Baufreton et al., 2005) and that autonomous firing is disrupted in models of PD (Zhu 
et al., 2002a), abnormal STN activity pattern could not be solely due to dysregulation 
of HCN channels. The ionic mechanism(s) responsible for the reduced pacamaking 
in STN neurons is still unknown. One potential candidate is ATP-sensitive potassium 
(KATP) channels. KATP channels are inwardly rectifying potassium channels that are 
inhibited by intracellular ATP (Zeng et al., 2007; Hibino et al., 2010). Their role in 
central neurons is not well understood but they are mainly thought to remain closed 
except under conditions of severe metabolic deprivation to limit cellular excitability. 
In parkinsonism, ATP deficiency due to increased patterning by cortical inputs 
and/or hyperactivity of STN neurons (Mallet et al., 2008b; Wichmann et al., 2011) 
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could therefore hypothetically represent conditions for excessive activation of KATP 
channels, leading to additional K+ efflux and compensatory reduction in excitability. 
Understanding the mechanistic involvement of KATP and/or other ion channels in the 
disruption of autonomous firing in STN neurons may further unravel novel therapeutic 
strategies that target (mal)adaptive changes in the parkinsonian basal ganglia.
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